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Abstract 
Diffusely adhering Escherichia coli (DAEC) is a bacterial pathotype that 
causes enteric and urinary tract infections. DAEC possesses adhesive struc-
ture called fimbriae/afimbriae for adherence to host receptors, which is essen-
tial for the following invasion. The typical class of DAEC including E. coli 
strains harbouring adhesins such as AfaE-I, AfaE-II, AfaE-III and Dr, form 
the fimbriae/afimbriae via a polymeric architectures. AfaE-III recognizes the 
glycophosphatidylinositol (GPI) Canchored protein Decay-Accelerating Factor 
(DAF, CD55) and CEA (CD66e) as receptors. 
The docking complex models of AfaE/CEA and AfaE/DAF have been de-
termined from mutagenesis and NMR-derived restraints. The solution struc-
ture of AafA, which is an AfaE homologue from Enteroaggregative E. coli 
(EAEC) has also been determined by multidimensional NMR techniques. 
The AfaE/CEA complex model reveals that the binding interface on the 
N-CEA is partially overlapped with N-CEA dimerisation interface. It has 
been found that the AfaE adhesin does not bind to a covalently linked N-CEA 
dimer, which is close to its native form. Binding kinetics, mutational analysis 
and spectroscopic examination of CEA dimers suggest that Dr adhesin can 
dissociate CEA dimers prior to the binding of monomeric forms. 
The Afa/DAF complex model implies the AfaE binds to domains CCP2 
3 
and CCP3 of DAF. The recognition of AfaE to DAF is possible to disturb the 
regulation of both classical and alternative passways of complement regulation. 
The solution structure of AafA reveals that it has an Ig-like fold and a very 
similar secondary, tertiary structure to that of AfaE. 
This study examines the solution structure of Afa/Dr adhesin and the 
interaction between its receptors. It also provides a powerful tool for the 
design of novel inhibitory strategies to treat E. coli infections. 
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Chapter 1 
Biological Introduction 
1.1 Bacterial-Prokaryotic World 
Bacteria are prokaryotic single-cell microorganisms with about three billion 
years history on our planet and they were also the only form of life for approx-
imately two billion years. Prokaryotes are found anywhere eukaryotes live, 
and also in some environments which are considered too harsh for eukaryotic 
cells. Therefore, the limit of life on our planet is usually defined by the ex-
istence of prokaryotes. Whilst for the human body, microorganisms do not 
usually reside in the internal tissues such as blood, brain, muscle, etc, the 
constant contact of the surface tissues such as skin and mucous membranes 
with environmental organisms increase the chance of colonisation by various 
microbial species. Bacterial population is about 10 times the number of hu-
man cell in the body of healthy people. However, Escherichia coli is the best 
known bacterium that regularly associates itself with humans, being an invari-
able component of the human intestinal tract E. coli was first described by 
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Theodor Escherich in 1885 as Bacterium coli commune. For many years it was 
considered to be a commensal organism of the large intestine until 1935 when 
a strain of E. coli caused an outbreak of diarrhoea among infants. During 
the last century, a number of medically important E. coli strains were char-
acterised. Partly driven by this interest, this bacterium became a workforce 
in microbial genetics. In 1997, the complete genome sequence of E. coli was 
determined (Blattner et al., 1997). Generally, Escherichia coli can colonise the 
gastrointestinal tract (GIT) of human infants very soon after birth. However, 
it does not cause disease until normal gastrointestinal barriers are destroyed. 
E. coli is a consistent inhabitant of the human intestinal tract. However, it 
comprises no more than 1% of the total bacterial biomass. 
1.2 Pathogenesis of Escherichia coli Strains 
1.2.1 Pat hotypes and Pathogenesis 
Recognition of the most common E. coli serotypes is based on the identifica-
tion of the 0, H and K antigens. Serotype used to be the main criterion to 
distinguish the small number of strains that cause disease. For example, the 
serotype 0157:H7 is uniquely responsible for causing HUS (haemolytic uremic 
syndrome). Nowadays, E. coli subtypes are classified by their unique virulence 
factors, particularly in the case of diarrhoeagenic strains (those that cause di-
arrhoea). Pathogenic enteric E. coli can be divided into at least six groups: 
enterotoxigenic E. coli (ETEC), attaching and effacing enteropathogenic E. 
coli (EPEC), enteroinvasive E. coli, enterohemorrhagic E. coli (EHEC), en- 
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teroaggregative E. coli (EAEC), and diffusely adhering E. coli (DAEC). Ex-
traintestinal Pathogenic E. coli can also lead to urinary tract infections (UTIs) 
and neonatal meningitis. 
E. coli strains have virulence attributes related to different pathogenesis 
mechanisms. These can be classified into several "pathotypes" which lead 
to three general clinical syndromes: enteric/diarrhoeal disease, urinary tract 
infections (UTIs) and sepsis/meningitis. 
1.2.1.1 Enteric Pathogens 
Enteropathogenic E. coli (EPEC): EPEC can cause watery, sometimes 
bloody diarrhoea. They are a leading cause of infantile diarrhoea in develop-
ing countries and areas. The cause of this type of infection was thought to 
be linked to the consumption of contaminated drinking water as well as some 
meat products. EPEC was the first pathotype of E. coli to be described and 
now it is one of the best understood. The first step in EPEC infections is the 
bacterial attachment and propagation on the host cell surface via bundle form-
ing pilus (BFP) which is carried by all EPEC strains. EPEC exhibits a pattern 
of localized adherence (LA) in which bacterial clusters form on the cell surface. 
Furthermore, some strains can form smaller bacterial clusters after long incu-
bation periods and they are called LA-like (LAL). The attaching and effacing 
(A/E) lesion is the key feature of EPEC infections. This is characterised by 
attachment to the apical enterocyte membrane and destruction of the brush 
border microvilli via specific aggregation of actin, which forms a pedestal, at 
the site of adherence. The so-called locus of enterocyte effacement (LEE ) 
not only encodes the ability for inducing A/E lesion, but also the Type III 
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Figure 1.1: Pathogenic schema of diarrhoeagenic E. coli. a). EPEC can destroy 
normal microvillar architecture in bowel enterocytes. 1. Initial adhesion, 2. Protein 
translocation by type III secretion, 3. Pedestal formation. b). EHEC attach and efface 
lesion in colon. Shiga toxin (Stx) participates and can lead to potential life-threatening 
complications. c). ETEC can also adhere to small bowel enterocytes and induce watery 
diarrhoea by the secretion of heat-labile (LT) and/or heat-stable (ST) enterotoxins. d). 
EAEC adheres to both small and large bowel epithelia in a biofilm and can produce 
secretory enterotoxins and cytotoxins. e). EIEC can invade colonic epithelial cell, lyse 
the phagosome and move with nucleating actin microfilaments. f). DAEC elicits a 
signal transduction effect in small bowel enterocytes. Finger-like cellular projections 
can grow and wrap around the bacteria. (Figure adapted from Kaper et al. 2004). 
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secretion system (TTSS) (McDaniel et al., 1995), shown in Figure 1.1a. The 
bacteria inject intimin receptor (Tir) into host cells and insert it into the host 
cell plasma membrane. Tir interacts with intimin on the bacterial surface to 
facilitate the adhesion. There are also several EPEC virulence factors encoded 
outside the LEE, such as lymphostatin (LifA). 
Enterohaemorrhagic E. coli (EHEC): EHEC is mainly found in the 
bovine intestinal tract and in humans can cause bloody diarrhoea (haemor-
rhagic colitis), non-bloody diarrhoea and can progress to the potentially fatal 
haemolytic uremic syndrome (HUS). Infection can arise by intake of under-
cooked meat, lettuce and even apple juice. EHEC contains a type III secretion 
system that injects the translocated intimin receptor (Tir) to the host cells, 
promoting intimate attachment via an interaction with the outer membrane 
protein intimin. In addition, the twin arginine translocation (Tat) system is 
required for the secretion of another EHEC virulence factor, Stx (also called 
verocytotoxin (VT)). (Figure 1.1b) (Karmali, 2004; Pradel et al., 2003). Stx 
has five identical B subunits and a single A subunit, which are responsible for 
binding the holotoxin to the glycolipid globotriaosylceramide (Gb3) on the cell 
surface and terminating protein synthesis, respectively. Stx is produced in the 
colon and enters the kidney via the bloodstream, where it can damage renal 
endothelial cells and block the microvasculature, which can lead ultimately to 
HUS. Stx is also associated with bloody diarrhoea, haemorrhagic colitis, necro-
sis and intestinal perforation due to colon damage. There are many serotypes 
of Stx-producing E. coli, but those that have been clinically associated with 
bloody diarrhoea are designated as EHEC. Of these, 0157:H7 is the prototype 
and most often implicated in illness worldwide. 
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Enterotoxigenic E. coli (ETEC): ETEC is an important cause of di-
arrhoea in infants and travellers in developing countries or regions of poor 
sanitation. It is acquired by ingestion of polluted food and water and adults 
in endemic areas evidently develop immunity. ETEC colonises the surface 
of the small bowel mucosa, expresses enterotoxins and ultimately causes di-
arrhoea. Colonisation is mediated by one or more proteinaceous fimbria or 
fibrillar colonisation factors (CFs). ETEC can be catalogued into two groups: 
the heat-labile enterotoxins (LTs) and the heat-stable enterotoxins (STs) (Fig-
ure 1.1c). ETEC strains may produce one or both of them. Secretion of LT 
via type II secretion system can trigger a series of cellular responses and fi-
nally lead to diarrhoea (Sears and Kaper, 1996). ETEC is one of the most 
common pathogens in developing countries. However, those countries usually 
have lower rates of colon cancer because one of the heat-stable enterotoxins 
suppresses colon cell proliferation (Kaper et al., 2004). ETEC adhesin are 
fimbriae which vary from different species. The symptoms of ETEC infections 
include diarrhoea without fever. 
Enteroaggregative E. coli (EAEC): EAEC is characterised by attach-
ing in an aggregative manner without producing LT and ST. EAEC was also 
thought to be associated with persistent diarrhoea in adults and especially in 
young children. EAEC is able to bind to jejunal, ileal and colonic epithelia 
and cause non-bloody diarrhoea without invading or causing inflammation, 
although mild inflammatory changes are observed in animal models (Kaper 
et al., 2004). For EAEC infections, the first step is the colonisation of the in-
testinal mucosa, mainly the colon, by fimbrial structures known as aggregative 
adherence fimbriae (AAFs), which also belong to the Afa/Dr adhesin family 
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and form thick biofilm (Figure 1.1d). As a second step, plasmid-encoded toxin 
(Pet) is secreted via type V secretion system, which eventually leads to exfoli-
ation of epithelial cells (Navarro-Garcia et al., 2007). Other enterotoxins and 
cytotoxins including Shigella enterotoxin 1 (ShET1) and Enteroaggregative 
Heat-Stable Toxin 1 (EAST1) are also secreted, the mechanism of which are 
still unknown (Kaper et al., 2004; Croxen and Finlay, 2010). EAEC infections 
induce mild but significant mucosal damage. 
Enteroinvasive E. coli (EIEC): In most cases, EIEC induces watery 
diarrhoea but can also cause colitis and dysentery. EIEC share some of the 
virulence properties associated with Shigella dysenteriae. EIEC attaches and 
then invades the colonic enterocytes by endocytosis (Clarke, 2001) followed by 
multiplying within epithelial cells. EIEC has a special outer membrane protein 
rather than a fimbrial adhesin in other strains such as EPEC and DAEC 
(Figure 1.1e). The typical symptoms of EIEC are dysentery-like diarrhoea 
with fever. 
Diffusely Adhering E. coli (DAEC): DAEC is sometimes considered 
as one type of EPEC. More recently, it has been identified as a unique patho-
type, characterised by a pattern of diffusely adherence (DA) to Hep-2 cell 
monolayers. There are two classes of DAEC strains. For one of them, DA 
patterns of DAEC are usually characterised by the presence of afa/dra/daa-
related operons (Figure 1.1f). Afa/Dr DAEC infections usually lead to urinary 
tract infections (UTIs) and enteric infections. The other class of DAEC in-
clude strains that express an adhesin involved in diffuse adherence (AIDA-I), 
which is a potential cause of infantile diarrhoea (Kaper et al., 2004). These 
DAEC strains potentially possess one or more homologues of LEE charac- 
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teristic of EPEC, which may contribute to the pathogenic potential of these 
DAEC strains. As the AfaE adhesin of interest in this study is from DAEC, 
more detailed introduction is given in the Section 1.3. 
1.2.1.2 Urinary Tract Infections 
Uropathogenic E. coli (UPEC): UPEC causes 90% of the urinary tract 
infections (UTIs) in anatomically-normal, unobstructed urinary tracts. These 
bacteria colonise the periurethral area and ascend the urinary tract to the 
bladder. Bladder infections are 14-times more common in females than males 
by virtue of the shortened urethra. Uropathogenic E. coli possesses several 
different virulence traits including type 1, P, S and F1C pili, which are coded 
by the fim, pap, sfa and foc operons, respectively. These different pili recognise 
a broad range of receptors and mediate bacterial adherence to and invasion of 
host cells. UPEC does not possess the type III secretion system common to 
other pathogenic E. coli strains, however it utilises so-called type I and type 
V secretion systems instead (Henderson et al., 2004). The type I secretion 
system releases a toxin called a—hemolysin (HlyA), which is encoded by about 
50 % of UPEC isolates (Marrs et al., 2005). HlyA may be involved in the 
lysis of host cells to enhance the release of nutrients and facilitate bacterial 
growth (Cavalieri et al., 1984). Type V-secreted toxins, such as the vacuolating 
autotransporter toxin (Vat) and the secreted autotransporter toxin (Sat) are 
often produced by UPEC strains. They are characterised by their ability to in-
duce cytopathic effects in target host cells, including vacuolation and swelling. 
UPEC can also secrete other toxins such as cytotoxic necrotizing factor 1 
(CNF1), which affects many eukaryotic cellular functions such as formation of 
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actin tree fibres, induction of membrane ruffling and the modulation of inflam-
matory signalling pathways by activating the Rho family GTPases RhoA, Rac 
and Cdc42 (Etienne-Manneville and Hall, 2002; Wiles et al., 2008). 
1.2.1.3 Neonatal Meningitis 
E. coli strains invade the blood stream of infants from the nasopharynx or 
GI tract and are carried to the meninges. The K-1 antigen is considered the 
major (about 80 %) determinant of virulence among strains of E. coli that 
cause neonatal meningitis. K-1 is a homopolymer of sialic acid. The K-1 
polysialic acid capsule acts as a mimic of the polysialic acid (PSA) chains 
attached to human embryonic and neonatal neural cell adhesion molecules 
(NCAM), which may interfere with normal brain maturation by competing 
with neural PSA for sites on NCAM. A newborn infant can acquire pathogens 
from its mother's flora or from the environment. The bacteria will translocate 
from the intestinal lumen to the bloodstream and then circulate (Bonacorsi 
and Bingen, 2005). The bacterial proteins FimH and OmpA will bind to 
the surface of brain microvascular endothelial cells (BMECs). The following 
bacterial invasion will be facilitated by several invasins including IbeA, IbeB, 
IbeC, As1A, OmpA, type 1 fimbriae (FimH) and also CNF1, as mentioned 
above (Xie et al., 2004). Rearrangement of the actin cytoskeleton plays an 
important role in the invasion of BMECs by E. coli K1. After the bacteria 
traverse the BMECs, they invade the meninges and central nervous system 
(CNS), multiply and induce the release of proinflammatory compounds such 
as chemokines and cytokines, etc. It can ultimately cause higher blood-brain 
barrier permeability and pleocytosis (increase in leukocytes in the spinal fluid). 
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The E. coli K1 invasion of the BMECs ultimately leads to meningitis and 
neuronal injury (Kim, 2003; Xie et al., 2004). 
1.2.2 Pathogenic Escherichia coli Adhesins and Invasins 
Several pathogenic E. coli strains have specific adherence factors that let them 
attach to the host and propagate disease. These adhesins form hair-like ap-
pendages which are known as fimbriae, pili or fibrillae. Normally, fimbriae are 
rods with a 5-10 nm diameter while fibrillae are smaller in diameter (2-4 nm), 
long, curly and flexible. In some other cases, the fimbriae can form either on 
the microbial cell surface, so-called nonpilus adhesins or a collapsed fimbria 
structure, called afimbria (Anderson et al., 2004b). 
The interaction between pathogen and host cell is usually required for ex-
tracellular colonisation or internalisation, which is typically mediated by ad-
hesins on the surface of the microbe. However, both bacteria and host cells are 
negatively charged and repulse each other when they approach (Donnenberg, 
2000). Most pathogenic E. coli forms hair-like appendages called pili or fim-
bria that extend out from the bacterial surface to increase the binding affinity 
for bacterial adhesion. Generally the recognition and binding to host cells 
will trigger several cellular events, which in most cases results in activation 
of innate immune defence or the subversion of cellular processes to facilitate 
bacterial adhesion or invasion (Betis et al., 2003; Servin, 2005). 
Clinical trials have already shown that some vaccine candidates can suc-
cessfully target and block the bacterial attachment to host cells (Langermann 
and Ballou, 2003). Depending on their type, fimbriae are assembled in different 
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ways in bacterial cells. 
Chaperone-Usher Pill Type P (pyelonephritis-associated) fimbriae were 
the first to be identified and now the best characterised. These permit coloni-
sation of the urinary tract up to the kidneys and are thus characteristic of 
uropathogenic E. coli (UPEC), which have also been mentioned above. The P 
pilus is encoded by 11 genes of the pap (papA-papK) gene cluster, which are 
secreted into the periplasm by Sec apparatus. The type P pilus organelle is 
then assembled by the chaperone-usher pathway, which involves two separate 
proteins, namely a periplasmic chaperone and an outer membrane usher. 
The chaperone in the chaperone-usher system interacts with each pilus 
subunit (pilin) after translocation into the periplasm. During this process, the 
chaperone drives the folding of the pilin, which is degraded in the absence 
of the chaperone. The formation of the stable chaperone-pilin complex also 
prevents the formation of premature pilin-pilin interactions in the periplasm 
(Kuehn et al., 1991, 1993). The usher protein exists as a dimer in which two 
pores are formed in the outer membrane, however, only one usher pore is used 
at a time for secretion, whilst the other pore remains in its closed form. Based 
on the earlier structural studies, each pore comprises a channel 45 A x 25 A 
in diameter which is large enough to let an intact pilin pass through (Remaut 
et al., 2008). For secretion, chaperone-pilin complexes are recruited by the 
N-terminal domain of one usher subunit and directed towards a base of the 
growing pilus. The recruitment of the incoming pilin also dissociates the N-
terminal domain of the other usher subunit, making it available for recruitment 
of the next chaperone-pilin complex. The N-termini of twin pore usher protein 
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work like two arms that alternate in the recruitment of chaperone-pilin com-
plexes for secretion in a stepwise manner. The pilus grows through the usher 
pore as a linear fibre (Figure 1.2) (Saulino et al., 2000; Thanassi et al., 1998; 
Remaut et al., 2008). 
The chaperone-usher system of organelle assembly is found in the fim sys-
tem of type 1 pilus (Hull et al., 1981; Saulino et al., 2000) and many other 
bacterial pili (Zav'yalov et al., 2009), including the Afa/Dr family of adhesins, 
which are detailed in this study (Details are described in the Section 1.3.1.3 
on Page 42). 
Retractile Type IV Pili Many Gram-negative bacteria such as EPEC, 
Salmonella, Neisseria gonorrhoeae and Neisseria meningitides, express Type 
IV Pili as polymeric adhesive surface structures (Craig et al., 2004). Type 
IV Pili are essentially composed of a homopolymer of a single pilin subunit 
capped at the tip with a different adhesive subunit. Many accessory molecules 
including prepilin peptidases, putative nucleotide binding protein, prepilin-like 
proteins, cytoplasmic membrane proteins, and outer membrane proteins are 
required for biogenesis. Type IV pili are formed at the cytoplasmic membrane 
rather than in the extracellular space compared with type 1 and P pili. The 
intact organelle is then extruded across the outer membrane. Once the pilus 
tip recognises and binds to the target surface, the bacterial cell retracts the 
pilus through the cell wall to pull it towards the target cell. Type IV pili are 
also involved in bacterial adhesion to host cells (Tobe and Sasakawa, 2002). 
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Figure 1.2: Biogenesis of Type 1 pili. a) Cryo-electron microscopy structure (left 
panel)and schematic representation (right panel) of protein complex responsible for 
Type 1 pili biogenesis. The two usher subunits are labelled usher 1 and usher 2, with 
N-terminal domains labelled N1 and N2, respectively. The grey box in left panel shows 
that the chaperone-pilus subunit (FimC—FimA) complex is positioned by N-terminal 
domain of usher 2 in a way that the N-terminus of the subunit (FimA) is proximal to 
the hydrophobic grove of the previously assembled subunit for donor strand exchange. 
Right panel also shows two possible positions of the plug domain. b) Usher protein 
mediated pili assembly. The chaperone-subunit complex (FimC—FimnA) is first recruited 
by N2 (step 1). The donor strand exchange of the newly recruited pilus subunit FiniA 
with FimF will trigger dissociation of chaperone FimC1  and N1 (step 2 and 3). The 
dissociated N1 will recruit another chaperone—usher complex (step 4) to assemble the 
pili (step 5), which is followed by dissociation of N2 (step 6), forming a complete circle 
for pili assembly. Figure adapted from Waksman and Hultgren 2009. 
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Pili in Gram-positive Bacteria The discovery of pili in Gram-positive 
bacteria was many years later than in Gram-negative bacteria. The mechanism 
of Gram-positive pili's assembly was unveiled in 2004. In the Corynebacterium 
diphtheria, pili are composed of three subunits: SpaA, SpaB and SpaC. All 
these three subunits are synthesised in the cytoplasm and translocated across 
the membrane by the Sec machinery. Assembly of pili in gram-positive bac-
teria is completely different from that in Gram-negative bacteria. However, 
the architecture is quite similar as SpaA forms the major component of the 
pilus shaft, which is capped by SpaC. SpaB is spaced at regular intervals along 
the shaft. Similar export of pilin subunits has been found in other pathogenic 
species such as Clostridium perfringens and Actinomyces naeslundii (Lauer 
et al., 2005). However, in Ruminococcus albus, the pilus subunit shows similar-
ity to that of Gram-negative type IV pili both morphologically and genetically. 
As in Gram-negative pathogens, Gram-positive pili seem to play an important 
role in the adhesion of bacteria to host surfaces (Mandlik et al., 2008). 
Non-organelle Adhesins Some adhesins from the autotransporter family 
and intimin utilise a single outer membrane protein rather than organelles 
such as pili as adhesive structure. For example, antigen 43 (Ag43), AIDA-I 
and TibA are three E. coli adhesins belonging to a subclass of bacterial au-
totransporters that use the type V secretion system (Henderson and Nataro, 
2001). The protein itself is sufficient for directing its transport across the 
host membrane. These proteins consist of two subunits, a passenger domain 
and a /3-domain. An N-terminal leader sequence is cleaved when the protein 
is secreted into periplasmic space. The 0-domain forms a pore in the outer 
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membrane and the passenger domain then passes through the 0-domain tran-
locating itself across the outer membrane (Le Bouguenec, 2005). 
Both ligand and receptor are produced by EPEC and EHEC En-
teropathogenic and enterohemorrhagic E. coli possess an extra adhesion sys-
tem in addition to pili and fimbria by providing both the ligand and the re-
ceptor. EPEC and EHEC produce outer membrane adhesins called intimin a 
and 7 respectively, which mediate bacterial attachment to intestinal host cells 
and effacement of intestinal microvilli, called "attaching and effacing" (A/E) 
(Jerse et al., 1990; Oswald et al., 2000). All intimins possess an N-terminal 
periplasmic tail, a conserved transmembrane domain and a non-conserved C-
terminal extracellular domain that interacts with receptors on the cell surface. 
All intimins found thus far bind to Tir (Translocated intimin receptor), which 
is also produced by bacteria and fixed into the membrane of the host cell 
through the type III secretion system. The interaction between intimin and 
Tir triggers actin condensation and facilitates attachment to the cytoskeleton 
of the host cell (Kenny et al., 1997; Touze et al., 2004). 
1.2.3 Invasion Strategies 
The extracellular space is normally a harsh environment for pathogens due 
to the physiological conditions and activities. Bacteria have thus developed 
strategies to invade the host cells. This can be done via two different mech-
anisms: a) direct translocation of bacterial proteins into the host-cell cytosol 
that promote rearrangements of the plasma membrane architecture, inducing 
pathogen engulfment and b) using intracellular compartments for persistence 
35 
in target tissues. 
Integrin Engagement Some bacteria can bind to integrins or cadherins to 
induce signalling and drive themselves across cell membranes via interactions 
with the actin cytoskeleton. Several pathogens seem to interact with host-cell 
receptors, particularly with a5 /31 integrin and trigger actin cytoskeleton rear-
rangements that can lead to cellular invasion. The first bacterial invasion pro-
tein was described as invasin, a surface protein of Y. enterocolitica and Y pseu-
dotuberculosis (Isberg et al., 1987). Invasin can tightly bind to several members 
of the /31 chain integrin family (Isberg and Leong, 1990). Although the short 
cytoplasmic tail of integrins is not involved in enzymatic activity directly, it in-
teracts with components that act as linkage of cytoskeletal-associated elements 
(Kaper et al., 2004). 
Pili-mediated Invasion Type 1 pilus is the adhesive structure of UPEC 
which can colonise the urinary tract. The main receptor for FimH adhesin 
in bladder epithelial cells is part of the tetraspanin molecule uroplakin la 
(UP1a) (Zhou et al., 2001). UP1a together with three other uroplakin proteins 
normally form plaques which covers the entire luminal surface of the bladder 
epithelium, providing an impermeable shield. It has been hypothesised that 
the highly dynamic physiological endocytosis of the UP1a-containing plaques 
is hijacked by UPEC to produce invasion. Previous study shows that the 
interaction between FimH and bladder cells triggers a signalling cascade which 
eventually leads to the bacterial invasion (Martinez and Hultgren, 2002). 
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Shigella and Salmonella: Type III Secretion Systems Shigella spp. 
and Salmonella spp. were considered different species due to their charac-
teristic associated diseases, as they cause acute gastroenteritis or systemic 
typhoid fever and dysentery, respectively. However, modern molecular biology 
has proved that these microorganisms belong to the same bacterial cluster as 
E. coli, having genes that enable them to invade and colonise target cells in 
the similar ways (Parsot, 2005). Both Shigella and Salmonella employ a type 
III secretion system (TTSS). In Shigella, more than 20 effectors have been 
reported being secreted by the TTSS into host cells after initial attachment. 
Protein IpaB and IpaD bind at the tip of the TTSS and trigger a signalling 
cascade within host cells. IpaB and IpaC insert themselves into the host cell 
membrane and from a pore which induces injection other proteins into the host 
cell and actin polymerisation, subsequently leading to the entry of bacterium 
(Sansonetti, 2001). In Salmonella, a similar mechanism has also been found for 
the effectors SipB and SipC, whilst SipA helps to maintain the formed actin 
polymer by inhibiting the actin depolymerising (McGhie et al., 2004). 
1.3 Diffusely Adherent E. coli (DAEC) 
DAEC was characterised when Scaletsky et al observed that EPEC could at-
tach to HeLa cells with two distinct patterns, termed localised adherence (LA) 
and diffuse adherence (DA) (Scaletsky et al., 1984). Since then, there have 
been several factors found associated with diffuse adherence in E. coli. The 
first of these to be characterised was AIDA-I from EPEC strain 2787 which 
causes infant diarrhoea. AIDA-1 was shown to be sufficient for diffuse adher- 
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ence in strain 2787 (Benz and Schmidt, 1990). A second adhesive structure 
(F1845 fimbriae) was identified in E. coli strains C1845, which had been iso-
lated from a child with persistent diarrhoea (Bilge et al., 1989). 
Initially, the identification of DAEC was purely dependent upon its diffuse 
pattern of adherence to epithelial cell lines (Scaletsky et al., 1984). This as-
say is generally used to identify whether a patient has an enteropathogenic 
infection. DAEC was then identified by the presence of daaC, however, it did 
not identify all strains of DAEC (Bilge et al., 1989). Later PCR primers were 
developed to encompass DAEC harbouring the genes for all of the members of 
a family of adhesins, the Afa/Dr adhesins (Le Bouguenec et al., 2001). Still, 
the nature of these primers relies on the assumption that all DAEC express at 
least one member of this adhesin family. 
1.3.1 Afa/Dr Adhesins 
1.3.1.1 Gene Organisation 
One class of DAEC harbours Afa/Dr adhesins (Afa/Dr DAEC) and are present 
in up to 50% of isolates from children with protracted diarrhoea and 25%-50% 
of cystitis isolates. These E. coli adhesins form polymeric structures termed 
fimbria and afimbria on the outer membrane and are encoded by afa gene 
clusters (afas) and afa/dra/daa-related operons in most cases. They are ex-
pressed by uropathogenic and diarrhoea-associated E. coli strains. The afa-1 
operon was the first determinant to be identified that encodes an adhesin not 
associated with visible fimbriae on the bacterial surface. Various operons with 
very similar genetic organisation and sequence similarity have been found sub- 
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Figure 1.3: Schematic of the genetic organisation and function of each gene of 
afa/dra/daa-related operons. 
sequently in strains that cause both intestinal and extra-intestinal infections. 
All of these operons share a similar genetic organisation as shown in Figure 
1.3. 
Afa-I involves six genes, afaA, afaB, afaC, afaD and afaE that belong to 
the same transcription unit, while afaF forms a distinct transcriptional unit 
(Garcia et al., 1996; Le Bouguenec et al., 1993). The four genes from A to D 
encode accessory proteins that are highly conserved among the whole family 
while gene E, which encodes the adhesin, is more divergent, leading to the 
production of antigenically distinct adhesins. The proteins encoded by afaA 
and afaF have high sequence similarity to the proteins PapB and PapI, re-
spectively. PapB and PapI are responsible for the regulation of expression of 
the P-pilus on the surface of E. coli. The afa family of gene clusters exists 
in both uropathogenic and diarrhoeal E. coli (Labigne-Roussel et al., 1984; 
Le Bouguenec et al., 1993; Zhang et al., 1997). Other related operons such as 
dra, nfa operons from UPEC (Ahrens et al., 1993; Nowicki et al., 1987; Pham 
et al., 1997) and the daa operon from diarrhoeagenic strains have also been 
reported. The gene subtypes afaEl, afaE2, afaE3 (and draE, which is only 
three residues different from afaE3), afaE5, dra, drat, daa and nfa encode ad-
hesins designated as afa/Dr adhesins (Le Bouguenec et al., 2001; Servin, 2005), 
as shown in Table 1.1. These adhesins are reported to recognise the Cromer 
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Table 1.1: Adhesins encoded by afa/dra/daa-related gene clusters 
Adhesin 
Subtype 
Operon Host Pathogenicity Morphology Identified cellular 
receptor 
AfaE-I afa-1 Human D,UTI A/F DAF 
AfaE-II afa-2 Human D,UTI A DAF 
AfaE-III afa-3 Human D,UTI A DAF, 	CEACAM1, 
CEA, CEACAM6 
AfaE-V afa-5 Human D,UTI A DAF 
AfaE-VII afa-7 Bovine - A Unknown 
AfaE-VIII afa-8 Animal, 
Human 
- A Unknown 
Dr dra Human UTI F DAF, 	CEACAM1, 
CEA, 	CEACAM6, 
Collagen 
Dr-II drat Human UTI A DAF 
F1845 daa Human D,UTI F DAF, 	CEACAM1, 
CEA, CEACAM6 
Nfa-I nfa-1 Human UTI A DAF, CEA 
D: diarrhea; UTI: Urinary Tract Infections; A: afimbrial; F: fimbrial; DAF: Decay-Accelerating Factor; 
CEACAM: Carcinoembryonic antigen-related molecule. 
blood group antigen Dr on the human decay-accelerating factor (DAF, CD55) 
as a receptor, a characteristic that enable the bacteria to promote agglutina-
tion of human erythrocytes even in the presence of mannose (a property known 
as "mannose-resistance of hemagglutination"). The afaEl, afaE3 and afaE5 
subtypes are statistically more prevalent than the afaE2 and daa subtypes 
in diarrhoeagenic strains. The distribution of afaE subtypes in afa-positive 
isolates from patients with pyelonephritis may differ in different parts of the 
world (Ishitoya et al., 2003). 
1.3.1.2 Gene regulation and expression of afa/Dr gene cluster 
The transcriptional regulation of one of the Afa/Dr fimbriae, F1845 has been 
studied in detail. F1845 fimbriae are expressed from the daa operon. The 
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operon is under control of two genes; daaA (afaA equivalent) and daaF (afaF 
equivalent), which is situated upstream and on the opposite direction to the 
rest of the operon. Lrp (Leucine-responsive regulatory protein) recognition 
sequences are found close to promoters implying that like the pap operon, the 
daa operon is under the transcriptional control of Lrp (Bilge et al., 1993). 
As in the case of other genes modulated by Lrp, daa promoter sequences 
are proximal to Lrp recognition sites which contain two GATC methylation 
sequences. The methylation pattern of these two regions renders the expression 
on or off. Lrp acts to differentially protect the regions from methylation by 
Dam (van der Woude and Low, 1994). 
The expression of F1845 and P-pili was also shown to be under the control 
of H-NS (White-Ziegler et al., 2000). H-NS appears to be the key regulator of 
expression of the fimbriae 1 response to environmental factors, such as sensi-
tivity to temperature, osmolarity, rich media, casamino acids and growth on 
solid media. daa transcription has been shown to be dependent on the CAP 
(Catabolite gene activation protein) complex (Bilge et al., 1993; White-Ziegler 
et al., 2000). 
The translation and processing of daaA-E mRNA, which is transcribed 
in one unit, has also been studied. The daaE ORF is cleaved from the rest 
of the transcript to allow differential expression. This process involves the 
translation in cis of an open reading frame that is found in between the daaD 
and daaE ORFs (Loomis and Moseley, 1998). It seems that this occurs during 
translation of the DaaP peptide, which interacts with the ribosome via the 
sequence GPP (Loomis et al., 2001). The cleavage of the mRNA is thought to 
involve a putative DEAH-box (Asp-Glu-Ala-His) RNA helicase, HrpA (Koo 
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et al., 2004). 
1.3.1.3 Assembly Components 
Homology searches of proteins encoded by the afa-3 operon reveal interesting 
insights into the method of assembly of the Afa/Dr adhesion complexes. The 
C protein has 27% identity to PapC, both outer membrane usher proteins 
involved in the translocation of adhesive pili to the cell surface. The B protein 
has 31% identity to PapD. These proteins are periplasmic chaperones and 
play key roles in the assembly of the same pili. AfaC and AfaB are therefore 
designated the usher and the chaperone respectively (Garcia et al., 1994). 
Adhesive structures on the surface of bacteria can be classified by the 
method in which they assemble on the surface of E. coli. The presence of 
the chaperone and usher protein means that the Afa/Dr adhesion complexes 
can be classified into the chaperone-usher family. However, although afaB 
and afaC share high sequence similarity with fimbrial chaperones and ushers, 
antigenically distinct adhesins are produced due to the highly heterogeneous 
afaE gene. Anderson et al. have shown that AfaE can form a fimbria structure 
on the bacterial surface, which is prone to collapsing onto the bacterial sur-
face and thus being observed as afimbria (Figure 1.4) (Anderson et al., 2004b; 
Garcia et al., 1996). 
Strategies for obtaining monomeric adhesins have been designed based 
on previous studies on the FimC-FimH chaperone-adhesin complex (Barn-
hart et al., 2000; Sauer et al., 1999, 2000a). The pilin (pilus subunit) has 
an incomplete immunoglobulin-like (Ig-like) fold, which lacks a C-terminal /3-
strand. A groove produced because of the absence of this strand exposes the 
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Figure 1.4: Comparison of fimbria structure and afimbria structure. 
hydrophobic core. The chaperone consists of two Ig domains (Sauer et al., 
1999), stabilises the pilin by inserting its G1 strand to the hydrophobic groove 
of the subunit, which complete the Ig fold. This process is called donor strand 
complementation (DSC) (Sauer et al., 2004). Each pilin possesses an unstruc-
tured N-terminal extension except the tip subunit. During the construction 
of the entire pilus, this flexible N-terminal extension binds to the groove of 
its adjacent subunit, displacing the chaperone via the so-called "zip in, zip 
out" mechanism and completing the Ig fold (Remaut et al., 2006; Waksman 
and Hultgren, 2009) . This process is termed as donor strand exchange (DSE) 
(Remaut et al., 2006) and the inserted N-terminal strand is antiparallel to the 
strand F of the complemented subunit and thus, a canonical Ig fold is recon-
stituted. DSE occurs at the outer membrane usher where polymerisation of 
adhesin subunits takes place (Remaut et al., 2006). 
This similarity between chaperones encoded by afa-3 and dra operons and 
organdies from other bacteria, suggest that DSC/DSE is employed in assem-
bly of the Afa/Dr family adhesins and this was confirmed by Anderson et al 
(Anderson et al., 2004b). In this study the first 16 N-terminal amino acids 
were removed and inserted at the C terminus to construct "donor strand corn- 
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Figure 1.5: Topology diagrams of Dr family adhesin polymers. A) AfaE-III oligomer. 
B) AfaE-dsc. C)Gel Filtration profile of AfaE (red) and AfaE-dsc (green) confirms 
that AfaE-dsc construct is a monomer. (Figure adapted from Anderson et al. (2004b); 
Remaut et al. (2008)) 
plemented" AfaE-III (Anderson et al., 2004b), referred to as AfaE-dsc in this 
study (Figure 1.5). All the AfaE used in this study is AfaE-dsc. 
Gel filtration chromatography shows a monomeric 17 kDa protein for AfaE-
dsc rather than four overlapped peaks (corresponding to monomer, dimer, 
trimer and tetramer) for WT-AfaE. NMR resonance linewidths in solution 
are inversely proportional to the T2 relaxation time, which decreases with in-
creasing molecular size and tumbling time, a measure of which is the molecular 
correlation time, re. An NMR experiment was also carried out giving dramatic 
improvements in the linewidths compared with wild type AfaE, indicating the 
formation of a monomer (Anderson et al., 2004b). 
Pathogenic E. soli that expresses afa operons can commonly lead to per- 
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(a) 
fa E 
Usher Protein 
Figure 1.6: Afa/Dr family pili architecture. (a) Electron micrograph of fimbrial 
Dr adhesins with a diameter about 2rim across. (b) and (c) are surface and cartoon 
representations of Dr Adhesin, respectively. For Afa-HI, subunit D (invasin, coloured 
in red) caps the subunit E (adhesin, coloured in teal, green and wheat). Donor Strand 
Complementation has been shown by using the same colour as the main subunit. (the 
usher protein, subunit C, is based on the PapC structure.) Electron microscopy picture 
adapted from Anderson et al. 2004b; Remaut et al. 2008) 
sistent diarrhoea and some extra-intestinal infections. The binding of the 
afa-expressing bacteria to epithelial cells is complicated and at least two Afa 
products, AfaD and AfaE are involved in this process. The AfaD subunit of 
the Afa adhesive sheath acts as an invasin. The adhesin is connected to a trun-
cated pilin subunit via the DSE mechanism. The AfaD invasin is presented 
at the tip of the structure, capping the growing fibre. This is shown in Figure 
1.6. 
Generally, microbial pathogens develop molecular interactions with host 
cell surfaces to enable extracellular colonisation and in some cases internali-
sation. In this case, AfaD and AfaE are responsible for the recognition and 
binding of specific host receptor molecules. 
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Figure 1.7: Zipper-like internalisation process. A).Microvillus-like extensions extend 
from the cell surface and are associated with bacteria. (B) Fused extensions forming a 
zipper-like structure. (C) Enlarged extension forming a zipper-like structure. 
1.3.2 Internalisation of Afa/Dr DAEC 
Adhesion of pathogenic Escherichia coli to host cells is the first step in coloni-
sation. afa/dra/daa operons were the first examples of single operons which 
are sufficient to promote both adhesion to host cells and invasion. 
For the afa-3 operon, an earlier study suggests that AfaE-III is required 
for adhesion and an AfaD-negative mutant exhibited a diffuse adherence pat-
tern similar to that of the wild-type strain. The adhesion was the first step 
of internalisation and leads to the elongation of the microvillar extension of 
epithelial cells. The microvilli then wrap around the bacteria, which is fol-
lowed by a zipper-like internalisation process — the host eel forms a vacuole 
and then engulfs the bacterium (Figure 1.7) (Kansan et al., 2004). Since the 
AfaE-negative mutant is unable to enter HeLa cells and AfaD concentration 
is important for the invasion process, the AfaD subunit is suggested to be an 
invasin (Jouve et al., 1997). However, the exact process of Afa/Dr internalisa-
tion is still unknown. The most recent study not only shows that the absence 
of AfaD or DraD subunits has no effect in the cell association and entry of 
bacteria, but also that AfaE-III or DraE adhesin subunits are necessary and 
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sufficient to promote the receptor-mediated bacterial internalisation into ep-
ithelial cells expressing human decay-accelerating factor (DAF), CEACAM1, 
CEA or CEACAM6 (Guignot et al., 2009). 
1.4 Receptors for Afa/Dr adhesins 
The Afa/Dr family of adhesins recognise the glycophosphatidylinositol (GPI)-
anchored proteins Decay-Accelerating Factor (DAF, CD55), the carcinoem-
bryonic antigen (CEA, CD66e) and type IV collagen as receptors. 
1.4.1 Type IV collagen 
About 90 % of urinary tract infections are caused by E. coli (Zhang and Fox-
man, 2003). Type IV collagen binding capacity is important for Urinary Tract 
Infections (UTIs) caused by Afa/Dr DAEC, as persistent mesangial deposits 
are formed in the kidney. Previous studies have shown that type IV colla-
gen binding mediated by the DraE adhesin can lead to the development of 
persistent renal infection (Selvarangan et al., 2004). Dr adhesin is the only 
member of the Afa/DrDAF family that recognise type-IV collagen (Wester-
lund et al., 1989). However, the role of the type IV collagen binding capacity 
in Afa/Dr DAEC-induced intestinal pathogenicity is uncertain. No type IV 
collagen has been found at the apical domain of polarised epithelial cells, where 
Afa/Dr DAEC colonise. Type IV collagen interacts with integrins expressed 
at the basal domain of polarised cells, to form a link between the basement 
membrane and epithelial cells (Beaulieu, 1999; Louvard et al., 1992). 
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Figure 1.8: Domain organisation of DAF. Four complement control protein (CCP) 
domains are GPI-anchored to membrane via a S/T rich domain. 
1.4.2 Decay Accelerating Factor (DAF) 
The complement system is an important part of the innate immune system. 
It is a biochemical cascade of proteins that helps to clear pathogens from an 
organism. It can be activated via three biochemical pathways: the classical 
complement pathway, the alternate complement pathway and the mannose-
binding lectin pathway. The complement system is regulated by complement-
regulating proteins (CRPs). DAF is a CRP and it plays a central role in 
preventing the amplification of the complement cascade on host cell surfaces 
(Servin, 2005). DAF consists of four complement control protein (CCP) do-
mains; each of them having 60 residues folded into a characteristic /3-strand 
structure that is connected via disulfide bridges. These four domains are GPI-
anchored to the cell membrane via a serine/threonine-rich region (Figure 1.8). 
Removal of CCP1 does riot affect DAF function, however, individual dele-
tion of CCP2, CCP3 and CCP4 completely abolishes DAF function (Brodbeck 
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et al., 1996). DAF acts as a receptor for all the human Afa/Dr adhesins, which 
recognise CCP3. The point mutation S165 to leucine in the CCP3 domain com-
pletely abolishes adhesin binding to DAF (Nowicki et al., 1993). It is possible 
that leucine sterically hinders the binding of Dr adhesin. In addition, residue 
S155 has been shown by mutagenesis to be a key amino acid residue interact-
ing with the Afa/Dr adhesin (Hasan et al., 2002). Residues G159, Y160 and 
L162 also help bind to Dr adhesins. Previous studies showed AfaE binds to 
CCP2 and CCP3, however CCP3 contributes most to the free energy of bind-
ing (Nowicki et al., 1988). The binding region for afaE and the complement 
pathway convertases lie in close proximity to each other on DAF, suggesting 
that binding of Afa/Dr adhesins might interfere with the complement regula-
tory function of DAF, leading to immunopathological lesions (Servin, 2005). 
The DAF binding site on AfaE-III has been identified via NMR chemical shift 
mapping and line-width analysis of backbone amides (Anderson et al., 2004b). 
There are only three residues-N52D, M88T and T111I-different between AfaE-
III and DraE. The following residues on DraE have been identified by mutage-
nesis to be important for DAF binding: P40, P43, R86, 185, T88, 1111, G113 
and Y115, as shown in Figure 1.9 (Korotkova et al., 2006b). These data have 
also been used for the docking of AfaE-DAF interaction in this study. 
1.4.3 CEACAMs 
1.4.3.1 Introduction 
CEA (CEACAM5) was the first protein in the CEACAM (Carcinoembryonic 
antigen-related cell adhesion molecules) family described as the tumour associ- 
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Figure 1.9: Solution structure of AfaE. Residues determined by NMR that are im-
portant for binding to DAF (P40, P43, 185, R86, T88,11 G113 and Y115) have been 
labelled purple. 
ated antigen carcinoembryonic antigen in human colon cancer tissue extracts 
(Gold and Freedman, 1965). CEA was considered as an oncofoetal antigen 
at that time while it is actually also expressed in normal adult tissue. The 
CEACAM family is a group of highly glycosylated homotypic/heterotypic cell 
surface intracellular adhesion molecules. CEACAM1 is the most highly con-
served member of the CEA family. 
Currently, seven members of this family have been found in humans: CEA-
CAM1 (biliary glycoprotein, CD66a), CEACAM3 (CEA gene family member 
1 [CGM1], CD66d), CEACAM4 (CGM7), CEA (carcinoembryonic antigen, 
CD66e), CEACAM6 (nonspecific cross-reacting antigen, CD66c), CEACAM7 
(CGM2) and CEACAM8 (CGM6, CD66b). There are also several CEACAMs 
found in mouse and rat, such as CEACAM2, CEACAM9 and CEACAM10. 
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Figure 1.10: Sequence alignment of the N-terminii of CEACAMs families. CEACAMs 
family proteins are proteins sharing a high primary, secondary structure similarity. 
CEA, CEACAM6, CEACAM7 and CEACAM8 have a GPI anchor while CEA-
CAM1, CEACAM3 and CEACAM4 insert into the cellular membrane via a 
C-terminal transmembrane domain. 
The CEACAM family belongs to the immunoglobulin superfamily (IgSF) 
of adhesion molecules and possesses a single conserved N-terminal Ig vari-
able (Igv)-like domain (Figure 1.10), in which the intra-chain disulfide bond 
is replaced by a salt bridge. The N-terminal domain is followed by up to 6 Ig 
constant (Igc)-like domains, as shown in Figure 1.11. The molecules are exten-
sively glycosylated on asparagine residues, mostly by multiantennary complex 
type carbohydrate chains (Yamashita et al., 1989, 1987). The carbohydrate 
content may constitute up to 50% of the total mass. 
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Figure 1.11: Models of the molecules in the CEACAM family (human) based on their 
cDNA structure. They all have an N-terminal domain followed by 0-6 IgC-like domains 
(either subunit A or B). CEACAM1,3 and 4 have a cytoplasmic transmembrane domain 
while CEACAM5,6,7 and 8 are GPI-anchored to the cell membrane. Asparagines are 
extensively glycosylated as shown as the black dots in the figure. 
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CEA develops during the early foetal period in columnar epithelial cells 
and goblet cells within the colon, mucous neck cells and pyloric mucous cells 
within the stomach, squamous epithelial cells of the tongue, oesophagus and 
cervix, in secretory epithelia and duct cells of sweat glands and epithelial 
cells of the prostate (Hammarstrom, 1999). Normally a healthy adult can 
produce approximately 50-70 mg each day (Kinugasa et al., 1994). CEA family 
members can exist as dimers in the plasma membrane of eukaryotic cells and 
are used as a key tumour marker. 
Cell adhesion In vitro studies reveal that CEA can act as homophilic (in-
teract with CEA) and heterophilic (interact with other proteins from the CEA-
CAM family) cell adhesion molecules when expressed on the tumour cell sur-
face (Oikawa et al., 1992; Zhou et al., 1993a). The N-domain is directly in-
volved in the cell adhesion, especially residues on the GFCC'C" face and on 
the CC' loop of this domain. Watt et al. (2001) have found that residues V39 
and D40 play critical roles in homophilic adhesion using the alanine-scanning 
mutagenesis approach (Watt et al., 2001). Residues in the lower region of the 
GFCC'C" face, which are closely associated with V39 and D40 and positioned 
in the molecular model, especially R38, Q44, T87 and Y34, failed to abrogate 
adhesion when mutated individually. Similar behaviour is found for residues 
191, V96 and E98, at the top of the GFCC'C" face and on the ABED face. 
Microbial Receptors CEA-related surface protein act as receptors for both 
bacteria and viruses. Fimbrial proteins of several strains of E. coli and Salmonella 
bind to D-mannosyl residues on CEA (Leusch et al., 1991). CEACAMs bind to 
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Neisseria gonorrhoeae and Neisseria meningitidis via a different mode, util-
ising the N-terminal Ig domains of human CEACAM1 and CEACAM3 and 
binding to the virulence-associated Opa protein. CEACAMs can also act as 
virus receptors, for example the mouse hepatitis virus (MHV) uses mouse 
CEACAM1. 
Innate Immunity CEA plays a possible role in the innate immune defence, 
protecting the colon from microbial attack and perhaps other areas like the 
upper alimentary tract, the bladder and the skin (sweat glands). Human CEA 
has been shown to bind and trap microorganisms, stopping them from reaching 
the microvilli of epithelial cells and invading them (Hammarstrom, 1999). 
Signalling CEACAM1 and CEACAM3 have long cytoplasmic tails contain-
ing ITIM and ITAM motifs, respectively (Kuespert et al., 2006). The mem-
brane proximal tyrosine residue in this motif of rat CEACAM1 was found to be 
phosphorylated by c-Src, Lyn and Hck in granulocytes and by c-Scr in epithe-
lial cells. Protein tyrosine kinase and protein tyrosine phosphatases are bound 
on phosphorylation of ITAMs and ITIMs respectively, leading to stimulation 
and termination of signalling, respectively. OpaCEA-mediated stimulation can 
activate small GTPases Racl and Cdc42 (Billker et al., 2002) and downregu-
late tyrosine phosphatase SHP-1 (Hauck et al., 1999). However, more studies 
are necessary to characterise their signalling role. 
Previously studies have shown that CEA-related molecules are recruited 
around adhering bacteria in enterocyte-like Caco-2 cells (Guignot et al., 2000b). 
In the same study, an anti-CD66 antibody was also used in an inhibition assay 
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Figure 1.12: Ribbon representation of N-CEA. Red residues are L18, L20 on B Strand 
of ABED face and T39 residues on CC' loop. Hydrophobic residues are coloured in grey. 
Positive residues are coloured in blue while negative ones are coloured in salmon. No 
cysteines are present in N-CEA. Aromatic residues are coloured in pink. Polar residues 
are coloured in teal. 
which shows that one or more CEA-related molecules function as receptors for 
Afa/Dr DAEC adhesins. Berger et al. demonstrated that only the Afa/Dr-I 
subfamily, which includes Dr, F1845 and AfaE-III adhesins, recognise CEA, 
CEACAM1 and CEACAM6 (Berger et al., 2004). 
1.4.3.2 Hoinophilic and Heterophilic Interaction of CEA 
For structural studies the structure of the N-terminal domain of CEACAM5 
(N-CEA) was assumed to be highly similar to that for N-terminal domain of 
murine CEACAM1 (Tan et al., 2002), shown in Figure 1.12. 
In terms of CEACAM1, a previous study has shown that mutation of valine 
39 to alanine on the CC' loop abolishes binding ability of CEACAM1-3-Fe to 
CHO-CEACAM1-4L transfectants. Mutation of serine 32 to alanine decreases 
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the binding ability while mutating tyrosine 34 (Y34A) does not affect binding. 
The accumulation of three mutations (S32A, Y34A and V39A) completely 
abolishes homophilic interactions. Residues V39 and D40 on CC' loop can 
also affect binding, however, residues around V39 and D40, including R38, 
Y34, Q44 and T87 at the lower region of the GFCC'C" face and 191, V96 and 
E98 at the top of the GFCC'C" face do not abrogate adhesion. Furthermore, 
mutations at position 28 and 39 increases the affinity for AfaE (Korotkova 
et al., 2006b). 
Previously studies have shown that residues Y34, V39, D40, R43 and Q44, 
are involved in the formation of the physiological dimer. Indeed, N-CEA mu-
tants S32N, V39A and E99A which showed decreased homophilic interaction, 
bind to DraE with affinities similar to wild type N-CEA (Korotkova et al., 
2006b). Therefore, the mutagenesis data and structural analysis suggest that 
DraE can recognise both CEA monomers and dimers as binding partners. 
Residues on CEA responsible for hetero- and homo-interaction have been char-
acterised recently (Korotkova et al., 2008b) (Figure 1.13). 
1.5 Mechanisms of Pathogenicity 
1.5.1 Internalisation 
Afa/Dr DAEC strains enter epithelial cells by a zipper-like mechanism and 
then replicate within. These E. coli strains show enhanced resistance to innate 
and adaptive immune defence response (Mulvey, 2002). 
After Afa/Dr DAEC recognises CEA or DAF, the GPI-anchors of these re- 
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Figure 1.13: Mapping of N-CEA residues directly involved in homophilic interaction 
and receptor binding. Residues directly engage in dimerisation shown in green. N-CEA 
residues involved in DraE binding shown in red. The residues common to DraE and 
dimerisation shown in yellow. 
ceptors may facilitate clustering by enhancing the lateral mobility of DAF and 
CEA within the host plasma membrane (Figure 1.14). Receptor clustering may 
affect the assembly and activation of host signalling molecules and complexes 
that could modulate cytoskeletal alterations that lead to bacterial uptake. The 
internalisation event involves the redistribution of the cytoskeleton-associated 
factors ezrin and a-actinin along with rearrangements of both microtubules 
and F-actin. DAF recognition could potentially regulate the entry process by 
stimulating Ca2+-dependent signalling and activating protein tyrosine kinases, 
PIP-3 kinase, protein kinase C and phospholipase Cry (Guignot et al., 2001; 
Peiffer et al., 1998). However, whether a5/31  integrin is involved in facilitating 
bacterial entry is still controversial (Guignot et al., 2001, 2009). 
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Figure 1.14: Internalisation process of Afa/Dr DAEC. (I) Interaction with fully dif-
ferentiated, polarised epithelial cells. Afa/Dr DAEC interacts with membrane-bound 
receptors (including CEA and DAF).The recognition triggers signalling which involves 
protein tyrosine kinases, phospholipase, phosphatidylinositol 3-kinase and other protein 
kinase, which leads to loss of microvilli. Changes in the distribution of tight junction-
associated proteins lead to an increase in paracellular permeability. (II). interaction 
with undifferentiated cells. The internalisation of Afa/Dr DAEC. Figure adapted from 
Servin (2005) 
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1.5.2 Urinary Tract Infections (UTIs) 
Epidemiological studies show that DAEC strains that express adhesins of the 
Afa/Dr family are involved in 25 to 50% of cases of cystitis in children and 
30% of cases of pyelonephritis in pregnant women (D'Orazio and Collins, 1998; 
Daigle et al., 1994; Nowicki et al., 2001). E. coli expressing the Dr adhesin is 
also believed to increase the risk of recurrent UTI by two times, suggesting its 
potential association with recurrent and chronic UTI (Zhang et al., 1997). 
DAF and type IV collagen, recognised by Dr adhesin, are both expressed in 
renal tissue. A previous study has shown that the presence of the Dr adhesin 
seems not to be important for the early stage of colonisation and infection, at 
least in the mouse urinary tract, but it was proven to be important for the long 
term colonisation of the mouse kidney experimentally (Hagberg et al., 1983). 
Dr+ E. coli is able to colonise the renal interstitium and significant histologi-
cal changes corresponding to tubulointerstitial nephritis, including interstitial 
inflammation, fibrosis and tubular atrophy, were found in the kidney tissue 
of Dr+-infected mice but not in that of Dr- infected mice (Goluszko et al., 
1997b). Selvarangan et al proposed a two-phase infection process. First, bind-
ing to DAF receptor expressed on epithelial cells may promote the first step of 
kidney infection, followed by internalisation and translocation of bacteria to 
the renal parenchyma. Secondly, Type IV collagen binding may be required 
for establishing persistent colonisation (Selvarangan et al., 2004). 
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1.5.3 Cell Signalling 
Although they do not necessarily have any transmembrane or intracellular do-
mains, GPI-anchored proteins can regulate intracellular signalling events by 
aggregating within membrane lipid raft microdomains (Servin, 2005). In hu-
man T cells, cross-linking of DAF with an anti-DAF MAb and a secondary 
antibody can lead to cell proliferation (Davis et al., 1988). After DAF cross-
linking, cytoskeletal protein reorganisation including clustering of actin, tubu-
lin and vimentin beneath capped DAF has been reported on T lymphocytes 
(Kammer et al., 1988). Peiffer et al found that the DAEC C1845-DAF inter-
action involves the recruitment of a signal transduction molecule. The C1845 
DAEC can induce F-actin rearrangement (Peiffer et al., 1998). Goluszko et 
al also found that the binding of a bacterial ligand might cause cross-linking 
of DAF. Following the clustering of DAF, cytoskeleton proteins rearrange to 
facilitate bacterial invasion. Also, rearrangement of DAF at the adherence site 
due to strains which express the Afa/Dr adhesins (Dr, Dr-II, F1845) was less 
significant compared to strains bearing AfaE-I and AfaE-III (Goluszko et al., 
1999). CEA and CEACAM6, the other two GPI-anchored receptors for the 
Afa/DrCEA adhesins, are recruited around Dr-positive bacteria (Berger et al., 
2004). 
1.6 Aims of the Project 
The colonisation and invasion of DAEC can lead to urinary tract infections and 
enteric infections. AfaE recognise CEACAMs and DAF on the host cells. Al-
though there is binding information for the interaction between DEAC Afa/Dr 
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family adhesins and their receptors, none of the structures of these complexes 
is known. However, the atomic resolution level is becoming more and more 
important for modern vaccine/drug development. 
This study aims to provide the structure of the complex between AfaE and 
CEA. By comparison with the homo-/heterophilic interactions of CEA, this 
work will provide detailed insight into ligand recognition by CEA. 
Determination of the structure of the complex between AfaE and another 
receptor DAF is also an aim of this project. 
This study also aims to solve the structure of another Afa/Dr family ad-
hesin from EAEC and elucidate the reasons for different receptor recognition 
despite high primary, secondary and tertiary structure similarity. 
61 
Chapter 2 
Protein NMR Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is a powerful technique that 
can be used to study the structure, dynamics, and chemical kinetics of a broad 
range of biochemical systems. This chapter aims to give a basic description of 
NMR theory and also the techniques directly relevant to the methods used in 
this study. 
2.1 Basic Principles of NMR 
Quantum mechanically subatomic particles (protons, neutrons and electrons) 
have a property known as spin. However, in some atoms, such as 160, 12C, 
there is no overall spin as the individual spins are paired with each other. 
These atoms are also called "NMR silent". However, in some atoms (such as 
1H and 13C) the nucleus does possess an overall spin. Basically overall spin I 
follows these rules in Table 2.1. 
The spinning nuclei have angular momentum, P, and charge is comparable 
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Table 2.1: Relationship between overall spin and number of protons and neutrons 
No.of Protons No.of Neutrons 	I 
Even 	 Even 	 No spin 
Odd Odd Integer Spin 
Odd(/Even) 	Even(/Odd) 	Half-integer spin 
I= 1/2 	 I= 1 	 I= 3/2 
Figure 2.1: Nuclei with a magnetic quantum number I have 21+1 orientations. 
to a moving charge (current) on the macroscopic scale. This charge gives rise 
to a magnetic moment, p, such that 
/-t = -YP 
	
(2.1) 
where 7 is the magnetogyric ratio. It is a constant for any given nuclide. 
When placed in a external static magnetic field (B0), the nuclear magnetic 
moment of a nucleus will align with the field of strength B0 in 2/ + 1 ways, as 
shown in Figure 2.1. 
The motion of the magnetic moment when placed in a static external mag-
netic field is just like a spinning top or gyroscope in the Earth's gravitational 
field. This motion is termed Lai 	mor precession. The rate of precession, ie. 
angular velocity (c.,)Irad • s-1 or v/Hz) is: 
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1,1 
• 
Figure 2.2: Nuclei precess at a rate that depends on the field strength and the mag-
netogyric ratio of the spin. 
w = --y1=30 (rad • .9-1 ) 	or 	v =
27 B
o(Hz) 
r 
(2.2) 
This is also known as the Lai 	tor frequency of the nucleus. NMR can 
occur when the nucleus absorbs a quantum of energy, which meets following 
condition: 
= hv = her Bo 	 (2.3) 
where h is Plancks constant, and v is the Larmor frequency. For a spin-half 
nucleus in the applied static field, the two states have two possible orientation 
with respect to the static field, either parallel (the a-state) or antiparallel 
(the 13-state), which correspond to lower energy level and higher energy level, 
respectively. 
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Figure 2.3: The excess nuclei in the a state represent a bulk magnetisation vector Mo 
along z axis. 
As described by the Boltzmann distribution: 
Na 	A E/kBT 	hkB°T = e 	= e B 
NO 
(2.4) 
Where Na and Ng represent the number of nuclei in the spin orientation, 
kB is the Boltzmann constant and T is the temperature. The lower energy 
level will thus contain slightly more nuclei than the higher level. These excess 
nuclei can be excited into the higher level with electromagnetic radiation. The 
frequency of radiation needed is equal to the difference in energy between the 
energy levels. This also explains why NMR will become more sensitive at 
higher magnetic field and lower temperature. There is only a small excess of 
nuclei on the lower energy which can be excited by radiation. The population 
of excess nuclei in the a state can be represented as a collection of spins 
distributed randomly about the precessional cone and parallel to the z axis, 
which means bulk magnetisation vector Mo lies along the z axis, as shown in 
Figure 2.3 
z 
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65 
a) 	 b) 	 c) 
A Z 
 
,.." - 74-0 -.) 
/ 
V,  
Figure 2.4: Effect of a pulse on bulk magnetisation. a). B1 pulse will push the Mo 
towards the —y axis. b) and c). The flip angle can be 180° or any angle depending on 
how long the pulse is applied along the x axis. 
2.2 Pulse NMR 
Once a pulse is applied to the magnetisation along the x axis, the vector will 
rotate towards the y axis in x-y plane (the "right-hand-rule"), as shown in 
Figure 2.4 
The angle 0 through which the vector turns, also known as the flip angle 
or tip angle depends on the amplitude and duration of the pulse. Combining 
Figure 2.3, Figure 2.4b shows a 90° pulse leads to no magnetisation on the 
z-axis, which means there are equal numbers of nuclei at the low (a) and 
high energy (13) level. Further radiation can place the vector along the —z 
axis (shown in Figure 2.4c). The —z aligned magnetisation means there are 
more nuclei in the 0 state than a state. Once this pulse is switched off, the 
transverse magnetisation precesses in the x-y plane around the z axis (Bo field). 
However, the transverse magnetisation produces a non-zero magnetic moment 
in the x-y plane, which leads to a time dependent current in the receiver coil. 
The signal received, which is called the free induction decay (FID), represents 
bulk magnetisation that exists in the x-y plane. Fourier Transformation (FT) 
A Z  
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Figure 2.5: Vector model representation of a one-pulse experiment. (a). The equilib-
rium bulk magnetisation shown by the shaded arrow is bought to the y axis by a 90° 
pulse along the x axis (red dot track). (b). After the 90° pulse, the transverse magneti-
sation decays back to the initial state by precessing about the z axis. This precession 
gives signal in the receiver coil (x-y plane) (c). An FID is observed by detection at y 
axis. (d). The resonance peak at certain frequency is observed after Fourier Transform. 
is used to transform the FID, which is time domain data into the frequency 
domain spectrum we see at the most times (Figure 2.5). 
A biological sample includes numerous spins thus gives a complicated FID 
signal. However, it could easily be Fourier Transformed with the help of a 
modern computer (Figure 2.6). 
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Figure 2.6: Fourier Transform. FT converts time domain data into frequency domain. 
2.3 Chemical Shift 
All different nuclear (same type) spins cannot be distinguished if there were 
no other kinds of interaction in addition to each spin's magnetic moment in-
teracting with the external magnetic field ("Zeeman" interaction) as the same 
type nuclei would have the same frequency. In fact, for a given isotope, dif-
ferent chemical environment generate different local magnetic fields. Thus the 
same type of nucleus will have different resonance frequencies. This effect can 
be described using a quantity called the shielding constant a by the following 
equation 2.5 : 
v _= B0 (1 — a) 	 (2.5) 
As long as the nucleus has electrons, the shielding constant will have a 
non-zero value. There are several factors that contribute to the shielding con-
stant such as diamagnetic shielding and ring current effects. Practically, a 
specific compound is used as a reference, whose resonance frequency is set to 
the chemical shift value of zero. The chemical shifts of other resonances are 
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expressed as the difference in electron shielding to the reference nucleus, as 
shown in equation 2.6: 
liref 
0 = 	 106 
Vref 
(2.6) 
where, U and //ref are the resonance frequencies (MHz) of the nucleus of 
interested and reference, respectively and ö is the chemical shift of the nucleus 
under study. By introducing reference sample, Equation 2.6 makes the chemi-
cal shift independent of magnetic field strength. There are several factors that 
contribute to the shielding constant such as paramagnetic shielding and ring 
current effect. 
2.4 Nuclear Coupling 
2.4.1 Scalar (or J) Coupling 
The orientation of spin B in the magnetic field produces a small polarisation 
of the electrons mostly in the s orbitals surrounding spin B. However, this 
polarisation in turn can affect the electron density distribution of spin A which 
is directly bonded to spin B. This process is called scalar coupling or J coupling. 
Due to such an influence of the other nucleus, the magnetic field at each nucleus 
will be either greater or less than B0 by a constant amount, which is designated 
as J. The two energy states will now be four in a B0 independent pattern, as 
shown in Figure 2.7. The magnitude of J coupling reduces rapidly as the 
number of bonds separating the nuclei increases. Couplings between nuclei 
connected by more than three bonds are usually close to zero. 
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Figure 2.7: Energy diagrams and spectra of spin systems with two spin-half nucleus. 
(a) without and (b) with J coupling. Figure adapted from Cavanagh (2007). 
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VD = 472r3 
lrycy2 (1 — 3 cost 0) (2.7) 
2.4.2 Dipolar Interaction 
The dipolar interaction in NMR spectroscopy plays a very important role in 
structural biological studies as it depends on both orientation and distance 
between dipole-coupled nuclei. Their relationships can be given in the following 
formula: 
in which h is Planck's constant, -yi and rye are the gyromagnetic ratios of the 
dipolar coupled spins, 0 is the angle between the dipolar vector and magnetic 
field and r is the distance between two dipolar coupled spins. In the spectrum, 
rip is the portion of frequency shift contributed by the dipolar coupling. Two 
protons which are separated by 3 A in space will have dipolar coupling at 
about 4.5 kHz. However, it decreases rapidly with an increase of distance 
between dipolar coupled nuclei as a function of r-3. In solution, the rapid 
tumbling of the protein molecules give no overall dipolar coupling. However, 
the dipolar interaction can still contribute to relaxation, which forms the basis 
of the Nuclear Overhauser Effect (NOE). 
2.4.3 Residual Dipolar Coupling 
In solution, the nuclear dipolar coupling is averaged to zero owing to rapid 
molecular tumbling. To give the protein molecule a preferential position rather 
than random tumbling will lead to incomplete cancellation of the dipolar cou-
pling. In the past several years, approaches have been developed to partially 
align macromolecules in solution with anisotropic media to regain a small 
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proportion of the dipolar coupling, which is called residual dipolar coupling 
(RDC). As RDC gives information about the angle relative to the external 
magnetic field, which means that it can give information about the relative 
orientation of parts of the molecule, it is now widely used in protein NMR 
structural studies. 
2.5 Relaxation Processes 
After an excitation pulse, the system will establish its equilibrium. As the 
excitation process is an absorption process, nuclei which are at the excited 
state will gradually relax and return to the thermal equilibrium state. As 
the energy gap between spin levels of NMR spectroscopy is much smaller than 
other spectroscopic technique such as IR or UV, the relaxation process in NMR 
is much longer. However, the long lifetime of the relaxation process does not 
only provide narrow linewidths but also time to manipulate the spin systems 
after excitation. There are two different types of relaxation process (Edwards, 
n.d.). 
2.5.1 Spin-Lattice (longitudinal) Relaxation 
After pulse excitation, the bulk magnetisation vector of nuclear spins is moved 
away from the thermal equilibrium +z axis, which alters the population of 
different energy states. The recovery of the magnetisation along the z axis is 
called longitudinal relaxation. In longitudinal relaxation energy is transferred 
into the surroundings, in the form of heat. However, the energies involved are 
so small that temperature changes in the bulk sample are undetectable. The 
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v 
Figure 2.8: Longitudinal relaxation process. The excited magnetisation along the y 
axis decreases gradually while the z axis magnetisation increases. 
rate constant of this process is called the spin-lattice or longitudinal relaxation 
rate (R1), which is usually quite long (typically few hundred msec in protein 
NMR spectroscopy). There are several factors which affect the longitudinal 
relaxation process including molecular size, temperature, solution viscosity 
and molecular shape. Longitudinal relaxation restores the magnetisation back 
to the z axis as shown in Figure 2.8. 
2.5.2 Spin-Spin (transverse) Relaxation 
As the bulk magnetisation vector is the sum of numerous microscopic vectors, 
it possesses phase coherence after a pulse. These individual spins will have 
different surrounding environments as sonic spins will experience a slightly 
greater local field than the mean while the others will experience a slightly 
smaller field. In transverse relaxation energy is transferred to neighbouring 
nuclei, which leads to loss of transverse magnetisation eventually. The half-
life for this process is called the spin-spin or transverse relaxation time (T2) 
(Figure 2.9). 
In non-viscous liquids, usually T2 = T1, but other processes like scalar 
coupling with quadrupolar nuclei, chemical exchange and interaction with a 
paramagnetic centre (mentioned later in this study), can accelerate the T2 
relaxation such that T2 becomes shorter than Ti. 
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Figure 2.9: 11-ansverse relaxation process. The bulk magnetisation has been coloured 
in red while the individual spins are coloured in pink. a). The equilibrium bulk mag-
netisation shown by the shaded arrow is brought to the y axis by a 90° pulse along the 
x axis. (b), (c), (d) show the individual magnetisation vector is farming-out, this leads 
to no net magnetisation in the transverse (x-y) plane. 
The transverse relaxation determines an important property in NMR spec-
troscopy, which is the line width. For exponential relaxation, the line-shape is 
Lorentzian with a half-height linewidth, Av112 of 
= 1 	
(2.8) 
.L 2 
In protein NMR, by comparing with the empirical line width of the protein 
at the molecular size, the experimental line width can give a rough idea of the 
solution behaviour of the protein such as oligomerisation and aggregation, etc. 
2.6 Protein NMR 
2.6.1 One-dimensional 11-I NMR 
Each 1D NMR experiment consists of two phases: preparation and detection. 
During preparation the spin system is set to a defined state. During detection 
the resulting signal is recorded. In the simplest case the preparation is a 90° 
pulse (in our example applied along the x axis) which rotates the equilibrium 
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Figure 2.10: 1D NMR spectrum of AfaE-dsc. The experiment was run at 308 K, pH 
5.0 acetate buffer. Different regions represent different types of protons in the protein. 
magnetisation Mz onto the —y axis (My). After this pulse each spin precesses 
with its own Larmor frequency around the z axis and induces a signal in the 
receiver coil. The signal decays primarily due to T2 relaxation and is therefore 
called the free induction decay (FID). 
For getting a better signal to noise (S/N) ratio, the experiment is usually 
repeated many times. Because part of the randomly occurring noise will be 
cancelled by adding all these experiment repeats together, a better S/N is thus 
achievable. After summation the data are Fourier Transformed to yield the 
final 1D spectrum. 
For detailed protein NMR analysis, where many nuclei give rise to extensive 
signal overlap in a 1D spectrum, most experiments are run as 2D and 3D NMR 
spectroscopy (see below). However, 1D 1H NMR spectroscopy is still very use-
ful to characterise the state of the protein. Despite signal overlap, there are 
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still quite a few useful features in a 1D NMR spectrum (e.g. 100 pM). First of 
all, a good signal-to-noise (S/N) ratio means a decent protein sample concen-
tration, which is essential for the multi-dimensional protein NMR experiments. 
Secondly, the resonance linewidth, given by the full-width at half-height, re-
flects the transverse relaxation rate constant, R2 (Figure 2.10). The value of 
line width and R2 are related to the rotational correlation time of the protein, 
which depends on molecular size, shape, solution viscosity and temperature. 
Larger proteins have longer correlation time thus larger line widths. It thus can 
be used to judge self-association state and dynamics. Most importantly, triple 
resonance 3D experiments which are essential for structure determination re-
quire good (long) T2. Thirdly, the resonance dispersion in the 1D spectrum 
indicates the integrity of the protein under the particular experimental condi-
tions chosen. The denatured protein will have chemical shifts close to those of 
an unstructured peptide while folded protein will exhibit a range of chemical 
shifts due to the anisotropic magnetic fields of proximal aromatic or carbonyl 
groups, as shown in Figure 2.11. 
In particular, the aromatic ring current shifted methyl or methylenes (usu- 
ally below 	ppm) are usually an indication of folded protein. Finally, the 
presence of the purity of the sample can also be concluded from the 1D spec-
trum. Low molecular weight impurities and other buffer components are ap-
parent as sharp peaks amid the broader envelope of protein resonances. 
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Figure 2.11: A typical 1D 1H spectrum of unfolded protein. The lack of dispersion 
in the HN region between 6 ppm to 11 ppm is a typical characteristic for an unfolded 
protein. No peaks below 0.5 ppm in the methyl region (0.5/ — 1.5 ppm) also suggest an 
unfolded protein. 
2.6.2 The 2D Heteronuclear Single-Quantum Coherence 
(HSQC) Spectrum 
1D protein NMR spectroscopy is essentially useless in protein structure deter-
mination as the peaks in protein 1D NMR spectrum are heavily overlapped. 
Heteronuclear NMR spectroscopy effectively solves these problems for proteins 
of at least up to molecular masses of 25-30 kDa, if the protein can be uni-
formly labelled with the NMR active isotopes 13C and 15 N. Multidimensional 
heteronuclear NMR experiments spread the spectrum into two dimensional or 
three dimensional space by correlating 13 C and 15 N (typically in protein NMR) 
with 1H resonances, which can be done via transferring coherence between the 
heteronuclear and 111 spins. In a typical protein 1H-15 N HSQC experiment, 
11-1 spin polarisation initially is transferred to the heteronucleus, 15 N in this 
case, via J-coupling. The heteronuclear frequency is then recorded, and the 
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Figure 2.12: Correlation in the 1H-15N HSQC experiment. The 1H spin polarisation 
is transferred to the 15N and then transferred back for detection. 
coherence finally is transferred back to 1H magnetisation for detection. 
The HSQC is the most commonly recorded 2D experiment and shows most 
of the NH groups in a protein including the backbone amide groups plus tryp-
tophan side-chain NE — HE groups, asparagine side-chain Na — H62 groups and 
glutamine side-chain NE — Ha groups. The arginine Are — HE peaks are in 
principle also visible, but because the NE chemical shift (r s.,75 ppm) is outside 
the region usually recorded (100130 ppm), the peaks are folded to a pseudo 
frequency. Due to the rapid exchange with H2O, side chain N—H groups of 
arginine and lysine may not be observed. The N—H groups of these two amino 
acids may also be visible but are also folded when at low pH. 
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2.7 Paramagnetic Relaxation Enhancement (PRE) 
NMR 
2.7.1 Brief Introduction 
The Nuclear Overhauser Effect (NOE) is a consequence of dipole-dipole cou-
pling between different nuclear spins, and is used to measure the distance be-
tween atoms in proteins (Wuthrich, 1986). The relation between the observed 
NOE intensity is ideally inversely proportional to the sixth power of the dis-
tance. Proton-proton NOEs are by far the mostly widely used in structure 
calculation. However, there are limitations in the application of NOE mea-
surements. NOE NMR spectra can only be detected for distances up to 5 A 
under normal circumstances. Also, for large proteins, the high level of deuter-
ation causes a limited numbers of NOE data to be available. Fortunately, 
paramagnetic NMR extends the distance of detectable interactions up to 25 
A. Paramagnetic centres affect the magnetic properties of surrounding nuclei. 
The unpaired electron at the paramagnetic centre provides relaxation mecha-
nisms which accelerate relaxation rates of neighbouring protons, which means 
shorter T1  (longitudinal)and T2 (transverse) relaxation times. This process is 
called paramagnetic relaxation enhancement (PRE). The transverse relaxation 
rate enhancement, R2para , is described by Equation 2.9, where S is the electron 
spin, 71  the proton gyromagnetic ratio, g the electronic g factor, 0 the Bohr 
magneton, r the distance between the electron spin and the nuclear spin, w1  
the resonance frequency of protons, and T c the correlation time of the vector 
connecting the electron and nuclear spins (Jahnke, 2002). 
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	) 	
(2.9 ) 
The magnitude of the paramagnetic relaxation enhancement (PRE) caused 
by dipolar interactions is proportional to the square of the gyromagnetic ratios 
and inversely proportional to the distance between the involved spins. The 
correlation time of the vector connecting the electron can also affect the PRE. 
Relaxation rates of protons within up to --,25 A will be enhanced by dipolar 
interactions with the unpaired electron of the spin label (Constantine, 2001). 
Paramagnetic Relaxation Effect (PRE) NMR can complement or even replace 
NOE measurements and improve the quality of derived structures. 
The correlation time of the vector connecting the electron and nuclear 
spins, Tc, depends on the rotational correlation time of the protein-ligand com-
plex (Tr ), the electronic relaxation time (T,) the lifetime of the complex, rm, 
according to Equation 2.10. 
1 	1 	1 	1 
— = — --
IC Tr Ts Tm 
(2.10) 
The electronic relaxation time, T5 , contributes significantly to the paramag-
netic system as, for example, T3 is typically in the order of 100 ns for nitroxide 
radicals used in this study and therefore much longer than the rotational cor-
relation time, Tr , which is typically in the order of a few nanoseconds. Since Tm 
is usually even longer than T3, Tc is dominated by Tr, the same correlation time 
that governs relaxation in diamagnetic systems. Given the high gyromagnetic 
ratio and the long effective correlation time, organic nitroxide radicals dras-
tically increase relaxation rates of neighbouring protons, while having little 
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Figure 2.13: Paramagneic labelling reaction. The methanethiosulfonate spin label 
with a sulfhydryl residue is coupled to protein cysteine via a disulfide bond. 
effect on chemical shifts. 
Some paramagnetic transition metals, for example Co2+, Ni2+, Fe3+ have 
very short electronic relaxation times in the order of 10-13-10'2 s. The re-
laxation of neighbouring protons is thus just slightly affected by these para-
magnetic centres as the electronic relaxation time is the determining factor 
(Jahnke, 2002). 
2.7.2 Site-Directed Spin Labelling 
Paramagnetic relaxation enhancement (PRE) has long been recognised as a 
method for providing long-range distance information (Kosen, 1989). How-
ever, paramagnetic spin labelling has not been used until suitable spin la-
bels more recently were found. Nitroxide spin labels with unpaired elec-
trons have been introduced into proteins at specific locations via a disulphide 
bond. The spin labels which are most widely used are 2,2,6,6,-tetramethyl-
1-piperidine-1-oxyl (TEMPO) and (1-Oxy1-2,2,5 ,54 etramethy1-3-pyrroline-3-
methyl) Methanethiosulfonate, (MTSL). Site-Direct Spin Labelling (SDSL) 
introduces such a paramagnetic nitroxide centre into appropriate locations of a 
target protein via disulphide bonds to cysteine residues (Figure 2.13) (Hubbell 
et al., 1998). 
81 
..-•S-.. --C€4,..., CP 
	CH3 .... ---- ............. .-- 
S S CH3 	,,,C13, _ ..... 
+ HS 	Ca O 
Cysteine Sidechain 
Figure 2.14: Diamagnetic analogue labelling reaction. The box shows the different 
functional group compared with the paramagnetic chemical MTSL. 
Thus an ideal site-directed spin labelling protein sample should have all 
the properties of a normal NMR sample, provided that all cysteines have been 
reduced, to avoid undesirable reaction with the spin label precursor. 
2.7.3 Parallel Labelling for Control 
A previous study has shown that appropriately placed nitroxide spin labels 
typically perturb structures of soluble protein only minimally (Battiste and 
Wagner, 2000). However, to minimize the effects induced by covalent attach-
ment of labels on the system under study, a parallel labelling technique can be 
used with a diamagnetic form. The diamagnetic form should be similar both 
in structure and in chemical and physical properties to the paramagnetic form. 
In this study, a diamagnetic analogue of MTSL was used (Figure 2.14). 
Previously studies have shown that the labelling efficiencies are similar to 
paramagnetic labelling (Liang et al., 2006). 
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Chapter 3 
Protein Sample Preparation 
3.1 Gene Cloning and Mutagenesis 
All the primers are attached as Appendix I in full detail. For PCR cloning of 
all samples, the following recipe in Table 3.1 was used: 
The primers were synthesised by MWG (Eurofins). The DNA sequence of 
cloning or mutagenesis products was confirmed by DNA sequencing performed 
either by ABC (Imperial College London) or Cogenics. 
Table 3.1: PCR reaction recipes 
Total Volume: 	1004 
	
69µL 	ddH2O 
10µL Buffer(10X) 
10µL 	dNTPs (2.5 mM) 
2µL DNA Template (20 ng/ ;IL) 
4µL 	Oligo 1 
4µL Oligo 2 
1µL 	P fu DNA Polymerase (Promega) 
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•, alat-dsc 
LacO 
, BarnH I 
His-Tag 
ATG 
PT5 4r;.\ 
afaE-dsc 
in pQE-30 
3856 bp 
 
Hind III 
STOP 
AmpleIIIIn 
Col I 
 
Figure 3.1: AfaE-dsc was inserted into the pQE-30 plasmid at BamHI and HindIII 
restriction sites. The afaE gene was fused with a hexa histidine-tag (His-tag) at its 
N-terminus. 
3.1.1 Cloning gene encoded AfaE-dsc 
AfaE-dsc has previously been cloned in the lab in the plasmid pRSETa. How-
ever, in this study, the afaE-dsc gene was subcloned into pQE-30 plasmid 
(Qiagen) at BarrtHI and HindIII restriction sites for a higher yield, as shown 
in Figure 3.1 
3.1.2 Cloning genes encoded N-CEA 
pET-32 was commercially available from Novagen (Figure 3.2). The N-terminal 
thioredoxin tag, His-tag and S-tag were removed by cloning the gene into Ndel 
and Xhol fragments. The protein of interest was expressed with a C-terminal 
fusion only. 
The N-terminal CEA gene was inserted into pET-32 (Novagen) at Ndel 
and Xhol restriction sites as shown in Figure 3.3. 
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N-CEA 
--Xho I 
\ His-Tag 
STOP 
tide I 
RB 
/11/111r- 
lac 0 /`r, 
/7/ 
PT7 
N-CEA 
in pET-32 
5725 bp 11 origin 
pEIRV2orl 
Ap 
T7 promoter 01. 	lac operator 	Xbal  rbs 
TAATACGACTCACTATAGGGGAATTGTGAGEGGATAACAATTECCETCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGA 
Trx-Tag 	 Msci 	His-Tag 
TATAIrTTAT70.GO ..315bp.. CTGGCOGGTTCTGGITCTGGCCATATOCACCATCATCATCATCATTETTCTGGICTGGTGCCACGOGGTICT 
NdeiMetSer 	105aa.. .LeuAlaGlySerGlySerGlyHisMetHisHisHisHisHIsHisSerSerGlyLeuValProArgGlySer 
00.Sqagprimer# 699450 
S-Tag NspV 	 Kpnl 
	 thrombin 
GGTATGAAAGAAACCGCTUTGETAAATTEGAACGCCAGEACATGGACAGCCCAGATCTGGGTACCGACGACGACGACAAG 
GlyMetLysGluThrAloAloAlaLysPheGluArgGInHisMetAspSerProAspLeuGlyThrAspAspAspAspLys 
enterokMase 
Figure 3.2: pET-32 Multiple cloning site (MSC) region. Restriction sites Ndel and 
Xhol which were used for CEA and DAF cloning are highlighted in red. 
Figure 3.3: -CEA was inserted into a pET-32 plasmid at NdeI and Xhof restriction 
sites. 
pET-32a(+) 	 Eagl 	Aval 
Ncol Eccf01Banill Ecdil Sac! 	Sall 1i1nrH11 NoM 	)07o1 His-Tag 
GCCATGGCTGATATEGGATCCGAATTEGAGETCCGTEGACAAGETTGOGGCCGCAICTEGAGrACCACCACCACCACCACTGAGATCCOGETCCTAA 
AloMetAloAsplleGlySerGluPheGluLeuArgArgGInAloCysGlyArgThrArgAlaProProProProProLeuArgSerGlyCysEnd 
Bpd1021 	 T7 terminator 
CAAAGCCOGAAAGGAAGETGAGTTGGCTGETGCCACCGCTGAGCAATAACTAGCATAACCCETTGGGGCCTETAAACGGGTETTGAGGGGTTUTTG 
LysProGluArgLysLeuSerTrpLeuLeuProProLeuSerAsnAsnEnd 
T7 temenalor primer#69337a 
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Figure 3.4: Different DAF constructs were cloned into pET-32 vector at NdeI and 
XhoI. 
Table 3.2: DAF domain position and length 
Domain Designated Amino Acid Position (Sequence) 
Name 
1 CCP1 	aa3--aa65 (DCGLPPDVPNAQPALEGRTSFPEDTVI-
TYKCEESFVKIPGEKDSVICLKGSQWSDIEEFCNRS) 
2 	CCP2 	aa66"-aa129 	(CEVPTRLNSASLKQPYITQNYF- 
PVGTVVEYECRPGYRREPSLSPKLTCLQNLKW-
STAVEFCKKK) 
3 CCP3 	aa130-,aa191 (SCPNPGEIRNGQIDVPGGILFGATISF-
SCNTGYKLFGSTSSFCLISGSSVQWSDPLPECREI) 
4 	CCP4 	aa192,-aa253 	(YCPAPPQIDNGIIQGERDHY- 
GYRQSVTYACNKGFTIVIIGEHSIYCTVNNDEGEWS-
GPPPECRG) 
3.1.3 Cloning genes for various DAF constructs 
The template cDNA was purchased from OriGene (CatNo.SC119802). The 
same cloning vector used for CEA was also used for all the different DAF 
constructs, as shown in Figure 3.4: 
Different complement control protein (CCP) domains were defined accord-
ing to a previous publication as shown in Table 3.2 (Kuttner-Kondo et al., 
2000). 
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4 Dpn I Digestion 
• • 
Figure 3.5: The process of site-directed mutagenesis. The primer contains desired 
mutation (cross) are aligned and extended by PfuUltra DNA polymerase via PCR.The 
original template (Green and Yellow) are then digested with DpnI. 
These constructs were cloned from the primers detailed in Appendix I. Con-
structs containing CCP3&4, CCP1&2&3&4 (hereinafter referred to as CCP34, 
CCP1234 respectively) were also cloned. 
3.1.4 Site-Directed Mutagenesis 
For producing mutants, QuikChange II Site-Directed Mutagenesis Kit (Strata-
gene) was used. The two reverse complement primers, both containing the de-
sired mutation were designed with a 15bp overhang at both ends. An overview 
of the process is shown in Figure 3.5. 
A mutated plasmid containing staggered nicks was generated by PCR. The 
product was digested with Dpnl at 37 °C for 1 hour. DpnI, which is specific for 
methylated and hemimethylated DNA, was used to digest the parental DNA 
template and to select for mutation-containing synthesised DNA. 5 pL of the 
digested product was transformed into 50 pL XL-1 Blue Supercompetent Cells 
(Stratagene) for multiplication (Nelson and McClelland, 1992). 
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3.2 Protein Expression 
The transformation of all the DNAs encoding proteins used in this study fol-
lowed the same protocol. 3 AL DNA were transformed into 40 AL of the 
appropriate E. coli strain (Detailed below) followed by incubation on ice for 
about 40 minutes. 
The cells were heat-shocked at 42 °C for 45 seconds. After five minutes 
cooling on ice, the cells were incubated in a 37 °C incubator with 200 rpm 
shaking. The cells were then poured onto agar plates containing corresponding 
antibiotics and incubated at 37 °C overnight. The colony was picked and 
inoculated into 200 ml culture for overnight incubation with shaking at 200 
rpm. The cells were then diluted into large scale cultures at a ratio of 1:50. 
The culture was incubated at 37 °C for about 2 3 hours until the OD600nm 
reached 0.6. 500 µM Isopropyl--D-thiogalactoside (IPTG) was then added 
to induce the transcription. The culture was incubated at 37 °C for another 
4 hours. The cells were then harvested by centrifuging at 5000 rpm for 10 
minutes. The supernatant was discarded and pellet was flash frozen and kept 
in a -20 °C freezer for future purification. 
AfaE-dsc DNA was transformed into the E. coli strain M15 together with 
3 AL of pREP4 plasmid. The expression of recombinant protein in T5 pro-
moter system requires tight regulation by the presence of high level of the lac 
repressor protein. However, the pREP4 plasmid constitutively expresses the 
lac repressor protein encoded by the lad gene. The cell also keeps multiple 
copies of the pREP4 to maintain a high level of repression. Expression of re-
combinant proteins encoded by the pQE-30 vectors is rapidly induced by the 
88 
addition of IPTG when OD600„, reaches 0.6, but less than 0.9. IPTG binds 
to the lac repressor protein and inactivates it. The cells containing AfaE-dsc 
constructs had conferred Carbenicillin and Kanamycin resistance at 50 µg/mL 
and 25 µg/mL, respectively. 
N-CEA was transformed into the E. coli strain Rosetta which has been 
optimised for rare codon expression in E. coli. The cells were grown in media 
contains 50 µg/mL Carbenicillin and 25 µg/mL Chloramphenicol. 
All the different DAF constructs were transformed into E. coli strain BL21(DE3) 
with 50 µ,g/mL Carbenicillin. 
3.3 Protein Purification 
AfaE-dsc and N-CEA in this study were purified under denaturing conditions. 
The cell pellet from a 1 L culture of E. coli expression was resuspended and 
lysed in 15 mL denaturing binding buffer (100 mM NaH2PO4, 10 mM Tris.HC1, 
300 mM NaC1, 8M Urea, 2 mM Imidazole, pH 8.0) by French Press twice. 
The protein lysate was centrifuged at 15,000 rpm for 30 min. The pellet was 
discarded. The supernatant was passed though Ni-Agarose resin (Qiagen) by 
gravity as per the following procedure: 
• Column Equilibrium Washed with 10 ml ddH2O then 10 ml binding 
buffer 
• Binding Protein lysate was loaded 
• Washing Washed with 20 ml Binding Buffer and then 20 ml Washing 
Buffer (Binding Buffer with extra 8 mM Imidazole) 
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• Elution Eluted with 50 ml Elution Buffer (Binding Buffer with 250 mM 
Imidazole) 
The eluent from the Ni-Agrose was then subjected to refolding. 
3.4 Protein Refolding 
Different refolding methods were used for AfaE, N-CEA and different DAF 
constructs. 
3.4.1 Refolding of AfaE and N-CEA 
50 ml of protein eluent from Ni-Agarose resin column was dialysed against 4 
L phosphate buffer with 1 M urea (100 mM NaH2PO4, 10 mM Tris • HC1, 50 
mM NaC1, pH 8.0) at 4 °C overnight with gentle stirring. The protein was 
then dialysed a second time against acetate buffer (35 mM NaOAc, 15 mM 
Acetic Acid, 50 mM NaC1, pH5.0) overnight. 
3.4.2 Refolding of DAF constructs 
25 mM dithiothreitol (DTT) and 1 mM EDTA were added into 10 mL DAF 
eluent from the Ni-NTA resin column. After 2 hours room temperature incu-
bation with gentle stirring, the pH of the solution was adjusted to 3.0-4.0 with 
HC1, and the solution was centrifuged at 15000 rpm for 30 minutes at 4°C be-
fore being dialysed into 6 M Urea, 10 mM HC1 (pH3.0-4.0). After dialysis, the 
major contaminant (OmpA) precipitated and was removed by centrifugation 
(15000 rpm for 30 minutes at 4 °C) 
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Folding of solubilised DAF protein was carried out in 0.02 M ethanolamine, 
1mM EDTA, 0.5 M Arginine, 1 mM Cysteine and 2 mM Cystine (pH 11.0) 
using rapid dilution (1:50 v/v) with three additions of the same volume over 
a 32-h period. The protein was added into 4 L refolding buffer drop-wise 
with gentle stirring. The refolding buffer was then left at 4 °C overnight. 
This material was ultrafiltered with Amicon YM10 membrane (Millipore), the 
retentate (20 mL) was concentrated further with a 5 kDa Vivaspin concentrator 
(Sartorius) to 300 µL for NMR studies. 
3.5 Para-/Dia-magnetic Labelling 
For purified N-CEA with cysteine mutants, DTT was added to a final concen-
tration of 15 mM and incubated at room temperature for 2 hours. The DTT 
was then removed from the protein sample with a PD-10 desalting column 
(Amersham). About 10 fold molar excess (final concentration) of MTSL was 
solubilised in 10 µL acetone and added to the protein sample. The protein 
sample with MTSL was then incubated overnight at 4 °C with rotation. The 
protein was covered by foil to prevent the sample from direct contact with light. 
Excess MTSL was removed with a PD-10 column again and concentrated to a 
final volume of 200 AL with Vivaspin concentrators (Sartorius stedim biotech). 
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3.6 Protein Analysis 
3.6.1 Protein solubility analysis 
Protein solubility after expression was analysed with B-PER® (Bacterial Pro-
tein Extraction Reagent, from Thermo Scientific). The pellet from 1 ml of 
culture was resuspended in 100 AL and vortexed for 5 minutes, which is then 
followed by 5 minutes centrifugation at 13000 rpm. The supernatant contain-
ing the soluble fraction of the protein was then removed. Another 100 AL 
of B-PER reagent was added into the pellet and this vortexed for another 5 
minutes. The resuspended mixture contained the insoluble fraction. Both of 
these samples were analysed using SDS-PAGE. 
3.6.2 SDS-PAGE 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis, is a 
technique widely used in protein analysis. SDS is an anionic detergent which 
denatures proteins. The negatively charged SDS bound protein will migrate 
towards the anode in an electrical field. In denaturing SDS-PAGE separation, 
migration is determined by molecular weight rather than intrinsic electrical 
charge of the polypeptide. 
All the proteins in this study were mixed with Novex® Tricine SDS sam-
ple buffer (2X) (Invitrogen) in a 1:1 ratio. 15% acrylamide tricine gels were 
prepared using the recipe developed by Schagger et al (1987). The gels were 
assembled and run in a BioRad vertical electrophoresis unit. They were run 
for 45 minutes at 180 V and then stained with either Coomassie blue or In- 
92 
Table 3.3: Molecular weight and molar extinction coefficients of proteins used in this 
study 
Protein Molecular 	Molar Extinction Coefficient 
Weight 	/M-lcm-1  ©280 nm 
/kDa 
AfaE-dsc 17.4 	24075 
N-CEA 14.2 15930 
DAF3 	7.7 	7240 
DAF23 	15.7 18950 
DAF1234 29.4 	44890 
stantBlue (Expedeon). 
3.6.3 UV Spectroscopy 
Protein samples were quantified using UV spectroscopy. Samples were diluted 
1/100 in native buffer and the absorbance measured at a wavelength of 280 
nm was recorded. The protein concentration was then calculated using Beer's 
law: A = E • c • 1, where A is the absorbance, e is the extinction coefficient, 1 is 
the light path length and c is the molar protein concentration. The extinction 
coefficient of all protein samples in this study was estimated by the ProtParam 
tool from ExPASy as shown in Table 3.3). 
3.6.4 Gel Filtration 
Gel Filtration was carried out on a Superdex 200® column using an AKTA 
FPLC (Amersham Biosciences). Protein samples were run at pH 5.0 in 50 mM 
Acetate Buffer with 50 mM NaC1 unless specified. The size was estimated by 
using the gel filtration molecular weight markers from Sigma (Product No. 
MW-GF-70) containing the proteins shown in Table 3.4). 
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Table 3.4: Molecular weight marker used in gel filtration 
Protein 	 Approx. Mol. Wt. /kDa 
Aprotinin from Bovine Lungt 	 6.5 
Cytochrome C from Horse Heartt 	 12.4 
Carbonic Anhydrase from Bovine Erythrocytest 29 
Albumin, Bovine Serums 	 66 
Blue Dextran 	 200 
f and t, Proteins with same labels were mixed and ran together on the column. 
3.7 Surface Plasmon Resonance Analysis 
The SPR measurements were carried out in HBS-EP buffer (10 mM HEPES, 
pH 7.4, 150 mM NaC1, 3 mM EDTA, 0.005 % P-20 surfactant [BlAcore AB, 
Uppsala, Sweden]) on a BlAcore 3000 system (BlAcore AB). To analyse the 
interaction between N-terminal domain of CEACAM5 (N-CEA) and AfaE 
mutants, 650 resonance units (RU) of N-CEA were immobilized on a CM5 
research-grade sensor chip (BlAcore AB) by amine coupling chemistry using 
the manufacturer's protocols. The different AfaE mutants were dissolved in 
running buffer and analysed using a series dilution, with corresponding con-
centration labeled on the sensorgram. AfaE mutants were injected over the 
surface at a flow rate of 20 Fit/min for 2.5 min. 
The binding affinities were analyzed with BlAevaluation 3.0 software (BI-
Acore AB) with reference flow cell response subtracted. A 1:1 binding model 
has been used for fitting the binding data. 
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3.8 NMR Experiments 
3.8.1 NMR data acquisition, processing and analysis 
Most data were acquired on a Bruker DRX 500 MHz magnet equipped with 
a TXI cryoprobe unless specificied. Some experiments were run on Bruker 
Avance II 800 MHz also equipped with a TXI cryoprobe. The acquisition 
parameters of individual experiments are detailed in Table 3.5. 
1D NMR data were processed using Topspin software (Bruker Biospin Ltd). 
Both 2D and 3D NMR data were processed using NMRPipe software (Delaglio 
et al., 1995). The data analysis was performed in NMRView 5.0 (One Moon 
Scientific, INC). 
3.8.2 Paramagnetic Data Processing 
The HSQC spectrum of '5N labelled AfaE with non-isotope-labelled CEA cys-
teine mutant was recorded. The assignment of the AfaE HSQC spectrum has 
been previously elucidated (Anderson et al., 2004a). In a 1H-15 N HSQC, non-
isotope-labelled CEA would be invisible, however, the paramagnetic centre on 
the paramagnetic label will affect the relaxation rates of the protons on AfaE, 
which will lead to line broadening and a decrease in peak intensity. Peak 
intensity ratios of paramagnetic labelled spectrum over diamagnetic labelled 
spectrum were calculated for each residue. 
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Table 3.5: NMR experiments and acquisition parameters 
Experiment Nucleus Complex Spectral 
Points Width /Hz 
HSQC 
1H 
1.5N 
1024 
128 
6250 
1666.67 
1H 512 6250 
HNCACB 15N 41 1666.67 
13C 55 8333.33 
1H 512 6250 
CBCA(CO)NH 1.5N 41 1666.67 
13C 24 8333.33 
1H 512 6250 
HNCO 15N 40 1666.67 
13C 55 8333.33 
1H 1024 6250 
HNCA(CO) 15N 39 1666.67 
13C 55 1666.67 
1H 512 6250 
HBHA(CO)NH 15N 41 1666.67 
1H (indirect) 64 3001.2 
1H 512 6250 
HC(C)H-TOCSY 1.5N 32 4401.4 
1H (indirect) 128 4752.85 
13c 128 8810.572 
(H)CCH-TOCSY 13C (J-coupled) 30 4402.377 
1H 512 6250 
1H 1024 10000 
15N NOESY-HSQC 15N 40 2666.67 
1H (indirect) 138 10000 
15N NOESY-HSQC 1H 1024 10000 
(800 MHz) 15N 26 14084.507 
1H (indirect) 140 10000 
15C NOESY-HSQC 1H 512 10000 
(950 MHz) 15C 50 7936.51 
1H (indirect) 109 9090.91 
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3.8.3 PRE Data Analysis 
For PRE measurements, 2D 1H-15N HSQC spectra were performed. In this 
study, the PRE effect was measured directly from peak intensities, which may 
decrease due to the broadening of the peak. Relaxation during all periods 
of the HSQC where 1H is in the transverse plane was considered, including 
the INEPT and acquisition period. Potential differences between in-phase and 
anti-phase 1H magnetisation were ignored. Besides, peak intensity reduction 
can also occur through R1  relaxation of 111 during the t l evolution time; how-
ever, paramagnetic-induced Rl relaxation is typically insignificant compared 
to the R2 effects. Relaxation effects (R2 or R,) on 15N nuclei from the spin 
label were considered to be negligible compared to 1H due to the much lower 
gyromagnetic ratio. During the INEPT delays the intensity and relaxation 
rate has following relationship (Equation 3.1): 
/ox ,--,e, e-R2t 	and /red r-zz: e-R 2 t 
	
(3.1) 
Where /ox and /red are the peak intensities of oxidised (paramagnetic) and 
reduced (diamagnetic) spectra, respectively. t is the total INEPT evolution 
time of the HSQC (r- 9 ms) and /4 and R2 are the transverse relaxation rates 
for oxidised and reduced amide spins, respectively. The intensity in the direct 
dimension of the HSQC is shown in Equation 3.2: 
1 
/red "-' R2 (3.2) 
Because the total electron spin-enhanced relaxation rate R; is a sum of R2 
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and spin contribution R. . 
= R2 ± R7 	 (3.3) 
So the intensity ratio of a particular amide proton is equal to 
Ired R2 ± Rf2P 
Imc 	R2 e-R7 t 	 (3.4) 
The intrinsic R2 relaxation rate for each amide was estimated for the re-
duced spectrum and along with the measured intensity ratios was used to 
linearly fit for Rs2P 
The distance r between electron and nuclear spins can be calculated via 
Equation 3.5. 
r = 
[
K 	3Tc  )] 6 
Ere ± 1 + co 2
h
72 
	 (3.5) 
rc is the correlation time for this electron-nuclear interaction, wh is the 
Larmor frequency of the nuclear spin, and K is 1.23 x 10-32 cift6s-2  composed 
of the following physical constants 
K = —
15 
S (S 1) 72g2/32 
	
(3.6) 
where -y is the nuclear gyromagnetic ratio, S is the electron spin, g is the 
electronic g factor, and 3 is the Bohr magneton. For calculating distance, the 
approximation was made that 7, was equal to the global correlation time of 
the protein. 
From the above equations, the relationship between distance and Para/Dia 
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Figure 3.6: Relationship between peak intensity ratio (I p IT 	and distance. The aro., -dm,1   
correlation time used is 12 ns, 1.2 ns and 0.12 ns which are corresponding to red, blue 
and black curve, respectively. 
ratio can be plotted, as shown in Figure 3.6. 
7, can be estimated from Debye — Stokes — Einstein relation in Equation 
3.7 (Krishna and Berliner, 1999): 
4 wrii3 
Tc = 	 
3kBT 
(3.7) 
Where kB is Boltzmann's constant. 7-, is dependent on the temperature 
(T), viscosity of the solvent (77,,) and also hydrodynamic radius of the protein 
(r H ), which is the sum of the radius of protein molecule and thickness of hydra-
tion layer. However the value of Tc (12 ns) is estimated from previous studies 
(Reid, 1997). Figure 3.6 shows that the distance restraint is not sensitive to 
one order of magnitude variation in total correlation time if an error range of 
+ 3 A is allowed. 
5 
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3.9 Protein-Protein Docking 
The computer programme named High Ambiguity Driven protein-protein Dock-
ing (HADDOCK) was used for docking the structures of protein complexes 
(de Vries et al., 2007; Dominguez et al., 2003). X-ray crystallography and 
NMR are two major methods for protein structure determination. However, 
both of these two techniques encounter difficulties in dealing with structures of 
complexes. Dynamics and size limitations are major problems for X-ray crys-
tallography and NMR, respectively. Only about 4%1  of Protein Data Bank de-
positions are of protein-protein/RNA/DNA complexes. However, various bio-
chemical and/or biophysical experimental data can be used for protein-protein 
interaction characterisation, including bioinformatics prediction, mutagenesis, 
NMR titration and NMR anisotropy data. HADDOCK can incorporate all 
of these different data as Ambiguous Interaction Restraints (AIRs) into the 
programme to drive the docking process. 
As suggested by the published protocol, to define AIRs, only residues with 
solvent accessibility higher than 50% are used, regardless of which experimen-
tal data are included. These high solvent accessible residues are classified into 
two groups as either 'active' or 'passive' residues which are those thought to 
be directly involved in the interaction and their neighbours, respectively. The 
definition of 'active' and 'passive' residues depends on the data. For mutagen-
esis data, for instance, the active residues are those that have been shown by 
mutations to eliminate the complex formation. For NMR chemical shift per-
turbation mapping, active residues will be those that have significant change 
1By June 2009, 2373 out of 58236 deposits in Protein Data Bank (PDB) are from Protein-
Protein/RNA/DNA complexes. 
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(3.8) 
in chemical shift or peak intensity. In this study, the paramagnetic NMR data 
were converted to the distance restraints with the relationship shown in Fig-
ure 3.6. An AIR is defined as an ambiguous intermolecular distance (diAB ) 
between any atom m of an active residue i of protein A (miA) and any atom 
n of both active and passive residues k (IV?, in total) of protein B (nkB ), and 
vice versa. The effective distance dieftfB for each restraint is calculated using 
the Equation 3.8. 
Where Natoms  indicates all atoms of a given residue and Nr„ the sum of 
active and passive residues for a given protein. The passive residues do not 
have direct AIRs to the partner protein but can satisfy the partner protein 
active restrants (Dominguez et al., 2003). The docking process consists of 
three different stages: 
1. Randomisation of orientations and rigid body energy minimisation (EM). 
The two partner proteins are positioned at 150 A from each other in 
space and each protein is randomly rotated around its centre of mass. 
Typically 1000 complex conformations are calculated and 200 structures 
with minimum intermolecular energies are refined. 
2. Semi-rigid simulated annealing in torsion angle space (TAD-SA). Three-
stage simulated annealing refinements are performed and resulting struc-
tures are then subjected to 200 steps of steepest descent EM. 
3. Final refinement in Cartesian space with explicit solvent. This step con-
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sists of refinement in an 8 A shell of TIP3P water molecules. The final 
structures are clustered using the pairwise backbone RMSD at the inter-
face. A cluster is defined as an ensemble of at least two conformations 
displaying an iRMSD (backbone RMSD at the interface) smaller than 
1.0 A. The resulting clusters are analyzed and ranked according to their 
average interaction energies (sum of Eel„, Evd,,, EAcs) and their average 
buried surface area. 
With the ability to integrate all kinds of biochemical and biophysical exper-
imental data together, HADDOCK provides a versatile and accurate docking of 
protein complexes, as judged by test cases with known complexes (Dominguez 
et al., 2003). 
As the peaks in the HSQC spectrum are quite noisy, generally only residues 
with peak intensity ratio of Ipara/Idia  less than 0.8 were considered affected by 
paramagnetic labels. 
HADDOCK version 1.2 with default parameter setting has been used for 
docking in this study. 
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Chapter 4 
Interaction between AfaE and 
N-CEA 
CEA (CEACAM5, CD66e) is one of the host-cell receptors for the AfaE ad-
hesin. However, no structures of complexes of the Afa/Dr adhesins with any 
of their receptors have been reported due to technical challenges, such as poor 
protein behaviour, and low interaction affinity (Wang, 2002). However, the 
structure of the complex could be of use for the design of novel inhibitory 
strategies to treat E. coli infections mediated by Afa/Dr adhesins. In this 
study, different techniques have been investigated for structure determination 
of the AfaE/N-CEA complex. 
4.1 Construct Optimisation 
The low solubility of N-CEA (about 20 AM in aqueous solution) and low AfaE-
CEA binding affinity makes it difficult to implement NMR studies on the 
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AfaE-CEA complex. Aimed at obtaining a more soluble and stable complex 
for structure determination, mutagenesis of both AfaE and N-CEA was first 
attempted. 
4.1.1 AfaE Mutagenesis 
Mutagenesis on AfaE was attempted for increasing the binding affinity between 
AfaE mutants and N-CEA. 
Previous studies have shown that the D52N, I85M and I111T mutations 
on DraE decrease affinity of binding to N-CEA (Korotkova et al., 2006a). 
Since DraE and AfaE only differ in three residues at three positions (D52, 185 
and Il 1 1 for DraE whilst N52, M85 and T111 for AfaE). N52 and T111 on 
AfaE were mutated to aspartic acid and isoleucine respectively to increase the 
affinity. Another residue M85I was also tested. The binding affinity for these 
AfaE mutants and N-CEA were measured by SPR. 
4.1.1.1 SPR Introduction 
Surface Plasmon Resonance records the evanescence electric field (E), total 
internal reflection (TIR) and surface Plasmon waves. When light propagates 
through two non-absorbing materials with different refractive indices and the 
incident angle is larger than a critical angle, the light will be reflected rather 
than refracted. This phenomenon is called total internal reflection. The net 
energy of the light beam will not be affected due to this reflection process. 
An evanescent wave is emitted, which decreases exponentially with distance 
from the interface. When the surface is covered with a thin metal layer, plane- 
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Figure 4.1: Experimental setup of an SPR experiment. The ligand was coupled to a 
dextran monolayer on the gold surface and analyte is passed over the surface. 
polarised incident light will penetrate into the metal and induce the electro-
magnetic surface Plasmon waves (Ricklin, 2005). 
In the SPR experiment, one binding ligand is usually coupled on the surface. 
An analyte is then passed over the surface of the flow cell. To avoid disrupt-
ing the binding and biological activity of the ligand, thiolated carboxymethyl 
dextran chains are used rather than direct coupling (Figure 4.1). 
The ligand are attached to the free carboxyl groups on the dextran via a co-
valent linkage. Theoretically, the signal is a stable baseline when only running 
buffer is passed over. Once the analyte has been passed, it starts associa-
tion at this stage, which is called association phase. After a certain period, 
equilibrium will be reached. Running buffer will replace the analyte once the 
injection is stopped, so the signal will go back to the level of baseline before 
association. When analytes are passed over the surface, a typical sensorgram 
can be obtained as shown in Figure 4.2. 
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a 
Figure 4.2: A typical SPR sensorgram. (a). Baseline signal level; (b). association 
until reach steady state; (c). dissociation; (d). regeneration. (e) signal back to original 
level. 
The unit of SPR response is the Resonance Unit (RU). The mass of molecules 
coupled to the surface affects the resonance units directly. Kinetic parameters 
such as association and dissociation rate constant (km, kof f ) then can be fitted 
and calculated from the binding curve pattern. 
4.1.1.2 SPR, Test for AfaE Mutants and Wild Type N-CEA 
N-CEA was immobilised on the CM5 (Biacore) chip while different forms of 
AfaE were passed over. 
A similar dose-dependent binding of the analyte (wild type and mutated 
AfaE, Figure 4.3) to the reference cells on the sensor chip CM5 was observed 
in all four binding tests (wild type CEA binding with wild type AfaE, AfaE 
N52D, AfaE I85M and AfaE T111I). For binding of AfaE N52D mutant to wild 
type CEA (data shown below), some binding curves showed negative values, 
which was probably due to the heterogeneity of immobilised ligand, as the 
CEACAM family exhibit homophilic interactions. Expression and solubility 
tests in this study confirm this, suggesting that there is not just one form of 
CEA on the sensor chip. Furthermore, amine coupling produces a random 
immobilisation, which can lead to multiple binding orientations of the analyte. 
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Figure 4.3: SPR sensorgram of wild type AfaE and wild type CEA. Lower trace shows 
RMSD of data fit into a 1:1 model. Reference cell signals have been subtracted from 
the sample cell. 
Data from the analyte flow cell with and without the reference cell response 
subtracted were fitted to the 1:1 binding model (Figure 4.4). 
The complex of wild type CEA and AfaE T111I mutant shows a similar 
sensorgram compared with that of WT CEA and WT AfaE (Figure 4.4), how-
ever, WT CEA binding with AfaE N52D (Figure 4.5) or I85M (Figure 4.6) 
mutants shows an abnormal binding character. The negative signal might 
mean either that there was more binding to reference cells than sample cells 
or the coupled CEA ligand on the sensor chip was disturbed by the AfaE. 
The binding affinity of these samples was fitted to a 1:1 binding model and 
summarised in Table 4.1. 
x2 values of all the KD values except that of wild-type AfaE are much 
higher than 10, which is typically the acceptable fitting level. Therefore the 
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Figure 4.4: SPR sensorgram of wild type CEA and AfaE T111I mutants. Lower trace 
shows RMSD of data fit into a 1:1 model. Reference cell signals have been subtracted 
from the sample cell. 
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Figure 4.5: SPR sensorgram of wild type CEA and AfaE N52D mutants. 
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Figure 4.6: sensorgram of wild type CEA and AfaE 185M mutants. 
Table 4.1: Data fitting of analyte How cell with reference cell signal subtracted 
Wild Type N52D I85M T111I 
KD/M 7.41 x 10-10 1.24 x 10-9  5.64 x 10-19  1.43 x 10 9 
Standard Error 6.81 x 10-6  1.07 x 10-5  9.77 x 10-6  5.59 x 10' 
X
2 1.76 x 10-3  79.6 316 2.13 x 103 
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data do not fit a 1:1 binding model. 
The major reason causing the sensorgram character and high x2 in the 
data fitting is the oligomerisation and heterogeneity of immobilised ligand. 
CEA forms a multimer even in a reducing SDS-PAGE gel, therefore some 
heterogeneity is likely to exist in the dextran layer. 
It is very difficult to obtain a reliable binding affinity from the above SPR 
binding data. However, it is quite obvious that different AfaE mutants give sig-
nificantly different binding patterns, which might indicate mutations at these 
positions may lead to very different binding models for these mutants. None of 
the AfaE mutants were thus used in the later studies to minimise the potential 
structure perturbation of the AfaE/CEA complex. 
4.1.2 N-Terminal CEA Mutagenesis 
A previous study has shown that the N-terminal Ig variable (Igv)-like domain 
of CEACAM is sufficient for bacteria to bind (Korotkova et al., 2006b). Only 
the N-terminal domain (N-CEA) has been used in this study. Based on the 
crystal structure of N-CEA solved by our collaborator, different mutations 
were carried out considering different physiological and biological properties. 
4.1.2.1 Crystal Structure of N-CEA 
The crystal structure of N-CEA (PDB id 2QSQ) has been solved by our col-
laborator at 1.8 A resolution (Figure 4.7) (Korotkova et al., 2008b). 
The primary, secondary and tertiary structures of N-CEA are very similar 
to those of CEACAM1 (Fedarovich et al., 2006; Tan et al., 2002). This dimeric 
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Figure 4.7: Stereo view of N-CEA dirner crystal structure. 
crystal structure was suggested to be a native conformation as two molecules 
in the asymmetric unit are related by a non-crystallographic twofold rotation 
axis. Indeed, residues Y34, V39, D40, R43 and Q44, previously reported as 
important for homophilic cell adhesion, were directly engaged in the binding 
interface in the dimeric crystal structure, as shown in Figure 4.8. 
This indicates that the interface shown in Figure 4.8 is involved in the 
physiological dimer. 
4.1.2.2 L18S/L2OT Double Mutation 
The hydrophobic character of amino acid side chains is considered to be a 
dominant driving force for protein folding. It is also one of the major factors 
determining protein stability (Tsai et al., 1997). CEACAM family members 
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Figure 4.8: Position of residues important for homophilic interaction on the dimeric 
CEA crystal structure. These residues locate at the binding interface of N-CEA dimeric 
interface. 
possess N-terminal domains that have large exposed hydrophobic areas. Fortu-
nately, the native CEACAM proteins in vivo are highly glycosylated and these 
sugars cover the hydrophobic area, leading to a more stable native protein in 
vivo. A previous study shows that N70 in CEACAM1 is a glycosylation site 
(Tan et al., 2002). The glycan at N70 is believed to cover the whole ,3-sheet 
hydrophobic region of --, 650 A2 including V7 and P8 on strand A, L18 and 
L20 on strand B, L74 on strand E, and probably also Y68 and 166 on strand 
D (Tan et al., 2002) (Figure 4.9). 
The same study has also shown that the glycan-shielded ABED face is much 
more conserved than the GFCC/C" face. This might indicate that the signif-
icance of the hydrophobicity in the ABED face is important to the solubility 
of the protein. As the N-CEA in this study is expressed in E. coli, the lack of 
glycosylation presumably contributes to the protein instability. The GFCC'C" 
face, whilst being hydrophobic in nature is conversely non-glycosylated in vivo. 
The L18S and L2OT double mutation on N-CEA (both on B strand of ABED 
face, hereinafter referred to as CEA1820) thus was designed to reduce the 
hydrophobicity on the ABED face (Figure 4.9a). CEA1820 mutant was well 
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b. 
Figure 4.9: Mapping of hydrophobic surface on N-CEA molecule. Hydrophobic 
residues of CEACAMla have been coloured in pink (both light and dark). a.ABED 
face exhibits high hydrophobicity. Leul8 and Leu20 have been coloured in deep pink. 
Asn70, which has been coloured in yellow, is believed to be a potential glycosylation 
site whose glycan covers the ABED hydrophobic face. b. Va139 has been coloured in 
red on the opposite face. 
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Figure 4.10: N-CEA L18S L2OT expression and solubility test. Cells were solubilised 
in Urea, B-PER® as soluble fractions and insoluble fraction, respectively. The size of 
the upper bands in the soluble fraction correspond to the size of N-CEA dirner, trimer 
and tetramer, respectively. 
expressed, as shown in Figure 4.10. 
CEA1820 mainly exists in the form of inclusion body when expressed in E. 
coli cells. Expressed N-CEA should have a molecular weight of 14.26 kDa. 
4.1.2.3 Va139A1a Mutation 
As shown in Figure 4.9b, the CC' loop on the GFCC'C" face exhibits a char-
acteristic bended conformation, and is also unique among the immunoglobulin 
superfamily (IgSF). Y34 and several hydrogen bonds are believed to keep the 
CC' loop in a rigid conformation. The bending in the region leads to the ex-
posure of the sidechain of 11e41. The whole region, Thr38-Thr39-A1a40-11e41 
is thought to be a biologically important motif for CEACAM1 binding to re-
ceptors such as to MHV spike glycoprotein (Tan et al., 2002). The V39A 
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Figure 4.11: N-CEA V39A expression and solubility test. Cells were solubilised in 
Urea, B-PER® as soluble fractions and insoluble fraction respectively. The size of the 
upper bands in soluble fraction corresponds to the size of N-CEA dimer, trimer and 
tetramer, respectively. 
substitution was thus investigated as a potential monomer promoting muta-
tion. 
N-CEA V39A (hereinafter referred to as CEA39) was also overexpressed, 
as shown in Figure 4.11. The CEA39 mutant exists mainly in an insoluble 
form as well as CEA1820 despite expressing well. 
4.1.2.4 Gel Filtration Profiling 
CEA1820 and CEA39 have similar expression levels as wild type CEA. Their 
oligomerisation states were tested with gel filtration (Figure 4.12). 
All three protein samples were purified from 1 L LB media and followed the 
same purification and refolding protocol. For wild type CEA, there are two 
peaks eluting at around 27 kDa and 13 kDa. These two peaks might correspond 
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Figure 4.12: Gel filtration profile of wild type CEA and its mutants. Wild type CEA, 
CEA V39A and CEA L18SL2OT are coloured in black, blue and red, respectively. 
to dimer and monomer, which should be 28.5 kDa and 14.3 kDa, respectively. 
The wild type CEA thus exists mainly in dimeric form in solution. The long 
tails of both of these two proteins indicates a dynamic association/dissociation 
process. 
CEA1820 shows about a two fold increase in protein solution concentration. 
It is also predominantly in a dimeric form as the peak elution volume is closer 
to its theoretical size of dimer. The sharp peak indicates CEA1820 in solution 
is more homogeneous than the other two proteins. This might indicate that 
the CEA1820 mutation impairs hydrophobic homophilic interaction and leads 
to sample with high solubility. 
The gel filtration profile shows that the protein size of CEA39 is closer 
to monomer and also a more homogeneous sample compared with wild type, 
which is consistent with previous publication that V39A mutation was able to 
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Figure 4.13: Gel filtration profile of wild type AfaE, CEA1820 and their complex. 
abolish its dimerisation (Watt et al., 2001). The peak appears at molecular 
size slightly greater than theoretical monomer indicating the residue V39 is 
likely involved in the homophilic interaction of CEA (Watt et al., 2001), and 
a dynamic exchange might exist between monomer and dimer. 
To keep its native dimeric solution behaviour and avoid potential alterna-
tion in biological function, CEA1820 has been used in this study. "N-CEA" 
and "CEA" in the following text regarding experiments done in this study are 
referred to as CEA1820. 
4.1.2.5 Purification of the AfaE/CEA Complex 
Gel filtration was attempted to purify the protein complex of AfaE and CEA1820 
(Figure 4.13). 
Purified wild type AfaE, which is 17.1 kDa and CEA1820 were mixed. The 
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tiny peak at around 35 kDa might be AfaE/CEA1820 complex at around 1:1 
ratio. It was concluded the infeasibility of obtaining AfaE/CEA complex via 
mutations and gel filtration separation. As has been reported previously for 
WT AfaE/CEA interaction, the failure of the purification via gel filtration 
might be due to low affinity and dynamic exchange. 
4.2 	Structure Determination of AfaE/CEA Com- 
plex 
4.2.1 Preliminary model of the AfaE/CEA complex 
HADDOCK was used for NMR restraint-guided docking. The initial restraints 
were derived from previously published mutagenesis data (Korotkova et al., 
2006b,a). 
Before starting the HADDOCK calculation, Ambiguous Interaction Re-
straints (AIRs) need to be generated. At this step, surface exposed (solvent 
accessible area greater than 40 % in this case) residues were classified into ac-
tive or passive judged from whether they participate in binding or not. AfaE 
residues R6, P27, Q31, L33, R70, M72, S75, A76, D88 (Korotkova et al., 
2006a) and G133 and CEA residues F29, D40 and Q44 have been reported as 
key amino acids in the AfaE/CEA interaction (Korotkova et al., 2006b). The 
solvent accessible area for these two proteins was calculated by the programme 
NACCESS (http://www.bioinf.manchester.ac.uk/naccess/).  
After solvent accessible area filtering, AfaE residues R6, P27, Q31, L33, 
M72, A76, D88 and G133 and CEA residue F29, D40 and Q44 were classified 
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a. 	 b. 
Figure 4.14: AIR definition for AfaE (a) and N-CEA (b). Active residues have been 
coloured in pink. Passive residues have been coloured in green and residues responsible 
for binding but have solvent accessible area less than 50 % were coloured in yellow. 
Table 4.2: Ambiguous residues defined for preliminary structure of AfaE/CEA com-
plex 
AfaE 
	Active Res. 	6,27,31,33,70,72,75,76,88,133 
Passive Res. 	2,22,29,73,74,79,87,91,134 
CEA 
	Active Res. 	29,40,44 
Passive Res. 	39,41,42,56,59,93 
as "active" residues. Surface neighbouring residues were also solvent accessible 
area filtered and classified as "passive" according to the published protocol, as 
shown in Table 4.2 (Figure 4.14). 
The docking process followed the default protocol. 200 final refined struc-
tures for the AfaE/CEA complex were clustered according to a pair-wise 
R.MSD cut-off of 1.5 A, producing a single, large cluster. The average flexible 
interface energy for the best cluster was -1527+59 kcal-mol'. The preliminary 
docking model is shown in Figure 4.15. 
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4.2.2 Site-Directed Spin Labelling 
Paramagnetic site-directed spin labelling can provide distance information be-
tween the paramagnetic centre and protons within about 25 A of the param-
agnetic centre. In this study, paramagnetic centres were introduced into the 
CEA protein via disulphide bond to mutated cysteine residues. AfaE was 15 N 
isotope labelled, the PRE on AfaE which is caused by a paramagnetic cen-
tre on CEA could thus be monitored in '11-15 N HSQC spectra as non-isotope 
labelled CEA is invisible. 
4.2.2.1 Labelling Position Selection 
To minimise the structural disruption on AfaE/CEA complex, candidate residues 
for cysteine mutagenesis were chosen near the binding face of the preliminary 
structure (above) but not within it, and also ideally with the side chain point-
ing outwards from the binding interface. Although 12 different positions on 
CEA were tested, many were either unstable or had low expression levels; 
however, five mutants gave useable data for the structure calculation. The 
single-site mutants chosen were V39C, R43C, Q54C and L95C, as shown in 
Figure 4.15. 
4.2.2.2 Quantification of AfaE and CEA Concentrations 
Our collaborator has shown that the Afa/CEA interaction fits to a 1:1 bind-
ing model by SPR studies. 2D 1H-15 N HSQC spectra were recorded in the 
presence of either MTSL-labelled or dMTSL labelled mutant N-CEA at a 1:1 
molar ratio of AfaE:CEA. The AfaE/CEA concentration was initially brought 
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Figure 4.15: Paramagnetic label positions based on the preliminary structure. AfaE 
is coloured green and CEA is coloured purple. The positions of five labels are coloured 
yellow. 
to 1:1 based on the UV2sonm  measurement. However, the resulting CEA con-
centration was deemed about 10 times higher than that of AfaE, based on 
signal-to-noise ratio of an NIVIR 1D 1H spectrum. For the following studies, 
the relative quantification of these two binding partner were thus judged from 
the structured methyl group signal intensities (Figure 4.16). 
4.2.2.3 Parallel Labelling for Control 
Previous studies show that "appropriately placed" nitroxide spin labels should 
provide little or no perturbation on the structure of the protein complex (Liang 
et al., 2006). However, to check for the possible interference of the label, a 
diamagnetic control was applied to the same position as a reference. 
The paramagnetic label is about 8 A in length and could potentially inter- 
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Figure 4.16: Protein sample quantitation via structured methyl group comparison. 
The red and blue arrows indicate the methyl group signals of CEA R43C and AfaE, 
respectively. The similar intensity indicates a similar concentration of the two binding 
partners. 
122 
a. 
10: 
10! 
10i 
10! 
111 
113 
115 
117 
119. 
121 
12.": 
12: 
127 
125 
131 
* 
• ° 	0 	• 00  o . e ®  • Tow 	e• h& 
o ft 	0 4 1w61 o ®o 00 ire 0 cf° 0 • 	. 	0 
8 	o 0 ,as 
n.-- 	
• I% 
0 a ab • © % 
e 0. e°  a do o 0 
• 
• o 	0 o # 	 f o 8 e A 1000 : 0 • 
[33 0 fir 	0  
% ' d' 0o 0 	
0 
0 0& 	 • 
• 
0W92 00 
00 0  
o 
0 	° (10 CZ 	0 
0 
0 0 
A320 
0 0  
0 
0 
0 
0 
9.5 9.3 9.1 8.9 8.7 8.5 8.3 8.1 7.9 7.7 7.5 7.3 7.1 6.9 6.7 
b. 
Figure 4.17: Effect of diamagnetic labels. (a.). HSQC spectrum of 15N labelled AfaE 
with (red) and without (black) diamagnetic labelled CEA L95C. The peak labelled with 
a blue star is a sidechain peak. (b). Most obviously affected residues in HSQC were 
mapped on the preliminary structure. (Green:AfaE; Purple,CEA; Pink, Affected AfaE 
residues; Red, CEA L95C label) 
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fere with the native protein surface. A diamagnetic label with a similar size 
and chemical structure as that of a paramagnetic label was thus introduced 
to allow for these effects to be taken into account. The most affected residues 
were A32, L33 and W92 in the HSQC mapping (Figure 4.17a). These three 
residues are located close to each other on the structure (Figure 4.17b), sug-
gesting that the decrease in peak intensity is likely caused by the diamagnetic 
label attached close to them. 
As can be seen in the 2D HSQC spectrum of AfaE in complex with CEA 
L95C (Figure 4.17) chemical shifts are unperturbed by the label, indicating 
the structure is unaffected. However, slight broadening of a small number 
of residues was observed. Given that the PRE effect is inferred from peak 
intensities this indicates the importance of diamagnetic control experiments. 
4.2.2.4 Paramagnetic Relaxation Enhancement (PRE) Data 
Due to paramagnetic relaxation enhancement (see Chapter 2), several peaks 
in the paramagnetic labelled sample showed significant broadening compared 
to those of the diamagnetic labelled sample. 
Both Figure 4.17 and Figure 4.18 show an overlay of spectra without notice-
able shifts, meaning that the complexes of AfaE with paramagnetic labelled 
CEA and CEA without label are nearly identical. The addition of diamag-
netic label also leaves the AfaE spectrum unchanged. The peaks that have 
significant changes in intensity (indicated by arrows in Figure 4.18) are those 
affected by the paramagnetic centre introduced by the labels. 
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Figure 4.18: HSQC of 15N AfaE with paramagnetic (red) and diamagnetic (black) 
labelled CEA L95C. 
4.2.3 PRE Data Analysis 
The peak intensities of paramagnetic labelled and diamagnetic labelled sam-
ples for every AfaE residue were measured in NMRView (version 5), using in-
house scripts for peak picking. The ratio was plotted against residue number 
as shown in the following figures (Figure 4.19A, Figure 4.20A, Figure 4.21A, 
Figure 4.22A and Figure 4.23A). In these figures, the relative orientation be-
tween AfaE and CEA might be different from the actual complex since the 
preliminary docking complex model has been used. 
131- 
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4.2.3.1 AfaE with CEA L95C-labelled 
The overlay of 1H-15 N HSQC spectrum of 15 N AfaE with either paramagnetic 
or diamagnetic labelled CEA L95C is shown in Figure 4.18. 
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Figure 4.19: PRE experiment data analysis of AfaE/CEA L95C-labelled. A).11-1-15 N 
HSQC peak intensity ratio plotted against residue number of paramagnetic labelled 
sample over diamagnetic labelled reference for the 15N AfaE/CEA L95C complex. Red 
bars shows residues that were most affected, followed by pink, green to a lesser ex-
tent. Blue bars indicate paramagnetic intensity higher than the reference sample. B). 
Residues affected by the paramagnetic centre were mapped on the preliminary structure 
of the complex. Red, pink to green are AfaE residues which are most, medium and least 
affected by the paramagnetic label. L95C on N-CEA is also labelled in red. 
The affected residues are visually classified into three groups based on their 
degree of broadening and mapped on the structure in Figure 4.19b. The af-
fected residues are located within a well defined region judging from the struc-
ture of the complex. However, one exception is residue 157 which has a slightly 
lower I paralidia ratio than the noise level. It is situated at the other side of the 
AfaE structure with respect to the other affected residues. 
Residues from the paramagnetic labelled sample with higher intensities 
than the diamagnetic labelled sample have been coloured in blue in Figure 
4.19. There might be several explanations for this apparent increase. A32, 
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V40 and L33 are relatively weak peaks in the HSQC spectrum (Figure 4.18) 
and thus the noise level thus cannot be neglected. Another possibility is peak 
overlap. Residue G90, for example, is partially overlapped by another residue. 
These situations could explain positive results. 
Therefore, analysing the surrounding residues is important for excluding 
false positive results. Ideally, the region affected by the paramagnetic centre 
should show a "dip" in the intensity vs. residue plot, shown in a red dotted 
line in Figure 4.19. 157 was deemed to be artefactual by visual inspection as 
no surrounding residues showed any diminishment and was taken out of the 
final HADDOCK refinement calculation. It was caused by possible overlap 
with residue V28, as shown in Figure 4.18. 
The residues which are supposedly responsible for binding (Figure 4.19b) 
are located in the same area on the structure. This gives qualitative support 
that the data are reliable despite the low binding affinity. 157 is located on the 
opposite face of the protein from the other residues, which doubly confirms it 
is not genuinely broadened by the paramagnetic centre. 
4.2.3.2 AfaE with CEA V39C 
The overlay of '11-15N HSQC spectra of '5N  AfaE with either paramagnetic or 
diamagnetic labelled CEA V39C is shown in Figure 4.20. 
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Figure 4.20: PRE experiment data analysis of AfaE/CEA V39C-labelled. A).1H-15 N 
HSQC peak intensity ratio plotted against residue number of paramagnetic labelled 
sample over diamagnetic labelled reference for the 15 N AfaE/CEA V39C complex. Red 
bars shows residues that were most affected, followed by pink to a lesser extent. Blue 
bars indicate paramagnetic intensity higher than the reference sample. B). Residues 
affected by the paramagnetic centre were mapped on the preliminary structure of the 
complex. Red and green are AfaE residues which are most, and less affected by the 
paramagnetic label. V39C on N-CEA is also labelled in red. C). 1 H-15 N HSQC of 15 N 
AfaE with paramagnetic (red) and diamagnetic (black) labelled CEA V39C. 
128 
121 
le 	
0 • 
2  es  9  
12 	2 G 	 am co 
o  
a i e 0 608 • • 
0, 
12 	 j
Z en  	
..-1. 0 oo 	e eu  
12 13e 	 , 
131 	 0 0  
O ,: 0  
9.6 9.4 9.2 u.0 8.8 8.6 8.4 8.2 8.0 7.8 7.6 
111 
11 
The data are quite noisy compared to that of the CEA L95C mutant, which 
might be caused by a lower affinity. As CEA residue V39 is important for re-
ceptor recognition, it is possible that it is situated at the binding interface of 
N-CEA to AfaE. In other words, the para- or diamagnetic label could poten-
tially disturb the structure of the complex. However, mapping of the most 
broadened residues on the molecule reveals a distinct region on the surface. 
The data were thus still used for the final calculation. 
Residue Q51 shows a ratio of 1.61, which is unusual in a PRE experiment. 
This may be caused by partial overlap with another residue. 
4.2.3.3 AfaE with CEA R43C 
The overlay of 111-15N HSQC spectra of 15N AfaE with either paramagnetic or 
diamagnetic labelled CEA R43C is shown in Figure 4.21. 
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Figure 4.21: PRE experiment data analysis of AfaE/CEA R43C-labelled. A).1H-15 N 
HSQC peak intensity ratio plotted against residue number of paramagnetic labelled 
sample over diamagnetic labelled reference for the 15 N AfaE/CEA R43C complex. Red 
bars shows residues that were most affected, followed by pink, green to a lesser ex-
tent. Blue bars indicate paramagnetic intensity higher than the reference sample. B). 
Residues affected by the paramagnetic centre were mapped on the preliminary struc-
ture of the complex. Red, pink to green arc AfaE residues which are most, medium and 
least affected by the paramagnetic label. R43C on N-CEA is also labelled in red. C). 
1H-15 N HSQC of 15 N AfaE with paramagnetic (red) and diamagnetic (black) labelled 
CEA R43C. 
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The most affected AfaE residues 30, 37 and 38 are within the region of the 
binding interface and are consistent with the preliminary structure. However, 
residues K43 and T143 were slightly affected by the paramagnetic label and are 
located at another side of the binding interface. These residues are excluded 
from the final refinement calculation judging from their neighbouring residues 
which are not affected by the paramagnetic label. 
4.2.3.4 AfaE with CEA Q54C 
The overlay of 11-1-15N HSQC spectra of 15N AfaE with either paramagnetic or 
diamagnetic labelled CEA Q54C is shown in Figure 4.22. 
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Figure 4.22: PRE experiment data analysis of AfaE/CEA Q54C-labelled. A).11-1-15 N 
HSQC peak intensity ratio plotted against residue number of paramagnetic labelled 
sample over diamagnetic labelled reference for the 15 N AfaE/CEA Q54C complex. Red 
bars shows residues that were most affected, followed by pink, green to a lesser ex-
tent. Blue bars indicate paramagnetic intensity higher than the reference sample. B). 
Residues affected by the paramagnetic centre were mapped on the preliminary struc-
ture of the complex. Red, pink to green are AfaE residues which are most, medium and 
least affected by the paramagnetic label. Q54C on N-CEA is also labelled in red. C). 
1H-15 N HSQC of 15N AfaE with paramagnetic (red) and diamagnetic (black) labelled 
CEA Q54C. 	 132 
The CEA Q54C mutant shows a consistent binding interface when mapped 
on the structure, with the most affected residues situated in the centre and 
surrounded by residues less affected residues. 
4.2.3.5 AfaE with CEA L20C as Control 
The overlay of 'II-15 N HSQC spectra of 15 N AfaE with either paramagnetic or 
diamagnetic labelled CEA L20C is shown in Figure 4.23. 
133 
12 
12 
a 
o 
0 
0 
12 
13 
B. 
Leu 0,  
II 	411( 
' 	 101!\14 
1.3-
1.2-
1.1-
1.0 - 
0.9:  
0.8- 
3  0.7 
0.6: 
0.5 - 
0.4: 
0.3: 
0.2: 
0.0 	 
10 20 30 40 50 60 70 	0 90 10 110 20 130 140 
Resi.N . 
C. 
10 
11 
11 
11 
11 
11 
12 
12 
0 0 i 
a 6 
& 99  ge Oph 
u 0 	0 	' 	0 
a 
c 0  (1 0 	0 0 	,o 
0  a 	 0  0 
o o-2 oo 
4 
b 
6.5 
9.6 9.4 9.2 9.0 8.8 8.6 8.4 8.2 8.0 7.8 7.6 7.4 7.2 I.0 b.13 6.6 
Figure 4.23: PRE experiment data analysis of AfaE/CEA L20C-labelled. A). 1H-15 N 
HSQC peak intensity ratio plot against residue number of paramagnetic labelled sample 
over diamagnetic labelled reference for 15 N AfaE with CEA L20C complex. No major 
peak diminish was found. B). No peaks with major diminish has been observed. L20C 
on N-CEA was also labelled in red. C). 1H-15 N HSQC of 15 N AfaE with paramagnetic 
(red) and diamagnetic (black) labelled CEA L20C 
To validate the spin labelling experiment, Mutation L20C was chosen as 
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a control. Residue L20 is located remotely from the presumed binding site. 
Theoretically no paramagnetic relaxation enhancement should be observed. 
The result matches well with assumption. Although residue 43 shows a sig-
nificantly broadened peak, neither residue 41, 42 nor residue 44, 45 show any 
peak intensity influenced by the paramagnetic label. 
4.2.3.6 Summary 
The concentrations of the different CEA mutants was around 40-50 µM, which 
is approaching the detection limit for spectra with high enough S/N to al-
low quantitative analysis of peak intensities of 500 MHz NMR Spectrometer 
equipped with CryoProbe (if keeping the ratio of AfaE to CEA at 1:1). Al-
though the HSQC spectra were recorded for at least 128 scans per increment, 
the protein signal was still quite noisy. Some residues which were less intense 
than others in HSQC spectrum were approaching the noise level and thus were 
not considered for analysis. This can be seen in the CEA V39C mutant, where 
many fewer data points were recorded (Figure 4.20). However, it is possi-
ble that residues most affected by the paramagnetic label may be completely 
broadened in the spectrum and are therefore absent in the analysis. 
All HSQC spectra for these different titration experiments show no large 
chemical shift perturbations compared to the WT-AfaE HSQC spectrum. This 
allows the existing chemical shift assignment to be used in the data interpre-
tation. Importantly, it also means the structures of the complex with labels 
at different position are very similar. 
All of the six samples of AfaE with different CEA mutants lost signals for 
residues numbering from 27 to 36. These residues map to the presumed binding 
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interface of AfaE and N-CEA complex, shown in Figure 4.24, which may also 
suggest that this region of AfaE might undergo conformational exchange or 
that they are in intermediate timescale exchange between the free and bound 
forms or just change in dynamics generally. 
Figure 4.24: AfaE/CEA preliminary structure with AfaE residues from 27 to 36 
highlighted. These residues are "missing" from HSQC spectra of 15N AfaE and different 
labelled CEA mutant. 
The signal to noise ratio of the complex might also be affected by binding 
affinity. Ideally, the higher the affinity, the intenser paramagnetic effects could 
be reached due to a more rigid complex. To this end, saturating the titration 
by adding more CEA might help, but unfortunately, higher concentration leads 
to aggregation of the complex. 
Some AfaE residues apparently show stronger peak intensities in the pres-
ence of paramagnetic labelled CEA compared to diamagnetic labelled CEA, 
as shown in blue bars in the above figures. This is likely just a reflection of the 
noise level. As the genuine peak intensity was low, the contribution of noise 
to the ipara  dia ratio is thus considerable and thus all the bars on the plot 
have to be checked manually and considered in the context of neighbouring 
residues. 
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Table 4.3: The unambiguous distance restraint used for AfaE/N-CEA 
CEA Residue AfaE Residue Distance /A 	Error(+)/A 	Error(-)/A 
11 	 14.6 	 8 	 4 
30 13.7 8 4 
114 	 11.4 	 8 	 4 
Q54C 	 116 14.1 8 4 
118 	 13.0 	 8 	 4 
134 13.2 8 4 
136 	 12.1 	 8 	 4 
137 12.7 8 4 
11 	 15.7 	 8 	 4 
12 15.7 8 4 
30 	 14.0 	 8 	 4 
72 15.7 8 4 
V39C 	 73 	 15.7 	 8 	 4 
74 15.7 8 4 
75 	 15.1 	 8 	 4 
76 12.7 8 4 
95 	 12.5 	 8 	 4 
96 15.1 8 4 
37 	 14.5 	 8 	 4 
R43C 
	 89 14.3 8 4 
90 	 13.8 	 8 	4 
91 13.5 8 4 
4.2.4 HADDOCK Calculation 
The degree of intensity decrease was converted to distance restraints according 
to the calibration curve (see Section 3.8.3 on Page 97). PRE distance restraints 
used for the final calculation are as follows. 
As the distance calculated for HADDOCK simulation is the distance from 
the paramagnetic centre to its affected amide proton, the protein with the 
MTSL coupled to cysteine was built, as shown in Figure 4.25. 
The position of the MTSL molecule shown in Figure 4.25 has been sterically 
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Figure 4.25: Stick representation of N-CEA L95C with the paramagnetic label at-
tached. The distance from the paramagnetic centre to the backbone Ca is about 11 
A. 
optimised via energy minimisation. As the distance from the paramagnetic 
unpaired electron to the backbone amide is about 11 A, the error range was 
calibrated for the docking process and leads to a final range between plus 8 A 
and minus 4 A. 
These distance restraints were introduced into HADDOCK as unambiguous 
restraints. The ambiguous restraints shown in Table 4.2 used for preliminary 
structure calculation were also integrated into the final calculation, as ambigu-
ous restraints. 
The 200 final water-refined structures for the AfaE/N-CEA complex were 
clustered according to a pairwise RMSD cut-off of 2.0 A, producing a single 
cluster of 130 structures. The average intermolecular interaction energy for 
this cluster was -2042 ± 46 kcal•mol-1. Figure 4.26a shows an overlay of the 
10 water-refined structures with the lowest interaction energies from the top 
cluster. 
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b. 
a. 
Figure 4.26: Refined AfaE/N-CEA complex model. (a). C„ traces representing the 
superposition of 10 refined structures of the AfaE (orange)/N-CEA (purple) complex. 
(b).Stereo view of a ribbon representation of the structure of AfaE (orange)/N-CEA 
(purple) complex. 
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Table 4.4: N-CEA L95C PRE distance restraints for HADDOCK calculation 
CEA 	AfaE 	Cal.Distance Error(+)/A Error(-)/A Actual Distancet 
Resi. 	Resi. 	/A 	 /A 
11 	13.7 	8 	 4 	 11.7 
12 	15.5 8 4 10.3 
13 	13.2 	8 	 4 	 11.9 
26 	14.0 8 4 5.2 
L95C 	70 	15.9 	8 	 4 	 13.0 
72 	13.5 8 4 10.8 
74 	16.5 	8 	 4 	 14.9 
97 	14.3 8 4 9.6 
98 	13.1 	8 	 4 	 11.4 
99 	16.4 8 4 12.7 
t Distance from the 11.7 of L95 to the amide of the corresponding AfaE residue. 
4.2.5 Structure Validation 
The N-CEA L95C spin labelling data, which was not included in the refine-
ment, was used for validation of the complex model. The calculated distance 
from PRE and actual distance measured from the complex model is compared 
in Table 4.4. 
The distances from the L95 of CEA to the corresponding AfaE residues are 
within the allowed error range of the calculated distance from the PRE except 
AfaE residue number 26. The actual distance of 5.2 A is slightly out of range, 
which may be due to longer side-chain of the para-/dia- magnetic label than 
the leucine side-chain. The AfaE/N-CEA complex model was considered to be 
consistent with the N-CEA L95C PRE distance restraints within the allowed 
error range. 
Figure 4.27 shows a consistent pattern of N-CEA L95C PREs mapped on 
the proposed AfaE/N-CEA complex model. No information was collected for 
residues coloured in yellow as these are prolines so would have no peak in 
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Figure 4.27: AfaE/N-CEA complex model validation. L95C has been colour in deep 
blue. A faE residues affected by spin labels have been coloured in red. AfaE residues 
affected to a less extent are coloured in pink. The residues coloured in yellow arc Pro24 
and Pro27. 
1H-15 N HSQC spectra. The results show that the L95C-label quantitatively 
validates the binding model. 
The structured model shows that the N-CEA binding site resides on strands 
A2, B and E of AfaE and buries approximately 1446 A2 of surface area. The 
structural statistics for the cluster of 130 structures are shown in Table 4.5. 
The complex model suggests that key AfaE side-chains contributing to the 
interaction include P27, T29 and Q31 from strand B; S91 and T95 from strand 
E and L10 from strand A2. N-CEA residues F29, Y34, Q44, P59, 191 and L95 
form the principle contacts at the interface, as shown in Figure 4.28. 
The mutagenesis data reviewed in the introduction section have also been 
mapped on the model of the complex (Figure 4.29). 
Figure 4.29 shows a superposition of the N-CEA crystal structure (PDB: 
2QSQ) and the structure of the AfaE/N-CEA complex (PDB: 2VER), which 
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Table 4.5: Structural statistics for cluster of 130 models of AfaE/N-CEA complex 
Construct and PDB code for deposited co-ordinates 	AfaE-dsc/N- 
CEA (2VER) 
Number of intermolecular restraints 
Total unambiguous PRE-derived 
Total ambiguous CSP-derived 
RMSD from experimental restraints and idealized cova- 
lent geometry 
Intermolecular restraints (A) 
Bonds (A) 
Angles (degree) 
Energies (kcal mol-1 ) 
ENOE 
Ebond 
Eangle 
Evdw 
Co-ordinate RMSD (A) 
All backbone atoms with the interface 
All backbone atoms 
46 
12 
0.46 ± 0.03 
0.0033 + 0.00004 
0.47 ± 0.007 
19.8 ± 2.5 
43.5 ± 1.1 
241 ± 7.0 
—1334 ± 18.5 
1.3 + 0.4 
1.6 ± 0.7 
Figure 4.28: Key residues involved in AfaE/N-CEA binding. AfaE is coloured in 
orange and N-CEA in light purple. 
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Figure 4.29: Representation of the superposition of the N-CEA dimer (purple ribbon 
and grey surface) and the AfaE/N-CEA complex (orange ribbon and grey surface). 
Structures are superposed over a single N-CEA molecule. The slab thickness is chosen 
to illustrate only the key interacting structural elements from AfaE and N-CEA. Key 
side-chains are coloured indicating the results of the mutagenesis experiments: Red 
signifies whether mutation of this position affects only the AfaE-dsc interaction, green 
for N-CEA dimerisation only and yellow where mutations affect either both interactions 
or only the AfaE interaction. 
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indicates a good consistency with the previously published mutagenesis data. 
The red residues which are those affected N-CEA binding to AfaE only have 
close contact to the AfaE molecule at loop AB and loop DD' (L95 and D40). 
The mutants that affect N-CEA dimerisation are situated in positions that 
overlap with the interface between N-CEA and AfaE (F29, 191 and Q44) (see 
Figure 1.13 on Page 57). 
4.3 Interaction between Dr adhesin and N-
CEA 
4.3.1 Mutagenesis Data of Dr adhesin/CEA Interaction 
A previous study shows that residues F29, D40 and Q44 of N-CEA are impor-
tant for interactions with E. coli Dr adhesins (Korotkova et al., 2006b). More 
mutants were examined in this study, as shown in Table 4.6. 
N-CEA mutants F29I, D40A, I91A and L95A have apparently lower affinity 
than wild type CEA binding to DraE. Interestingly, N-CEA mutants S32N, 
V39A and E99A behave like monomers and possess comparable magnitudes of 
dissociation constants to wild-type N-CEA. These results indicate that DraE 
can bind to N-CEA, regardless of its oligomeric state. Our collaborator has 
also shown that DraE/CEA binding data fit better a 1:1 stoichiometry of N-
CEA and DraE, which implies two binding possibilities (Natalia Korotkova, 
Department of Biochemistry, University of Washington, Seattle, WA 98195-
7242, USA). One is that either a single N-CEA dimer binds to two DraE 
molecules. The second possibility is that DraE can trigger the dissociation of 
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Table 4.6: Apparent DraE adhesion/N-CEA mutant dissociation constant (KD) 
CEA mutants Structuret 	KD (µM) 
N-CEA 	Dimer 	13.1 ± 2.5* 
F29R Monomer 	> 200 
F29I 	 Dimer > 200 
S32N Monomer 	12.8 ± 1.3* 
V39A 	 Monomer 	9.4 + 1.3* 
D40A Dimer 48.9 ± 3.1* 
Q44R 	 Monomer 	> 2001  
Q44L Monomer > 100 
Y68A 	 Dimer 	6.0 ± 0.8 
L74A Dimer 10.2 ± 0.9 
Q76A 	 Dimer 	14.6 ± 1.2 
H89Q Dimer 6.5 ± 0.5 
191A 	 Monomer 	55.0 ± 4.5 
L95A Dimer No binding 
L95S 	 Monomer 	> 100 
L95C Dimer > 100 
E99A 	 Monomer 	3.0 ± 0.8 
Note: The binding affinity was measured via SPR. The details are referred to Korotkova et al. 2008b 
t Data based on gel filtration properties. 
Affinity of N-CEA mutants to surface-bound DraE as reported in Korotkova et al. 2006b 
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N-CEA dimers before binding to monomers. 
4.3.2 Dr Adhesin and N-CEA V39C Dimer/Native Dimer 
To verify the interaction between the Dr adhesin and dimeric CEA, a CEA 
dimer covalently joined through a disulphide bond was constructed by our 
collaborator. From the structure shown in Figure 4.8 on Page 112, residue V39 
on one subunit makes a hydrophobic contact with V39 on the other subunit, 
and the two amino acids are separated by 2.6 A, a distance comparable to that 
of a disulphide bond. The structure of the covalently linked dimer of CEA 
V39C mutant has also been solved by X-ray crystallography (PDB id 2QST) 
(Natalia Korotkova, Department of Biochemistry, University of Washington, 
Seattle, WA 98195-7242, USA). The relative position of the two subunits in the 
V39C dimer is almost identical to that in the native N-CEA dimer. However, 
they differ slightly in the relative orientations of their monomeric subunits by a 
rotation of approximately 5-10 degrees. Therefore, the covalently linked V39C 
dimer and native N-CEA dimer share highly similar structures. 
SPR was used to measure the binding of the CEA V39C dimer to DraE. 
The N-CEA dimer was immobilised on the sensor chip and DraE fimbriae 
were passed through as analytes. No positive signal change was observed, 
which indicates no binding was detectable when DraE was passed over the 
sensor surface, as shown in Figure 4.30a. 
However, when 20 mM DTT was passed over the sensor chip before inject-
ing the DraE fimbriae, a positive binding signal was detected when DraE fim-
briae were passed through. Because the DTT is able to reduce the disulphide 
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Figure 4.30: SPR sensorgram of N-CEA V39C dimer and DraE interaction. N-CEA 
V39C was immobilised on the sensor chip. (a). DraE fimbriae passed thought the 
chip. No binding was detected. (b). The sensor surface was treated with 20 mm DTT 
injected for 3 min prior to the analysis. The sensorgram shows the interaction between 
CEA V39C and DraE fimbriae. (S and E refer to the start and end of injection) (This 
experiment was carried out by Dr. Natalia Korotkova) 
bond, this experiment indicates the DraE could bind to monomeric N-CEA 
(Figure 4.30b). These studies show that DraE does not bind to an N-CEA 
dimer, and the 1:1 binding stoichiometry (Section 4.3.1) is due to the dissoci-
ation of N-CEA dimer by DraE. 
With the help of previous published Tetramethylrhodamine iodoacetamide 
(TMRIA) labelling technique (Hamman et al., 1996), our collaborator demon-
strated that the binding of DraE dissociates the N-CEA dimer (Korotkova 
et al., 2008b). 
4.4 Discussion 
4.4.1 Sample Optimisation via Mutagenesis 
Sample optimisation has been performed to obtain a complex more amenable 
for further structural analysis. However, mutation of N-CEA and/or AfaE did 
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Figure 4.31: Hydrophobic V39 and G41 of N-CEA were surrounded by hydrophilic 
residues. The N-CEA molecule is coloured was colour by residue hydrophobicity from 
low to high in the pattern of `cyan/white/magenta' spectrum. The hydrophobic (black 
circle) surrounded by hydrophilic residues area (blue circle) is a typical cell surface 
receptor-ligand pattern. 
riot lead to any further improvement in solubility of the protein complex sam-
ple. For N-CEA, two different mutants L18S/L2OT and V39A were created. 
N-CEA V39A and D40A have been reported to cause a reduction in ho-
mophilic interactions (Watt et al., 2001). However, the CC' loop of N-CEA, 
where V39 and D40 reside, have been reported to be a biologically important 
binding site. The Y34 residue is conserved among the CEACAM family and 
its probable role is to keep the CC' loop maintained in a rigid conformation 
(Tan et al., 2002). Several potential hydrogen bonds are thought to con-
tribute to keep the conformation. For this characteristic pattern (Figure 4.9b 
on Page 113), it has been generally accepted that hydrophobic surface burial 
contributes most free energy to the binding of ligands, while their surrounding 
hydrophilic interactions contribute to the binding specificity (Clackson and 
Wells, 1995; Kim et al., 2001). 
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Residues V39 and G41 are surrounded by more hydrophilic residues (Figure 
4.31). This region is believed to be a binding site for many different recep-
tors, such as mouse hepatitis virus in the case of murine CEACAM1a (Tan 
et al., 2002). It is possible that for CEA, this same region is also important 
for homophilic interactions as the crystal structure of the native homodimer 
indicates that this region is buried at the interface. The N-terminal domains 
of many CEACAM family members are capable of binding to multiple opacity-
associated (Opa) proteins. The CEA crystal structure resolved in this study 
verified the presumption in the previous study (Tan et al., 2002). The CC' 
loop of CEA brings V39 and G41 together to form an integrated binding site. 
The V39A mutation was not used for sample optimisation in this study due 
to its possible biological significance. 
Hydrophobic burial is the one of the dominating driving forces in terms of 
protein folding and interaction. N70 is highly conserved among the CEACAM 
family and is supposedly a glycosylation site. The large glycan at this site 
covers the whole ABED face, including V7, P8 on the A strand, L18 and L20 
of the B strand, L74 on the E strand and Y68 and 166 of the D strand, and 
probably also Y68 and 166 of the D strand, an area --,650 A2. The glycan 
patch may stabilise the protein by shielding the hydrophobic area. Since the 
biological significance of the glycan is unknown and a previous report suggested 
that the ABED face is not important for binding, N-CEA L18S/L2OT was 
selected as a suitable mutant for structural studies. 
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4.4.2 Homophilic and heterophilic interaction of CEA-
CAMs 
CEA is expressed at high level and also widely distributed in epithelial cell 
membranes in the healthy adult intestine (Benchimol et al., 1989). It is usually 
linked to cytoskeletal proteins that facilitate pathogen access into their host 
cells after initial attachment. In this study, the crystal structure of native N-
CEA dimer and NMR-derived structure of the AfaE/CEA complex show that 
the N-CEA region responsible for E. coli Afa/Dr adhesin binding partially 
overlaps the region responsible for dimerisation. 
The size exclusion chromatography and analytical ultracentrifugation car-
ried out by our collaborator show that the N-CEA forms a homodimer with 
KD=0.8 µM (±0.4 itM). In the N-CEA dimer, the hydrophilic amino acid on 
one subunit could possibly form hydrogen bonds with the same residue on 
another subunit (Figure 4.8). Hydrophobic residue pairing of F29, V39, G41, 
191 and L95 of the associated N-CEA subunit can also provide the hydropho-
bic driving force to the N-CEA dimerisation. These hydrophobic contacts are 
crucial for the dimerisation because mutation of F29R, V39A, I91A and L95S 
(Table 4.6) dramatically reduce the homophilic interaction of N-CEA. The 
observation of an N-CEA dimer in solution implies that the CEA could poten-
tially mediate cell surface dimerisation in vivo, which is also characteristic of 
other proteins in the Ig super family. 
CEA receptors are also involved in heterophilic interactions with other 
members of the CEACAM family. Compared with CEA, CEACAM6 has three 
amino acid differences (F29I, Q44L and H89Q), which occur in the predicted 
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dimerisation region. Single mutation of Q44L on CEA has been reported to 
abolish its homophilic interactions. SPR studies reveal a low binding affin-
ity between CEA and CEACAM6 complex, which is consistent with the data 
showing poor cell adherence mediated by CEA/CEACAM6 contacts (Oikawa 
et al., 2000). Our collaborator has analysed the impact of mutations inhibiting 
CEA self-association on heterophilic binding of CEA to CEACAM1 and CEA-
CAM6. Some mutations that impair CEA dimerisation significantly lowered 
CEA/CEACAM1 and CEA/CEACAM6 binding affinity, suggesting that the 
region responsible for CEA dimerisation is also important for binding to other 
CEACAM proteins (heterophilic interaction). However, Q44R mutation of N-
CEA significantly increased binding affinity to CEACAM6. This amino acid is 
present exclusively in CEACAM8, among all the CEACAM proteins. A previ-
ous study shows that the CEACAM8 only binds to CEACAM6 for heterophilic 
interaction in a cell adherence assay (Kuroki et al., 2001). CEACAM8 is thus 
a potential physiological ligand of CEACAM6. These heterophilic interactions 
of CEA suggest that the homophilic and heterophilic interactions of all the 
CEACAM proteins probably use a similar binding mechanism. 
4.4.3 Interaction between the Dr adhesins and CEA-
CAMs 
The Afa/Dr adhesin of E. coli (DraE) recognises the N-terminal domain of 
CEA, CEACAM1, CEACAM3 and CEACAM6. This demonstrates that the 
CEA region directly engaging in dimerisation and the Afa/Dr adhesin recog-
nition partially overlap. All the residues mapped by mutagenesis affecting 
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Figure 4.32: Mapping CEA residues engaging in Neisseria gonorrhoeae and 
Haemophilus influenza binding. The native N-CEA solution dimer is shown in both 
(a) and (b). One subunit is shown as a surface representation and another subunit 
is shown as ribbon. The residues which are important for Neisseria gonorrhoeae and 
Haemophilus influenza are colored in orange (a) and yellow (b), respectively. 
both CEA dimerisation and Afa/Dr adhesin recognition reside in the over-
lapped binding interface. This suggests that Afa/Dr adhesins compete for 
N-CEA binding sites with existing N-CEA monomers. Neisseria gonorrhoeae 
expresses 11 isoforms of a certain adhesin called Opacity-related (Opa) pro-
teins. Opa adhesins can recognise CEA as well. It has been reported that the 
key residues on CEA responsible for Opa binding are F29, S32 and G41 (Bos 
et al., 1999). Haemophilus influenzae has also been reported to bind to CEA-
CAM receptors and residues critical for adherence are S32, Y34, V39, Q44, 
Q89 and 191 (Villullas et al., 2007) (Figure 4.32). 
Figure 4.32 shows that both the Neisseria gonorrhoeae and Haemophilus 
influenza binding regions on N-CEA reside on the Afa/Dr adhesin binding and 
dimerisation interface of N-CEA. This indicates that this area is responsible 
for a wide range of interactions. 
SPR analysis indicates that Afa/Dr adhesin does not bind to covalently 
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linked CEA V39C, which suggests that the CEA recognition of Afa/Dr adhesin 
would disrupt both homophilic and heterophilic interactions. 
The mechanisms of Afa/Dr adhesin binding to CEA was further analysed 
by attaching TMRIA to cysteine residues of CEA. Binding of TMRIA-labelled 
N-CEA to DraE resulted in a reduction of homodimer, which suggests that 
homophilic interaction of CEACAMs is disrupted by bacterial adhesions. It 
is thus possible that the Afa/Dr adhesin first binds an N-CEA dimer, triggers 
the dissociation of the CEA dimer to monomers, which enables the Afa/Dr to 
bind an N-CEA monomer. 
A similar mechanism has also been found in the invasion of Coxsackie 
virus. Coxsackie virus recognises its receptor CAR, which helps maintain the 
conformation of the tight junction (Cohen et al., 2001; van Raaij et al., 2000). 
The recognition disrupts the tight junction between epithelia, which assists 
the dispersion of Coxsackie virus (Walters et al., 2002). 
For CEACAM, targeting by Afa/Dr adhesins could also lead to a series 
of cellular signals. The tyrosine residues in the two immunoreceptor tyrosine-
based inhibitory motifs (ITIMs) on the cytoplasmic domain of CEACAM1 can 
be phosphorylated in epithelial and immune cells (Gray-Owen and Blumberg, 
2006). These two phosphorylated tyrosine residues can capture the protein 
tyrosine phosphatase (SHP1). However, for a CEACAM1 dimer, spatial hin-
drance makes the cytoplasmic domain impossible to harbour the SHP1 but 
allows binding of SRC-family protein tyrosine kinases (PTKs) (Obrink, 1997; 
Obrink et al., 2002). Therefore Afa/Dr adhesin binding to CEACAM1 may 
also trigger dissociation of the CEACAM1 homodimer, leading to the alterna-
tion of cell signalling pathways. 
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Chapter 5 
Interaction between AfaE and 
Decay Accelerating Factor 
(DAF) 
5.1 Introduction 
Decay-Accelerating Factor (DAF) is a 70 kDa plasma membrane protein that is 
broadly distributed on all blood cells and on endothelial and epithelial cells. It 
is a complement regulatory protein which protects autologous cells and tissues 
from complement-mediated damage by inhibiting the complement cascade at 
the C3 convertase step (Lublin, 2005). DAF thus plays vital roles in preventing 
or modulating autoimmune disease and inflammation. Besides this, DAF is 
also responsible for Afa/Dr adhesin recognition and can ultimately lead to 
internalisation. Different complementary control protein (CCP) domains from 
DAF in this case, have been expressed and tested for AfaE interaction in this 
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study. 
5.2 Construct Optimisation and Protein Ex-
pression 
DAF is a highly glycosylated protein in vivo. The expression of DAF in E. 
coli lacks this glycosylation on the surface which is hypothesized to cause the 
poor solution behaviour of DAF. Different approaches have been attempted 
for achieving a better behaved sample. 
5.2.1 Fusion with Thioredoxin Tag 
Thioredoxin has the ability to facilitate the reduction of other proteins by cys-
teine thiol-disulfide exchange. It thus has been widely used as a solubilisation 
tag especially in E. coli expression systems to assist the correct folding and 
keep them from precipitating. DAF containing the second and third CCP do-
main (DAF23) and all four CCP domains (DAF1234) were first cloned into 
pET-32 LIC (Merck) and tested (Figure 5.1). 
The sizes of DAF23 and DAF1234 with the thioredoxin tag are about 28 
and 38 kDa, respectively. The bands shown in red boxes correspond to the 
expected sizes of the proteins, however, no similar bands were found for the 
samples either taken at 3 hours after induction or no induction at all, which 
suggests the fusion protein is well expressed but is only expressed in significant 
amount 4 hours after induction. 
These protein samples were tested by 1D 'H NMR spectra, as shown in 
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M 
Size 
/kDa 
36.5 
31 
DAF23 with Trx 
1 2 3 4 5 
DAF1234 with Trx 
7 8 9 10 11 12 
Figure 5.1: SDS-PAGE of the expression test for DAF23 and DAF1234 fused with 
thioredoxin. Lane 1 and 2: soluble and insoluble fractions of sample harvested 3 hours 
after induction. Lane 3 and 4: soluble and insoluble fractions of sample harvest 4 hours 
after induction. Lane 5 and 6: soluble and insoluble fractions of uninduced sample. 
Lanes from 7 to 12 are the same fractions of DAF1234. 
Figure 5.2 and Figure 5.3. 
Both Figure 5.2 and Figure 5.3 suggest that both DAF23 and DAF1234 
fused with thioredoxin possess the same pattern of structured methyl peaks 
(around 0 ppm). Compared with thioredoxin on its own, no extra peaks were 
found in both cases, which suggests both DAF23 and DAF1234 are not struc-
tured. This was also verified by cleaving the thioredoxin off (spectra not 
shown). A strong peak at around 1 ppm also suggests a large portion of 
the molecules is unstructured. These two experiments indicate that the fusion 
with thioredoxin did not help produce structured soluble protein. 
5.2.2 DAF Constructs in the pQE-30 Vector 
Different DAF constructs were cloned into the pQE-30 vector with a His-tag 
fusion at the C-terminus only. The genes were transformed into M15 cells to-
gether with the pR,EP4 (codes for the lac repressor and neomycin phosphotran- 
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Thioredoxin 
10 	9 	8 	 6 	5 	4 	3 	2 	1 	0 	-1 	ppm 
Figure 5.2: 1D 1H spectrum of DAF23 with a thioredoxin tag. 1D 1H Spectrum of 
structured methyl peaks of thioredoxin is shown in red box. 
Thioredoxin 
• I 	..... 	• I 
10 9 8 7 	6 4 	3 	2 	1 	0 ppm 
Figure 5.3: 1D 1 H spectrum of DAF1234 with a thioredoxin tag. 1D 1H Spectrum of 
structured methyl peaks of thioredoxin is shown in red box. 
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DAF23_pQE-30 
Size 
/kDa 
21.5 
14.4 •+ 
6.0 Jaw 
I. 
Figure 5.4: SDS-PAGE of samples from the expression test of DAF23 in pQE-30. M 
indicates molecular weight marker. Lane 1 & 2, 3 & 4, 5 & 6 and 7 & 8 are soluble and 
insoluble fraction of protein sample harvested at 1, 2, 3 and 4 hours after induction, 
respectively. The red box shows where the bands are expected. 
ferase) plasmid following the protocol in Section 3.2. The protein expression 
level was analysed by SDS-PAGE (Figure 5.4). 
The expression of DAF23 in pQE-30 did not show a noticeable expression 
level of protein. 
5.2.3 DAF Constructs in the pET-32 Vector 
DAF constructs were also cloned into a pET-32 vector with a His-tag only. The 
genes were transformed into BL21(DE3) cells. The expression was analyzed 
by SDS-PAGE. 
The bands in the red box in Figure 5.5 indicate the protein was successfully 
expressed when cloned into the pET-32 plasmid. However, the protein exists 
mainly within inclusion bodies in an insoluble form. The protein was thus 
purified under denaturing conditions and different refolding protocols were 
attempted in subsequent studies. 
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Size 
/kDa 
21.5 
14.4 
6.0 AM 
DAF23_pET-32 
1 2 3 4 5 6 
Figure 5.5: SDS-PAGE of samples from the expression test of DAF23 in pET-32. M 
indicates molecular weight marker. Lane 1 & 2, 3 & 4, 5 & 6 and 7 & 8 are soluble and 
insoluble fraction of protein sample harvested at 1, 2, 3 and 4 hours after induction, 
respectively. 
5.3 Refolding of Inclusion Bodies 
The protein was purified under denaturing conditions and dialysed into pH 8.0 
phosphate buffer with 1 M urea overnight and then into pH 5.0 acetate buffer. 
The protocol has been described in detail in Chapter 3. 
No obvious methyl group peaks were observed in the 1D 1H NMR spectrum 
and the poor dispersion of the amide region also agrees with this (Figure 5.6). 
The protein is concluded to be unstructured. 
In contrast, the protein appeared to be correctly folded following the "rapid 
dilution" refolding method which involves instantly diluting denatured protein 
by 100 times in volume to 10 nM (White et al., 2004). A 1D 111 spectrum of 
the protein obtained under these conditions is shown in Figure 5.7. 
Ring current shielded methyl group peaks around 0 ppm and a dispersed 
amide envelope suggest the protein is structured. 
In summary, the construct optimization experiments suggest cloning the 
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Figure 5.6: 1D 1H NMR of DAF23 refolded by dialysis. The protein is mostly un-
structured. 
Figure 5.7: 1D 1H NMR spectrum of DAF23 refolded by rapid dilution. The struc-
tured methyl peak suggests DAF23 is folded. 
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DAF gene into the pET-32 vector yields an acceptable level of expression and 
fusion with the thioredoxin tag did not facilitate protein folding. Rapid dilution 
into native buffer successfully refolds the protein. All DAF constructs used in 
subsequent studies were cloned into the pET-32 plasmid with a His-tag only 
and were then refolded by rapid dilution, which has been detailed in Section 
3.4.2. 
5.4 AfaE/DAF Binding NMR Titration Ex-
periment 
Different DAF constructs have been titrated with 15 N AfaE for binding analysis 
via NMR HSQC spectra. However, due to the low concentration of the DAF 
construct, 15 N AfaE was used to monitor the interaction. The peak intensity 
in the methyl regions of the two proteins was used to estimate relative protein 
concentration for the titration. 
5.4.1 15 N AfaE titrated with DAF3 
A previous study has shown that AfaE-III binds to both CCP-2 and CCP-3 
of DAF protein but that CCP-3 contributes more to the binding (Anderson 
et al., 2004b). The single domain of CCP-3 has been cloned out separately for 
this study. AfaE was 15 N isotope labelled and titrated with unlabelled DAF3 
protein as follows (Figure 5.8). DAF3 (100 ,uM) and 50 /./M were first tested. 
15N AfaE was then added to 200 pcM via steps of 50 p,M. 
A significant number of peaks changed either their chemical shift or inten- 
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127 
12.c A
f  off• 
4 • 
131 
9.6 9.4 9.2 9.0 8.8 8.6 8.4 8.2 8.0 7.8 7.6 7.4 7.2 7.0 6.8 6.6 
Figure 5.8: HSQC spectrum of 15 N labelled AfaE before (black) and after (red) 
titration with unlabelled DAF3. The molar ratio of AfaE to DAF3 is 1:1 (blue) and 1:2 
(red). 
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Figure 5.9: HSQC of '5N AfaE (200 ii114) with DAF1234 (50 ii1V1). The molar ratio of 
'5 N AfaE to DAF1234 is 4:1 (Red). Black: 15 N AfaE. 
sity during the titration. 
5.4.2 15N AfaE titrated with DAF1234 
The full length DAF (DAF1234) was successfully refolded and titrated with 
AfaE, as shown in Figure 5.9. 
Because of the low signal to noise ratio in higher stoichiometrics of the 
complex, only those residues which have a significant change in intensity or 
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W92 \ 
G T134 G118  
tT135 
G119 
G136 	D45 
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—90° 
Figure 5.10: Key AfaE residue mapping for binding to full length DAF1234. 
chemical shifts have been mapped. These residues are mapped on the AfaE 
molecule, as show in Figure 5.10. As the S/N level of peak intensity in the 
titration is relatively low and no noticeable peak shift were observed, the key 
residues engage in binding were picked by the average broadening of their 
peaks. 
The affected residues T134, T135, G136 and T138 reside on the G strand 
of AfaE, while residues T113, L116, G118 and 0119 on the F strand, L56 on 
the C2 strand, D45, G52 in C1C2 loop and V7 in the A1A2 loop are also 
perturbed. These residues form a major binding interface on AfaE for binding 
to DAF1234. Residues A32 and W92 are close to V7 and form a binding 
interface "extension" to the AfaE surface. 
Further additions of DAF1234 to 15 N AfaE titration resulted in the spec-
trum in Figure 5.11. 
Most of the AfaE peaks are broadened beyond detection presumably due 
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Figure 5.11: NMR titration of 15N AfaE (100 itM) with full length DAF1234 (50 
pM). The molar ratio of 15N AfaE to DAF1234 is about 2:1. 
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Figure 5.12: NMR titration of 15N AfaE with DAF domains CCP2 and 3. 15N AfaE 
before titration is shown in black. Blue, green and red are 100 AM DAF23 with 50 AM, 
100 AM and 200 AMM of AfaE, respectively. 
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to fast T2 relaxation in the large molecular weight complex (46.7 kDa if with 
1:1 stoichiometry). 
5.4.3 15 N AfaE titrated with DAF23 
Previous studies show that both DAF domain CCP2 and CCP3 participated 
in Afa/Dr adhesin binding. DAF23 was successfully cloned and titrated with 
AfaE, as shown in Figure 5.12. 
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Figure 5.13: Key AfaE residue mapping for binding to DAF domains CCP2 and 3. 
The orientation of the molecule shown in the Figure 5.13 is as the same as that in Figure 
5.11. 
The binding interfaces of 15 N AfaE binding to DAF23 and DAF1234 are 
consistent with each other. However, in the case of DAF1234 binding, the large 
molecular weight of the complex broadened out many of the peaks. Compared 
with DAF1234 binding, additional residues are apparent, especially on the 
extension of the major binding interface, such as V5, L33 and G34 (Figure 
5.13). These are presumably also involved in the interaction with full-length 
DAF but were not picked up in the spectrum of the sub-stoichiometric ratio. 
5.5 	HADDOCK simulation of AfaE/DAF bind- 
ing complex 
A HADDOCK model was generated using restraints from either those mapped 
in the '51V AfaE and DAF23 titration or those described by the previous study 
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via mutagenesis scanning (Hasan et al., 2002). These residues were then filtered 
by solvent accessible area greater than 50 % (as determined by NACCESS). 
The following residues were those obtained as "active": L33, G34, E50, Q51, 
K53, W92, G94, T134 and T137. The "passive" residues are thus those surface 
neighbours of active residues which have a solvent accessible area greater than 
50 % (as suggested by the standard HADDOCK protocol). These residues are 
1, 2, 6, 9, 11, 29, 31, 46, 60, 62, 72, 73, 74, 76, 78, 79, 87, 88, 89, 91, 93, 124, 
125, 126 and 127. 
For the DAF protein, previous experimental data were used (Anderson 
et al., 2004b; Van Loy et al., 2002a). Residues have been renumbered to be 
consistent with the PDB deposited structure 1OJV. Residues E67, 182, N85, 
E96, G176 and 5182 were classified as active resides, whilst residues 63, 64, 68, 
69, 70, 71, 73, 79, 80, 83, 86, 92, 97, 99, 102, 105, 110, 119, 127, 128, 132,133, 
135, 136, 138, 149, 151, 158, 163, 166, 168, 171, 173, 174, 175, 177, 180, 181, 
184, 185, 186, 187, 189 and 190 have been classified as passive residues based 
on the above criteria. 
The HADDOCK 2.0 webserver was used for the docking (Figure 5.14). 
The docking process produced 10 clusters and the docking parameters of 
the lowest energy cluster are shown in Table 5.1. 
The data imported for docking is solely from the NMR titration carried 
out in this study. It is in line with previous publications that show both CCP2 
and CCP3 contributed to the binding. 
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Figure 5.14: AfaE/DAF23 complex docking model. AfaE is coloured in orange while 
DAF23 in purple. 
Table 5.1: Docking parameter of AfaE/DAF23 complex 
Construct and PDB code for deposited co- 
ordinates 
AfaE-dsc/DAF23 
HADDOCK score -76.4 ± 0.3 
RMSD from the overall lowest-energy structure 2.1 ± 1.3 
van der Waals energy (kcal • mol-1) -51.3 ± 11.4 
Electrostatic energy (kcal • mol -1) -268.8 ± 29.9 
Desolvation energy (kcal • mol -1) 18.7 ± 5.5 
Restraints violation energy (kcal mot') 99.3 ± 29.82 
Buried Surface Area (A2) 1723.0 ± 130.3 
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5.6 Analysis of the Model for the AfaE/DAF 
Complex 
5.6.1 Surface electrostatic potential analysis 
The stability of protein complexes is also governed by forces determining pro-
tein folding, including hydrogen bonds, van der Waals forces and electrostatic 
interactions plus the hydrophobic effects. Electrostatic potential complemen-
tarity has been shown to enhance protein-protein interactions (McCoy et al., 
1997). The surface potential of the AfaE/DAF23 complex has been analysed 
with Pymol. 
The negatively charged residues Asp45, Asp47, G1u50, Asp59 and Asp63 
of AfaE are located right on the binding interface which provides a large neg-
atively charged patch (Figure 5.15). The binding area of the AfaE region on 
DAF23 is positively charged and would therefore contribute significantly to 
AfaE/DAF binding via the complementary electrostatic charge. 
5.6.2 Hydrophobicity Properties 
Hydrophobic interactions can contribute considerably to protein-protein in-
teraction (PPI) (Tsai et al., 1997). The protein folding or PPI free energy 
contributed by the hydrophobic effect is around —15±1.2 cal/mol (Eisenberg 
and McLachlan, 1986; Vallone et al., 1998). 
No large hydrophobic patch has been identified in the model (Figure 5.16), 
however there is a slightly overlapping hydrophobic area on the DAF CCP3 
and AfaE surface, which might be one of the reasons CCP3 has higher affinity 
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Figure 5.15: Surface electrostatic properties of AfaE/DAF complex. The figure shows 
a 180° rotation of the HADDOCK model. Either AfaE or DAF23 is shown as a surface 
and the other shown in ribbon. AfaE was shown in orange ribbon and DAF23 in 
green ribbon. The surface is coloured according to the surface potential, from negative 
to positive charge in "red/white/blue" style spectrum. The region in the black circle 
shows possible electrostatic attraction which contributes to binding. 
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Figure 5.16: Surface hydrophobicity of AfaE/DAF23 complex. The residues with 
hydrophobicity from low to high was coloured from bluegreen to white then to magenta 
(most hydrophobic). The hydrophobicity scale refers to Kyte and Doolittle (1982). The 
region in red circle shows a possible region of hydrophobic complementarity which may 
contribute to the free energy of binding. 
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binding to AfaE compared to CCP2. 
5.7 Further Discussion 
This study provides a docking model for the structure of a Afa/Dr adhesin 
and DAF protein complex. The E. coli protein expression system is the most 
widely used so far and it provides a quick and reliable approach for recom-
binant protein studies. However, E. coli does not provide post-translational 
modifications such as glycosylation to the protein expressed. DAF is a glycosy-
lated protein in vivo. The lack of glycan at its surface may lead to a less stable 
form. Previous studies have shown that the N-linked glycan at N61, which 
resides at the interface between domain 1 and 2 is not involved in regulatory 
activity (Brodbeck et al., 2000) or recognising the Afa/Dr adhesin (Servin, 
2005). An E. coli expression system was thus used in this study. For getting 
a suitable sample for structural studies, various protein refolding techniques 
have been attempted. Gentle removal of denaturant by dialysis is the most 
common method used and was also the first to be tried in this study. How-
ever, no DAF construct was successfully refolded via dialysis. Different DAF 
constructs in this study were rapidly diluted from 1 pcM in 20 mL to 10 nM 
in 2 L refolding buffer which contains 0.5 M arginine, cysteine and also cys-
tine. Arginine has been reported previously to suppress protein aggregation 
during the refolding although the mechanism is still unknown (Tsumoto et al., 
2004). As the DAF is a cysteine rich protein (16 cysteines in the full length 
four domain construct), the free cysteine and cystine provided in the refolding 
solution might provide a dynamic exchange with the native cysteine of the 
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DAF construct, aiding disulphide bond formation. 
The docking model has shown that the AfaE binds to both CCP2 and CCP3 
(Hasan et al., 2002). However, previous mutagenesis data made by Hasan et al. 
(2002) do not map to the same location as the residues in the docking model, 
shown in yellow in Figure 5.17. Wild type Dr adhesin (DraE) was used in 
that study rather than AfaE, therefore it is possible that they bind to different 
regions on the protein. However, these two proteins display 98.1 % identity by 
differing in only 3 residues, with one of them on the DAF binding interface. 
It is also possible that the residues reported in the DAF mutagenesis that 
are important for binding actually stabilise the binding region of DAF CCP3. 
Another possible binding mechanism is also possible from our current data. 
AfaE could bind to both CCP2 and CCP3, in which case these binding events 
could compete with each other as well. This could be further analysed by 
NMR titration experiments between 15 N labelled DAF protein and unlabelled 
AfaE, from which the binding site on the DAF can be identified. 
DAF is a complement regulatory protein (CRP) which interacts directly 
with membrane-bound C3b or C4b. This recognition prevents the amplifica-
tion of the complement cascade in the host cell surface by inhibiting uptake 
of C2 and factor B. Previous studies have shown that the L149S/F150S muta-
tion diminishes DAF regulatory activity on both the classical and alternative 
pathway C3 convertases and mutation KKK from 127 to 129 to TTT has a 
mild effect on classical pathway regulation while it completely abolishes its 
alternative pathway regulatory activity. It is possible these residues are di-
rectly involved in the complement regulation. However, it is also possible that 
these mutations cause conformational changes for DAF as both L149 and F150 
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Figure 5.17: Mapping Residues which affect complementary system regulation on the 
AfaE/DAF binding model. AfaE is coloured in orange. DAF is shown as a surface 
representation and coloured in light purple. The residues coloured in red are L149, 
F150, K127, K128 and K129, which are supposed to be essential either for classical 
pathway regulation or alternative pathway regulation or both. The residues coloured 
in yellow have been reported to be important for Dr adhesin binding, which is far from 
the binding interface proposed in this study. 
arc large hydrophobic amino acids while KKK127-129 form a very positively 
charged region. These residues are mapped on the binding model resolved in 
this study, as shown in Figure 5.17. 
The AfaE/DAF structure shows that K129 is situated in the middle of the 
binding interface. Other residues which participate in complement regulation 
are too far from the actual binding region. The region on DAF responsible 
for Dr adhesin binding is partially overlapped with the region responsible for 
complement regulation. The hypothesis that Afa/Dr binding to DAF interferes 
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with the complement regulation function has then been verified at atomic 
resolution. 
However, all the above discussion is based on the relative position between 
these two domains. The flexibility between these two domains has not been 
addressed so far. 
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Chapter 6 
Structural Studies of AafA 
In this section, a brief introduction on the biology of AafA and the NMR ex-
periments for its structural determination is described. The solution structure 
of AafA has been successfully determined and also compared with AfaE. 
6.1 Biological Introduction 
6.1.1 Enteroaggregative Escherichia coli (EAEC) 
Enteroaggregative E. coli was first reported in 1987 and is believed to cause 
persistent diarrhoea in children and adults in both developing and developed 
countries. EAEC adheres to Hep-2 cells by aggregating in a "stacked-brick" 
manner to form a bacterial biofilm (Figure 1.1d). They do not secrete either 
heat-stable or heat labile enterotoxins (Nataro et al., 1998a). 
The EAEC strains first colonise the intestinal mucosa and then secrete 
enterotoxin and cytotoxins e.g. Shigella enterotoxin 1 (ShET1), the plasmid-
encoded toxin (Pet), and the enteroaggregative E. coli heat-stable toxin (EAST1) 
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into epithelial cells. EAEC infection causes watery diarrhoea, occasionally with 
blood and mucus. Patients typically experience mild intestinal inflammation. 
EAEC strains adhere to Hep-2 cells and intestinal mucosa by fimbrial struc-
tures known as aggregative adherence fimbriae (AAFs), which belong to the 
Afa/Dr family of adhesins. Three variants of AAFs including AAF-I, AAF-II 
and AAF-III have been identified and recently a fourth adhesin, called Hda, 
was found (Boisen et al., 2008). Interestingly, each of them are present in only 
a small portion of strains (Farfan et al., 2008). 
AAFs are encoded on a 60-65 MDa plasmid called pAA, which also en-
codes enterotoxin EAST1 and also Pet in some cases. Most of the previously 
described EAEC factors are under control of the global regulator called AggR, 
which is also encoded by pAA. 
As part of the Afa/Dr family of adhesins, AAF is also assembled via the 
chaperone-usher passway, which requires a periplasmic chaperone, an outer 
membrane usher protein and two surface-expressed subunits. The surface sub-
units include a major subunit and putative cap subunit. The chaperone and 
usher proteins are highly conserved among the family however, the major sur-
face subunits are quite divergent. 
6.1.2 AAF-II 
Based on the sequences of the major fimbrial subunits, four distinct AAF 
variants have been described. These four AAF variants include AAF-I, AAF-II, 
AAF-III and HdaA, which are encoded by the aggA, aafA, agg3A and hda gene 
clusters, respectively. AAF-II was the second EAEC adherence factor to be 
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Figure 6.1: Gene cluster of AAF-II. AAF-related reading frames are showed with 
purple arrows. The enterotoxins encoding pet and astA genes are shown with hollow 
arrows. 
described and is a 5 nm diameter fibre which is morphologically, antigenically 
and genetically distinct from AAF-I. Previous studies show that the aafA 
gene was part of a cluster of potential fimbrial biogenesis genes (Elias et al., 
1999b). Aaf-II is organised as two unlinked regions, region 1 includes aafA, the 
structural fimbrial subunit, aafR and the chaperone aafD. The usher protein 
aafC is located within region 2, shown in Figure 6.1. 
The protein has homology (encoded by aafC) to the chaperone genes of 
other fimbrial operons. Downstream of aafA are the Insertion Sequences 1 
(IS1) genes which have 98% identity to the /51 from the afa-3 cluster. Up-
stream of AAF-II, region 2 has a locus, aafD', which shows 57% nucleotide 
identity to the aafD genes, and also to other members of the PapD chaperone 
family of proteins. Downstream from the aafD' locus and in the same orien-
tation is a gene that has been designated aafC. aafC is 2583 nucleotides in 
length and encodes a protein that is 80% identical to AfaC, which is the usher 
protein of AFA-III. Downstream from the aafC protein was an ORF of 438 bp 
transcribed in the same direction, named aafB, which has a mass of 16.1 kDa. 
The aafB gene exhibits 59% identity to the invasin protein AfaD of AFA-III. 
AafB is 56% identical to the AggB protein of the AAF-I biogenesis cluster 
arid is thought to be a cap protein of the fimbrial, although this has not been 
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Figure 6.2: Sequence alignment of aafA-dsc and afaE-dsc. Predicted secondary struc-
ture is shown in red arrows. Similar residues are coloured in pale green while identical 
residues are coloured in green. 
proved (Elias et al., 1999b). 
6.1.3 AafA 
The Aaf-II organelle is comprised of two structural subunits, where AafA is the 
major one, which form the fimbrial structure. AafA exhibits 44.0% similarity 
and 14.8% identity to AfaE from AFA-III. The donor strand complemented 
sequence (see Chapter 1) alignment is shown in Figure 6.2. 
The protein sequence alignment shows the similarity between AafA and 
AfaE (coloured residues in Figure 6.2). The secondary and tertiary structures 
are thus thought to be the same for these two different proteins. The cysteine 
resides C3 and C35 are conserved, which indicate the potential disulphide 
bridge between these two cysteine residues might also exist in AafA. Aromatic 
residue Y135 and most hydrophobic residues are also conserved, which also 
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strongly suggests the high tertiary structure similarity between these two pro-
teins. 
6.1.4 Receptors 
AAF subunits are phylogenetically related to those of the Afa/Dr family. 
The AfaE adhesin binds to several receptors, including CEACAMs, decay-
accelerating factor (DAF). However, no previous study has shown whether 
AAF adhesin subunit binds to DAF or any other mucosal receptor. Recent 
studies show AafA binds to fibronectin, laminin and type IV collagen (Farfan 
et al., 2008). 
6.2 NMR for Protein Structure Determina-
tion 
It is interesting that AafA and AfaE share such high similarity of primary, sec-
ondary and tertiary structures, but have distinctive ligand binding properties. 
AafA has not been shown to bind to any AfaE receptors thus far. Structure 
determination has therefore been performed to provide a possible explanation 
at the atomic resolution level for any difference in binding behaviour. 
6.2.1 1D and 2D Experiment of AafA 
1D and 2D experiments are quick ways for providing important information 
before any further 3D experiments are undertaken. 
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Figure 6.3: 1D 1H spectrum of AafA. Sharp line widths and characteristic ring current 
shifted methyl peaks indicate a well-folded, monomeric protein. 
The 1D spectrum of AafA shows sharp linewidths which indicate a rela-
tively small size particle, in this case a monomer (Figure 6.3). The sample 
displayed very little aggregation over the course of data collection. Besides, 
the ring current shifted structural methyl peaks at around 0 ppm also suggest 
the protein is well structured. The peaks between 5 and 6 ppm also indicate 
the presence of residues in beta sheet. 
The 2D 111-15 N HSQC experiment also shows resolved peaks (Figure 6.13). 
The 1D and 2D experiment suggests AafA is a promising candidate for NMR 
structure determination. 
6.2.2 Introduction to Triple-Resonance Experiments 
Homonuclear 1H-1H NOE are typically used as distance restraints for calcu-
lating a protein structure. However, before the data can be used, so-called 
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sequence-specific assignment must be carried out. Ideally the more atoms as-
signed in the NMR spectrum, the more likely a better quality structure will be 
obtained. Two types of nuclear interaction including scalar coupling and the 
NOE via dipolar coupling are typically used in different NMR. experiments. 
Because the four bond scalar coupling is close to zero, the sequential assign-
ments must be mainly done by the inter-residue backbone NOEs for homonu-
clear correlations. However, inter-residue backbone NOEs may not occur. A 
third dimension, 13C is thus introduced into the process of assignment. Het-
eronuclear scalar couplings are larger than those between protons, which means 
the magnetisation transfer between heteronuclear and 13C-13C spins is more ef-
ficient. In addition, 13C labelling provides an extra frequency to spread signals 
further into a third dimension which leads to less ambiguity and consequently 
simplifies spectra dramatically. 
6.2.3 Backbone Chemical Shifts Assignment 
The names of the following triple resonance experiments are formed by follow-
ing the order of the coherence transfer pathways. Spins which do not evolve 
are given in parentheses. 
6.2.3.1 (HBHA)CBCA(CO)NH 
Magnetisation is transferred from 1H«  and 143 to 13C, and 13Cp, respectively, 
and then it is transferred from 13Cp to 13C„, and then to carbonyl 13C and to 
15NH. Ultimately it will be transferred to 1HN for detection (Figure 6.4). 
In the CBCA(CO)NH spectrum, the Co and C„ of the preceding residue 
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Figure 6.4: Magnetisation transfer in the CBCA(CO)NH spectrum. Atoms which are 
observed are coloured in red. Atoms through which magnetisation is transferred are 
coloured in blue. 
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Figure 6.5: Magnetisation transfer in the HNCACB spectrum. Atoms which are 
observed are coloured in red. Atoms through which magnetisation is transferred are 
coloured in blue. 
are correlated with the chemical shifts of the amide group (NH,HN). 
6.2.3.2 HNCACB 
Magnetisation is transferred from 11IN to 15NH, and then it is transferred 
from 15NH to 13C,,_1 and 13C,, and then to 13C,5,,,_ 1 and 13C)3, respectively. 
The magnetisation is transferred back, following the same route, to 11-IN for 
detection. (Figure 6.5). 
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Figure 6.6: Magnetisation transfer in the HNCO spectrum. 
In the HNCACB spectrum, the Ci3 and Ca of both preceding residue and 
current residue are correlated with the chemical shifts of the amide group 
(N H ,H N ). 
6.2.3.3 HNCO 
Magnetisation is passed from 1H to "N and then to carbonyl 13C via the 
15NH-13C0 J-coupling. Magnetisation is then passed back via "N to 'II for 
detection (Figure 6.6). 
In HNCO spectrum, the carbonyl C' of the preceding residue is correlated 
with the chemical shifts of the amide group (N H ,H N ). 
6.2.3.4 HN(CA)CO 
The magnetisaiton is transferred from 1HN to "N, and then to "Ca,_, and 
"Ca, via 15N-13c,  J-coupling and finally to carbonyl "Ci_ I and 13Ci. It is 
then transferred back to 'FIN following the same route for detection (Figure 
6.7). 
In HN(CA)CO spectrum, the carbonyl C' of both preceding residue and 
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Figure 6.7: Magnetisation transfer in the HN(CA)CO spectrum. Atoms which are 
observed are coloured in red. Atoms through which magnetisation is transferred are 
coloured in blue. 
current residue are correlated with the chemical shifts of the amide group 
(NH ,HN). 
6.2.3.5 Backbone Assignment Strategy 
Backbone triple resonance experiment can be considered as a 2D 'II-15 N HSQC 
spectrum spread into a third dimension by adding a 13C axis. Strips are thus 
extracted at the position of every 1H-15 N HSQC peak with different 13C cross 
peaks according to different types of experiment. Ideally, in an HNCACB 
experiment, both Ca , Co chemical shifts of the same residue and preceding 
residue can be obtained. More importantly, Ca will have positive signals while 
Co will have negative ones. In a CBCA(CO)NH experiment, only preceding 
Ca, Co will be on the strip at the same position. Using these two spectra 
together, it is possible to assign the Ca , Co chemical shifts. The process is the 
same as it in Dominoes, shown in Figure 6.8. Most importantly, for all the 
spin systems, it is possible to designate the inter-residue shifts, which provide 
the connectivity between the residues. 
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Figure 6.8: Determining sequential assignments using inter-residue chemical shifts. 
Each domino represents an amino aicd in a six residue protein. The pattern of dots on 
each side of every domino represent the chemical shift pattern of every residue. The 
shaded half of the domino represents the intra-residue chemical shift while the unshaded 
region represents the inter-residue chemical shift. The connectivity can thus be estab-
lished after both inter- and intra- resonance have been identified. Figure adapted from 
Rule and Hitchens (2006). 
The same assignment theory has also been adapted in the carbonyl corre-
lation experiments HNCO and HN(CA)CO. 
6.2.4 Side Chain Chemical Shift Assignment 
For NMR protein structure determination, protons, carbons and nitrogens 
need to be assigned as well. Complete side chain assignments were obtained 
by interpretation of spectra derived from through-bond and through-space 
experiments. 
The side chain assignments were mainly based on different experiments us-
ing various correlations of side chain carbon or hydrogen with previous assigned 
backbone atoms. 
6.2.4.1 CC(CO)NH 
Magnetisation is transferred from the side-chain protons to their directly at-
tached 13C nuclei. Then the magnetisation is transferred to carbonyl "C and 
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Figure 6.9: Magnetisation transfer in the CC(CO)NH spectrum. Atoms which are 
observed are coloured in red. Atoms through which magnetisation is transferred are 
coloured in blue. 
then to 15 NH and finally to 1HN for detection (Figure 6.9). 
In the CC(CO)NH experiment, aliphatic sidechains C and C13 are correlated 
with amide group (NH ,H N ). With previous assignments of amide group, it 
is possible to assign the aliphatic sidechains for all the backbone assigned 
residues. 
6.2.4.2 HBHA(CO)NH 
Compared with CBCA(CO)NH, magnetisation transfers follows the same path. 
However, the chemical shift is evolved on the 111, and 11-1,3 rather than on 
carbon atoms. Thus, the fic, and Hp frequencies are obtained from this exper-
iment. This forms the basis for sidechain experiments by extending these into 
the spin system by other TOCSY experiments (Figure 6.10). 
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Figure 6.10: Magnetisation transfer in the HBHA(CO)NH experiment. Atoms which 
are observed are coloured in red. Atoms through which magnetisation is transferred are 
coloured in blue. 
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Figure 6.11: Magnetisation transfer in the HCCH-TOCSY experiment. 
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6.2.4.3 HCCH-TOCSY 
Magnetisation is transferred from side-chain proton to its attached carbon then 
along the carbon backbone by TOCSY transfer before being transferred back 
to proton for detection. HCCH-TOCSY is a useful experiment as all the side-
chain protons are visible except protons on aromatic rings. The spectrum is 
also well resolved as only carbon and proton atoms on the same residue will 
be correlated. 
6.2.4.4 Other experiments 
Other side-chain experiment such as the (HB)CB(CGCD)HD and 
(HB)CB(CGCDCE)HE in which Ho and HE are correlated with the C,3 of 
aromatic sidechain are also performed. 
6.2.4.5 Experiments involving the NOE 
The experiments mentioned above utilise the scalar coupling of nuclear spins 
through bonds. However, nuclear spins are also able to interact through space, 
via dipolar coupling. Dipolar coupling occurs when the magnetic field of a 
nucleus is affected by the magnetic field generated by another nucleus. This 
provides the mechanism by which the Nuclear Overhauser Effect (NOE) can 
occur. The NOE is the change in intensity of a resonance due to saturation of 
a proximal spin. The NOE can be used to determine the internuclear distance 
(typically within 5 A) between two spins through space. With the help of 15 N 
or 13C-edited NOESY-HSQC spectra, we can determine the chemical shifts of 
protons usually within 5 A in space. The NOE is a major source of information 
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for structure determination by NMR spectroscopy. 
In some cases, NOESY spectra can also facilitate the side-chain resonance 
assignment. For example, the Hp and 11,5 on the aromatic amino acid are 
usually close to each other and have a vanishingly small scalar coupling. The 
NOE provides useful information in this case. 
6.3 Material and Methods 
6.3.1 AafA Production 
The donor strand complementary version of AafA (AafA-dsc) has been con-
structed in this study by moving the first 16 N-terminal residues to the C-
terminus, linked by the sequence DNKQ. 
The gene was cloned into pQE-30 with BamHI and HindIII, exactly the 
same as used in AfaE cloning (see Section 3.1.1) 
The protein expression and purification follows the same protocol used for 
AfaE as well (see Section 3.2 for expression, Section 3.3 for purification and 
Section 3.4.1 for refolding). 
The sample used for most experiments in this study was in 50 mM Ac-
etate Buffer, pH 5.0 with 50 mM NaCl. The concentration is about 500 FM. 
However, for RDC measurement the protein is in pH 7.5 phosphate buffer and 
for relaxation measurements (T1, T2 and Heteronuclear NOE), the protein 
concentration is at 200 pM. 
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6.3.2 AafA Backbone Assignment Experiment 
The experimental parameters used for data collection were detailed in Table 
3.5. 
6.3.3 Experiments for Measuring Protein Dynamics 
Tl, T2 and Heteronuclear NOE spectra were recorded with spectral widths 
of 7500 Hz sampled over 2048 complex points in the w2 (1H) dimension, and 
1945.9 Hz over 180 complex points in the w, (15N) dimension. T1  values were 
measured in a series of spectra with relaxation delays of 50, 300, 600, 900, 
1200, 1500 and 2000 ms. T2 measurements were taken with relaxation delays 
of 15.328, 30.656, 45.984, 61.312, 91.968, 107.296, 137.952 and 199.264 ins. 
The saturation time used for heteronuclear NOE experiment was 5 seconds. 
6.4 Results 
In this section, backbone and side assignments for most atoms of the pro-
tein have been discussed. In addition, the assignments of NOE spectra and 
structure calculation have also been introduced. 
6.4.1 Backbone Assignment 
The strategy of backbone assignment has been introduced in Section 6.2.3.5. 
Residues from A135 to 5140 have been shown in Figure 6.12 as an example. 
As for every N, HN correlation, the Ca, Co of both the same and the 
preceding residues are able to be assigned. The connectivity between residues 
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Figure 6.12: Backbone assignment example strip. "Strip 1" is CBCA(CO)NH spec-
trum and "strip 2" is HNCACB spectrum. C, and Co peaks are coloured in black and 
red, respectively. 
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Figure 6.13: 2D 11I-15N HSQC spectrum of AafA with backbone assignment. The 
residue number has been labelled in red. 
can therefore be obtained via an automated backbone assignment program 
called MARS (Jung and Zweckstetter, 2004). 
However, the first run of MARS only gave 71 % completeness of backbone 
assignment. Manual assignment, inspection and fine-tuning of chemical shift 
to match perfect connectivity between amino residues have been performed to 
finalise the backbone assignment. 
Excluding prolines, the backbone atoms of all residues have been assigned 
with the exception of five residues: N1, Q52, A106, 1107, L109 and R110 (Fig- 
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ure 6.13). However, Ni is the first residue in the AafA sequence (immediately 
after His-tag), and the N-terminus of proteins is typically a flexible region, 
which leads to the absence of NMR signal for these resides. No correlations in 
the HNCACB and CBCA(CO)NH spectra have been found for residue Q52. 
The chemical shifts of Ca and Co were obtained from the residue L53 via the 
CBCA(CO)NH spectrum. The assignments of the region 105PAIPLRP111 will 
be discussed below in Section 6.4.2. 
More structural information can be obtained from the chemical shifts. For 
alpha helix, the Ha and Co chemical shifts are usually lower than the average 
shifts, while Ca and CO chemical shifts are higher than average. The presence 
of beta-strand topology causes this pattern of chemical shifts to be reversed. 
Shifts displaying average values are designated as "coil". This property has 
been exploited by the Chemical Shift Index (CSI) (Wishart et al., 1992), which 
is added to provide consensus prediction of secondary structure from NMR 
shifts with high (approximately 90 %) accuracy (Figure 6.14). 
The CSI shows AafA is an all beta-sheet protein. The prediction of the 
beta strands is fully consistent with the AfaE solution NMR structure. 
6.4.2 Side-chains Assignment 
With the set of different experiments shown above, it is possible to assign 
nearly all the atoms. However, residues lacking connectivity such as those 
following proline need extra effort. 
The NOESY spectrum has been used for facilitating sequential assignment. 
Most of the sequential assignments were completed from the backbone triple 
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Figure 6.14: Chemical Shift Index (CSI) of AafA. A red line/circle indicates chemical 
shift lower than the average ± s.d. shift predicted to form a helix-like structure. Con-
versely, blue line/circles indicate chemical shift values higher than the average ± s.d. 
and suggest /3-strand structures. AafA apparently contains mostly 13-strand connected 
by turns according to CSI. 
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resonance experiment except the region 1°5PAIPLRP111. This is due to three 
prolines, which lose connectivity as no amide proton exists. However, the 11e107 
and Leu109 were assigned with the help of NOESY spectrum. A characteristic 
ring current shifted methyl peak NOE (below 0 ppm in this case) has not been 
assigned to any atom. Isoleucine and leucine are hydrophobic and typically 
in the hydrophobic core of the protein. The strips which comprise the lowest 
chemical shift NOE peak have been assigned to Leu109 (Figure 6.15). For 
some aromatic sidechains, NOESY has also been used to facilitate assignment. 
This set of peaks was not assigned in the backbone assignment. However, 
the characteristic ring current shifted HD21 peak is easy to spot in the "C-
NOESY spectrum. Usually the hydrophobic functional groups of such aromatic 
rings are packed in the protein hydrophobic cores. It is typical that these 
aromatic rings shift the frequency of nearby atoms from hydrophobic sidechains 
to about 0 ppm. This strip was finally assigned to Leu109. 
6.4.3 AafA Structure Calculation 
For NMR protein structure determination, both experimental data and known 
covalent and non-covalent features of the protein are needed. The experimen-
tal restraints include inter-proton distances derived from NOESY experiments, 
bond orientations derived from RDC experiments, dihedral angles from mea-
surements of three bond J-coupling and hydrogen bonds derived from amide 
exchange data, etc. Non-experimental restraints include bond angles and bond 
lengths etc. 
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Figure 6.15: Strips of L109 from 13C-NOESY spectrum of AafA. The blue dot line 
shows ring current shifted peak (HD21). 
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6.4.3.1 NOE Restraints 
NOE restraint lists are created by noting which proton resonances are close to 
a given reference proton, with their relative intensities inversely proportional 
to the inter-proton distance. This process is called NOE assignment and it can 
be done either manually, or using software to automate this time-consuming 
task. In this study, the NOE assignment process has been performed with 
the program called ARIA (Ambiguous Restraints for Iterative Assignment), 
version 2 (Linge et al., 2003b; Rieping et al., 2007). Ideally, the NOE peaks 
should be assigned to pairs of nuclei unambiguously. However, it is usually 
difficult as there are always several nuclei sharing the same chemical shifts. 
ARIA introduce all these possibilities into calculation by allowing ambiguous 
distance restraints (ADR) (Nilges, 1995). 
After the ambiguous NOEs have been defined, ARIA adopts an iterative 
assignment strategy. The whole calculation process typically consists of eight 
iterations. Each ARIA iteration consists of ensemble analysis, NOE calibra-
tion, removal of inconsistent NOEs, re-assignment of satisfied NOEs, merging 
of restraints and calculation of structures (Linge et al., 2003b). 
Ensemble Analysis During each iteration, 20 structures are calculated and 
ranked according to the total energy score (Etot) and 7 lowest-energy conform-
ers are used as a starting point for re-assignment in the next iteration. 
NOE Calibration NOE peaks are quantified by their volumes or intensi-
ties, both of which are proportional to the inter-proton distance. The NOE 
volumes decrease with the sixth power of distance. However in reality, the 
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relationship needs to be calibrated as spin diffusion, internal dynamics and 
chemical exchange can affect the NOE peak volume. For iteration 1-8, the 
calibration factor value has been evaluated by calculating the ratio of aver-
age experimental volume to the average theoretical volume from the previous 
iteration. For iteration 0, the calibration factor is estimated using another 
constant which corresponds to the average distance between spin pairs causing 
NOEs. The calibration factor is then used to calculate a distance target for 
each observed NOE. 
Ambiguous Distance Restraints (ADRs) A large fraction of NOEs can 
only be assigned ambiguously due to limited dispersion of chemical shifts. It 
is possible that a NOESY peak is actually the summed contributions from 
two or more individual NOEs. One of the most important features in ARIA 
is that ambiguous information can be combined to give unambiguous results. 
The combined unambiguous results were then back-calculated into volumes 
and summed during the simulated annealing (SA) process. 
Detection of inconsistent peaks Distance restraints arising from inap-
propriate crosspeaks (e.g. random noise, NOEs to water) are expected to be 
inconsistent with each other and with the true molecular structure provided 
that their influence is largely outweighed by correct NOE data. One of the 
tasks of automatic assignment is to identify and exclude these crosspeaks. 
ARIA adopts a violation analysis to identify inconsistent peaks. The restraint 
with higher violation than user defined tolerance is discarded. 
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Partial Assignment Each ARIA iteration involves reassignment of the NOESY 
spectrum, with the aim of eliminating unlikely contributions to each NOE. 
Each assignment to an NOE peak has been weighted by normalising its par-
tial volume such that they sum to 1.0. To reduce the number of possibilities, 
only the number of largest contributions with sum greater than a user defined 
ambiguity cutoff will be kept. In the first iteration, the cutoff is set to 1, effec-
tively allowing all possible assignment to proceed into the simulated annealing 
stage. The cutoff is gradually reduced to 0.8 to obtain almost unambiguous 
assignments after the last iteration. In some cases, the maximum number of 
contributions can also be limited to improve the quality of NMR structure 
ensembles. 
Merging Duplication of restraints within and between NOESY datasets 
leads to a biased restraint list. Nonviolated restraints with equivalent atom 
content are detected and only the restraints with the smallest distance are kept. 
A new structure ensemble is then calculated based on the merged restraint set 
and other restraints (e.g. h-bonds dihedral angles, RDCs). 
Structure calculation ARIA interfaces directly to Crystallography & NMR 
System (CNS) and employs simulated annealing protocols for structure calcu-
lation. 
Floating chirality assignment Stereospecific assignment of the two sub-
stituents of a prochiral centre is often difficult to achieve. In proteins, these are 
two methylene protons or the methyl protons of the isopropyl groups of valine 
or leucine. ARIA/CNS use a floating assignment method in which both al- 
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ternatives during structure calculation are tested. The energetically preferred 
solution is written to the data file. 
The above procedures are cycled through during each iteration. The sim-
ulated annealing protocol used during iterative assignment involves simplified 
non-bonded force potentials in a dehydrated state in order to keep calculation 
times to a minimum. Consequently, structures display artefacts such as unre-
alistic side chain packing and unsatisfied hydrogen bond acceptors and donors 
(Linge et al., 2003a). To improve structure quality, ARIA performs solvent 
refinement on the final ensemble of converged structures in a shell of water. 
For each structure of the final ensemble, a short trajectory with a full molecu-
lar dynamics force field, including electrostatic and Lennard-Jones potentials 
is calculated. Where relevant, parameters used in refinement are the same as 
those used for simulated annealing to avoid systematic differences. 
Generally, manual analysis in addition to the ARIA auto assignment is 
required. In this study, any peak violations greater than 0.5 A have been 
checked. 
6.4.3.2 Dihedral Angle Restraints 
Dihedral angles provide extra restraints on the structure during calculation. 
TALOS (Torsion Angle Likeliness Obtained from Shift and Sequence Similar-
ity) uses N, Ca, C)9 and C' chemical shifts of tripeptides to predict (k. and 4' 
backbone dihedral angles. It predicts the angles by comparing the local en-
vironment to a database which contains 20 proteins (Cornilescu et al., 1999). 
The latest version called TALOS+ expands the database to 200 proteins and 
lowers the error rate to below 2.5 % (Shen et al., 2009). TALOS+ searches the 
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best 10 matches and if the 1 and W angles are consistent across all sequences 
their mean and standard deviation are classified as "good" prediction. Only 
the predictions classified as "good" (124 out of 145 residues in this study) were 
introduced into ARIA as dihedral restraints. 
6.4.3.3 Disulphide Bond 
From the sequence alignment of the AafA sequence to that of AfaE, Cys3 and 
Cys35 were found to be conserved. It is presumed that these two cysteines 
form a disulphide bridge. The disulphide bond was integrated into calculation 
as an unambiguous distance restraint. 
6.4.3.4 Residual Dipolar Coupling Restraints 
For molecules tumbling isotropically in solution, the dipolar coupling is aver-
aged to zero and the splitting cannot be observed. However, if the isotropic 
distribution can be made anisotropic by partial orientation of the molecule, the 
splitting of the spectral lines due to dipolar coupling can be observed, which 
is called residual dipolar coupling (RDC). 
The extent of observed splitting caused by dipolar coupling is dependent 
on the internuclear distance and the angle of the inter-nuclear vector between 
the two nuclei close in space and the principle axis of the alignment tensor. By 
measuring RDCs between covalently bonded nuclei, the distance dependence 
is removed and the angular data derived from RDC can be used as restraints 
in structure calculation. However, the RDC is currently more widely used as 
NMR structure validation and refinement restraints by comparing the coupling 
derived from the structure and the measured couplings. 
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Anisotropic molecular rotation distribution can be obtained in one of the 
two ways; by use of the intrinsic asymmetry of magnetic dipoles of the molecule 
itself or by creating an anisotropic environment which can lead to the align-
ment of the protein. Normally globular proteins are not sufficiently anisotropic 
to generate noticeable molecular alignment. Alignment is thus generally gen-
erated by placing the protein in an anisotropic medium. Two of the most 
popular media used are mixed micelles (Sanders and Landis, 1995) and fil-
amentous bacteriophage, both of which possess a large anisotropic magnetic 
dipole, and therefore become aligned in the magnetic field. 
AafA RDCs were measured by alignment in bacteriophage. Unfortunately, 
a number of AafA peaks in the HSQC spectrum moved or disappeared in the 
presence of phage, which suggests interaction between AafA and bacteriophage 
(Figure 6.16). Therefore, no RDC restraints were integrated into structure 
calculation. 
The theoretical isoelectric point (pI) of AafA is 9.1. The protein is thus pos-
itively charged as the experiment was run at pH 7.5. All spectra except RDC 
experiments were recorded at pH 5.0 in this study. However, the bacteriophage 
precipitated the protein at pH 5.0 regardless of the NaCl concentration (up to 
600 mM). Because the bacteriophage used in this study is negatively charged, 
it is believed that the electrostatic attraction caused association between phage 
and AafA. No precipitant was found when the pH was increased from 5.0 to 
7.5 with 400 mM NaCl. Unfortunately, either the different pH or different 
salt concentration or protein-phage interaction shifts few peaks for the RDC 
experiment spectrum (Figure 6.16). The existing AafA backbone assignment 
could not being able to use in this experiment. The RDC experiment data 
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Figure 6.16: 111-15N HSQC spectrum which shows AafA interacts with alignment 
medium. HSQC recorded at pH 5.0 is shown in black while AafA in aligned media 
at pH 7.5 is shown in red. Many peaks have moved around and the regions circled in 
purple are shown as examples. 
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since was not included in the final calculation. 
6.4.4 AafA Solution structure 
The 15 lowest overall energy structures generated after 9 ARIA iterations 
were water refined in ARIA/CNS. The ensemble of structures overlaid with a 
backbone RMSD of 0.32 ± 0.11 A (Figure 6.17). 
As expected, the AafA solution structure shows an Ig-like fold, in which 
two beta sheets pack against each other. 
6.4.5 NMR Structure Statistics and Verification 
The structure statistics related to ARIA calculation have been summarised in 
Table 6.1. 
The Ramachandran plot is an important tool for protein NMR struc-
ture verification. The plot shows phi/psi backbone dihedral angle combina-
tions. The AafA structure has been submitted to Protein Structure Valida-
tion Suite (PSVS) (http://psys-1_3.nesg.org/). The built-in module Procheck-
NMR (Laskowski et al., 1996) shows that 63.9 % of backbone angles fall into 
the most favoured region of the plot while a further 30.3 %, 3.3 % and 2.1 % 
are located in allowed, generously allowed and disallowed regions Figure 6.18. 
Three residues are in energetically unfavorable regions of the Ramachan-
dran plot, A1a21 on AB strand loop, Met40 and Ala44 on the C strand. This 
may imply that the local conformation in these regions is incorrectly restrained. 
Asn127, G1n129 and A1a131 also reside in less favored regions (discussed below 
in Section 6.5). 
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Figure 6.17: Solution structure of AafA. A). 15 Ribbon representative of 15 lowest 
overall energy structure. B). Stereo view of AafA solution structrure (lowest overall 
energy). 
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Table 6.1: Structural calculation statistics of AafA 
Number of experimental Restraints 	 2845 
Total NOE-derived 	 2721 
Ambiguous 	 803 
Unambiguous 1918 
Intraresidue 	 686 
Sequential 415 
Medium-range (I i — j I. 4) 	 135 
Long-range (I i — j I> 4) 682 
Dihedral Angle 	 124 
RMSD from experimental restraints 
Distance (A) 
	
0.1363 ± 0.0293 
Dihedral angle (°) 
	
4.6516 ± 0.7490 
RMSD from idealized covalent geometry 
Bonds (A) 	 0.00711 ± 0.00094 
NOE (A) 0.1363 ± 0.0293 
Angles (°) 	 0.896 ± 0.068 
Improper (°) 3.042 ± 0.480 
Dihedral Angle (°) 	 41.737 ± 0.256 
vdw 	 446.427 ± 132.85 
Coordinate RMSD (A) 
Backbone atoms in secondary structure 	 0.3173 ± 0.1105 
Heavy atoms in secondary structure 0.6687 + 0.0080 
Energies (kcal • mol') 
Etotal 
ENOE 
Ebond 
Eangle 
Eirnproper 
Edihedrad 
Evdw 
Eelec 
—3110.86 ± 717.37 
1671.04 ± 824.814 
114.607 ± 35.8099 
495.201 ± 82.7163 
1655.39 ± 569.117 
756.574 ± 10.4157 
—1113.21 ± 161.845 
—5019.42 ± 98.7835 
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Table 6.2: Top 5 hits tertiary structure alignment for AafA structure by DaliA 
Match Protein PDB Z RMSD Total Aligned Identity(%) 
(chain) Score Residue Residue 
1 Class III RTK signal- 
ing assembly 
2026(U) 7.1 2.9 275 92 11 
2 Integrin aIIBb3 3FCS(A) 7.0 3.0 911 112 5 
3 AfaE-III 1RXL(A) 6.9 4.3 143 117 15 
4 Integrin a5133 1JV2(A) 6.6 3.5 927 118 8 
5 OspB-CT / Fab-H6831 1RJL(B) 6.4 3.2 221 93 8 
6.4.6 AafA Solution Structure Comparison 
Tertiary structure comparison was performed by DaliLite (Holm et al., 2008), 
which shows a high similarity with the structure of class III RTK signaling 
assembly, ectodomain of integrin IIBb3 and AfaE-III (Table 6.2). 
As the Ig fold is quite common, 1285 structures in total from the Protein 
Data Bank have a Dali Z score greater than 2.0, above which is classified as 
"significant similarity" . The AfaE shows a Z score of 6.9 to structures of AafA. 
Alignment of tertiary structure of AafA and AfaE shows a RMSD of 5.2 A over 
all atoms. 
AafA shows a very similar structure to AfaE (Figure 6.19). However, there 
are still some differences. First of all, the two short Al, A2 strandS aligns with 
the B and C-terminal G strand (see topology in Figure 6.20A), respectively. 
However, the A2 strand in AafA is not formed and no characteristic NOE peaks 
for 0-sheet have been found manually, which suggests the AafA might have no 
A2 strand parallel aligned with the G strand like in AfaE. Secondly, primary 
sequence alignment shows that residues P109, L110 and R111 are extra amino 
acids in AafA compared with AfaE. These three residues are located in the EF 
loop, which suggests a longer loop compared with AfaE. 
Thirdly, the region consisting of the D' and D2 strand is not as rigid as 
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Figure 6.19: Tertiary structure alignment of AafA and AfaE. AafA is coloured in 
green while AfaE is in orange. The alignment shows a high similarity between these 
molecules. 
Figure 6.20: Topology of AafA. A. Schematic of AafA. Arrows outlined by a dot 
line are present in the AfaE structure but absent from AafA structure. B. Structure 
alignment of AfaE and AafA. The loop like region in AfaE (orange) shows an anti-
parallel beta strand, whilst in AafA (green), this could not be defined well due to lack 
of long-range NOE as distance restraints. 
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L109 HD2 
Figure 6.21: Ring current shifted HD2 of L109 is close to both F66 and Y114. L109 
has been coloured in yellow and F66 and Y114 have been coloured in red. 
that in AfaE. Residues in this region show good signal-to-noise NOE peaks, 
however, no long-range NOEs have been identified. This might suggest that 
the region is very flexible. However, more details will be discussed in Section 
6.5. 
Ring current shifted HD2 of L109 is close to both F66 and Y114 (Figure 
6.21). 
From the solution structure of AafA, it can be seen that residue L109 is 
close to both F66 and Y114, both of which can shift the HD2 of L109. Such 
geometry is consistent with the previous sidechains assignment of L109 in 
Section 6.4.2. 
6.5 AafA Relaxation Properties 
Compared with TALOS, the new version TALOS+ provides an extra prediction 
for random coil index (RCI). RCI has been reported to quantitatively estimate 
protein flexibility (Berjanskii and Wishart, 2008). With protein backbone 
chemical shifts, TALOS+ is able to predict the motions within picosecond to 
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nanosecond range robustly (Berjanskii and Wishart, 2005). The RCI of AafA 
has been predicted as shown in Figure 6.22A: 
The prediction of RCI shows the region between residue 125 and 135 is 
dynamic. In addition, regions around residue 80 and 90 also display slight 
flexibility. 
Experimentally, the flexibility of the protein can also be measured by T1, 
T2 relaxation and Heteronuclear NOE experiments. Unfortunately, the T1  
relaxation data does not fit the exponential decay very well. The reason for 
causing this has not been discovered so far. 
The values of the three sets of relaxation measurements (NOE, Tl, and 
T2) are correlated with the mobility of each amide in the protein backbone. 
The flexible region on the protein will cause an increased T2 and decreased 
heteronuclear NOE intensity. Both the T2 data and the heteronuclear NOE 
data decreases suggest N-terminus of AafA is flexible. This also might be 
the reason that A2 strand is not forming in the solution structure. Residues 
number from 79 to 86 also show some flexibility. This region corresponds 
exactly to the D' strand (Figure 6.20A) and the flexibility of this region is 
explained by the lack of a rigid anti-parallel strand conformation. In the T2 
dataset, residues 125-135 show an increased T2 relaxation time. RMSD for 
each AafA residue shows that the region between residue 75 and 90 and region 
between residue 125 and 135 are not well defined by NOEs, which suggested 
that these regions are flexible. The region that encompasses the engineered 
loop (residues Asp126, Asn127, Lys128 and Gln129) is flexible. Interestingly, 
residues Asn127, Gln129 and A1a131 fall in disallowed region of Ramachandran 
Plot in Figure 6.18. The NOE assignment might be further improved in the 
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Figure 6.22: Relaxation properties of AafA. A). Black: Coil Index (RCI) predicted by 
TALOS+ protein AafA backbone chemical shifts. Region from residue number 125 to 
135 shows high flexibility. Red: RMSD of each AafA residue generated by ARIA/CNS. 
B). T2 relaxation analysis of AafA. C). 1H-15N Heteronuclear NOE data of AafA. The 
residues where a decreased relative intensity has been observed suggest a flexible area. 
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In summary, both T2 and heteronuclear NOE show consistent results in 
terms of protein flexibility. 
6.6 Discussion 
A recent work shows that AafA is able to bind to fibronectin, laminin and 
type IV collagen (Farfan et al., 2008), which are not recognised by AfaE. It is 
difficult to interpret the difference in biochemical properties by comparing the 
structures at the current resolution level. However, we can still conclude the 
following few points. 
Based on the primary sequence similarity with that of AfaE, the AafA 
subunit has been hypothesised to adopt DSC/DSE mechanisms as well. The 
AafA-dsc was created by cutting first 16 amino acids from the N-terminus and 
transferring to the C-terminus, following a short DNKQ linker (See Section 
1.3.1.3 for details). From the solution structure, both A- and F-strand seem 
to contact this donor strand to complete the Ig-like domain. 
The alignment of AafA to AfaE structure gives an RMSD of 5.2 A over 
all atoms. DaliLite also gives the alignment a Z-score of 6.9, which means a 
"significant similarity" between these two structures. Although in the case of 
AfaE, Al and A2-strands are aligned with B- and G-strands, respectively, the 
whole region is still quite flexible. The structure is stabilised via an N-terminal 
disulphide bond between residues Cys3 and Cys15, which is conserved among 
the Afa/Dr/Aaf family. 
The region containing the D'- and D2-strands is flexible according to T2 
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relaxation and heteronuclear NOE data. However, these two strands form a 
rigid anti-parallel strand pattern in AfaE. It is also the binding interface for 
AfaE to Decay Accelerating Factor from the docking model in this study. It 
is possible that the flexibility in this region prevents recognition of DAF by 
AafA. 
AAFs might use a distinctive mechanism for colonisation compared to other 
members of the Afa/Dr pilin subunit as they possess unique high isoelectric 
points (pI). AafA has a very high (9.1) pI, which means the AafA adhesin 
is positively charged under physiological pH conditions. A previous study 
analysed 56 E. coli mature pilin proteins. The five highest pI values were found 
for the pilins of the five known AAF pilin variants, ranging from 8.9 to 9.7. 49 
of the remaining pilin units have predicted pI values less than 7.0 and 45 of 
them are less than 6.0 (Velarde et al., 2007). It is postulated that negatively 
charged LPS may capture positively charged pili, hence most fimbriae are 
negatively charged at physiological pH. It has also been hypothesised that 
the dispersin (a protein which disperses the aggregative adherence pattern of 
EAEC) disrupt the electrostatic attraction between LPS and AafA subunit, 
which enable the fimbrial to extend from the surface (Velarde et al., 2007). 
Unlike the Afa/Dr adhesin, AAF adhesin is potentially capable of recognizing 
a broader spectrum of receptors by additional negatively charged species on 
the mucosal surface, such as highly sialylated mucins and the glycoprotein of 
the epithelial glycocalyx. It is possible that the flexible "D'—D2" region might 
be biologically significant for receptor recognition. 
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Chapter 7 
Conclusions and Future 
Perspectives 
Pathogenic E. coli causes a wide range of diseases in both humans and animals 
and is a pathogen of major relevance in medical microbiology. No matter which 
pathotype it is, adhesion to the host cells is usually the first step, followed by 
a series of cellular activities such as cytoskeleton rearrangement and signalling 
cascade. Most of the pathogenic E. coli strains share the same or a similar 
component, named the adhesin. Different adhesins recognise different receptors 
on the cells despite sharing a similar fold. Elucidation of the molecular aspects 
of the processes by which E. coli adheres to its receptors at atomic resolution 
level could clarify the difference and also lead to the potential development of 
effective strategies to prevent the emergence and recurrence of infections. 
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7.1 Summary and Conclusions 
DAEC strain adhesin AfaE subunit has been studied in terms of binding to its 
human host receptors CEA and DAF. Structure of one of AfaE's homologues, 
AafA has also been determined in this study. 
7.1.1 AfaE/CEA Interaction 
The project provided a reliable model for the complex of DAEC adhesin sub-
unit AfaE and its receptor CEA. The initial N-CEA sample displays low sol-
ubility and high aggregation. The sample optimisation has been successfully 
developed via protein surface hydrophobicity modification. Mutagenesis of 
L18, L20 on CEA to serine and threonine respectively could lead to a sample 
suitable for structural studies. 
Due to the low affinity and high on/off rate of AfaE/N-CEA interaction, 
the mutagenesis on AfaE has also been tried. The SPR suggested that the 
N52D, I85M, T111I had distinct effect on the AfaE/CEA interaction. These 
mutations are believed to be capable of changing the structure of the complex. 
NMR-derived restraints docking was adopted in the study rather than di-
rect structure determination of the AfaE/CEA complex. The paramagnetic 
centre introduced onto certain CEA position affects the transverse relaxation 
rate on the nearby protons (within 25 A), which can then be converted into 
distance restraints. These inter-protein distance restraints have since been 
introduced into the docking programme HADDOCK for structure calculation. 
The validated AfaE/CEA binding model shows that the CEA residues F29, 
Y34, Q44, P59, 191 and L95 are directly engaged in the AfaE/CEA binding. 
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A native N-CEA dimer structure was solved by our collaborator via X-ray 
crystallography. From the CEA native dimer, it is shown that F29, Q44 and 
191 are involved in non-covalent interactions with the same residues on another 
CEA subunit to form a homodimer. It has been suggested that the CEA 
binding surface for AfaE and CEA is partially overlapped. 
A covalently-linked CEA has been suggested to have an almost identical 
dimer structure to that of the native CEA homodimer. The AfaE subunit 
shows no binding to this homodimer. A further spectroscopic assay shows 
that the AfaE binding to CEA native dimer is able to trigger the dissociation 
of CEA homodimer. 
7.1.2 AfaE/DAF Interaction 
DAF3, DAF23 and DAF1234 have been constructed. Initially, all these differ-
ent constructs were unfolded after refolding via dialysis of denaturant (urea). 
A method of quick dilution and concentration successfully refolded the different 
DAF constructs. 
Different DAF constructs have been titrated with 15 N AfaE for binding 
interface mapping. The AfaE residues directly involved in DAF binding have 
been mapped and introduced into HADDOCK as unambiguous restraints. 
The resultant docking model exhibits that the binding area on AfaE is 
positively charged and interestingly, the binding area on DAF is negatively 
charged. It implies that the two molecules interact via electrostatic contacts. 
Residue K129 resides on the binding interface according to the docking 
model. Mutations on K127/K128/K129 have been reported to impair the 
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regulatory activity of both the classical and alternative pathway. It is possible 
that the recognition of AfaE by DAF affects complement system regulation. 
The model of the AfaE/DAF complex also shows that AfaE binds to both 
CCP2 and CCP3 domains, which is consistent with previous observation (An-
derson et al., 2004b). Some DAF residues which are supposed important for 
binding to AfaE in the previous study do not reside in the binding interface 
on the model. It is thus possible that AfaE could bind to other regions on the 
DAF protein as well. 
7.1.3 Solution Structure of AafA 
AafA exhibits a high sequence similarity (44.0 %) to that of AfaE. Most of 
the hydrophobic residues are conserved among the family in addition to the 
conserved cysteine residues. The AafA adhesin subunit adopts the donor 
strand complementation with other subunit on the pili. The donor strand 
complemented construct (AafA-dsc) was created. The engineered AafA-dsc 
behaviours like monomeric protein with high solubility in the NMR experi-
ments. 
The solution structure of AafA exhibits the same folding as that for the 
AfaE adhesin. Unlike in AfaE, the region containing D'- and D2-strand is 
flexible, as revealed from the NMR, relaxation experiments. The region is 
supposedly important for DAF recognition in the case of AfaE. This loop is 
the most distinct structural difference with AfaE. It is possible that the D'-
and D2-strand may affect recognition. 
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7.2 Future Perspectives 
This study answered many questions and has also left many unanswered. The 
future work for this project has been detailed below. 
7.2.1 AfaE and CEA Interaction 
It would be interesting to find out if the pathogenic E. coli exploits Dr adhesin-
CEACAM interaction to affect cellular functions in which CEACAM receptors 
participate. Some CEACAM1 isoforms contain two immunoreceptor tyrosine-
based inhibitory motifs (ITIMs) in the cytoplasmic domain which are phos-
phorylated in epithelial and immune cells (Gray-Owen and Blumberg, 2006). 
It has been suggested that in a CEACAM1 homodimer, spatial hindrance be-
tween adjacent cytoplasmic tails prevents access of downstream effectors to one 
of the two cytoplasmic ITIMs in each receptor (Obrink et al., 2002). Therefore 
Afa/Dr adhesin binding to CEACAM1 may trigger signalling by disruption of 
CEACAM1 dimers, inducing the recruitment of cytoplasmic kinases and phos-
phatases to the ITIMs of CEACAM1. Further studies will assess the specific 
roles of CEACAMs in mediating pathogenesis of Dr+ E. coli and may yield 
new information on the molecular mechanism that governs the interaction of 
E. coli with the host. 
7.2.2 AfaE and DAF Interaction 
Additional work needs to be done before we can reach a more detailed con-
clusion. First of all, the AfaE binding site on DAF has not been obtained 
directly by inferred mutagenesis. However, the mutagenesis data can lead to 
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the false positive results in terms of binding interface mapping due to potential 
structure disruption. The lack of such information can lead to a less reliable 
binding model. It would help if a 'H-1-5 N HSQC spectrum can be used for map-
ping the DAF residues directly involved in binding. This experiment can show 
whether the AfaE binds to other areas on the DAF with additional binding 
stoichiometry. 
7.2.3 Possible CEA-AfaE-DAF Trimer in vivo 
In human bodies, expression of CEACAMs members is exclusive to epithelial 
cells and CEA is most abundantly found on the apical surface of the gastroin-
testinal epithelium. However, it is also found on other mucosal epithelia such 
as nasopharynx, the lung and the urogenital tract as well as in sweat glands 
(Kuespert et al., 2006). DAF has a very wide distribution on all blood cells, 
endothelial cells and epithelial tissues as well (Lublin, 2005). Physiologically, 
it is possible that these two molecules are at the same place. 
With the docking models of AfaE/CEA and AfaE/DAF complex, it is 
possible to propose a trimer binding model in vivo(Figure 7.1). 
Judging from the alignment of these binding complex models, no spatial 
hindrance is spotted. The CEA-AfaE-DAF trimer is geometrically achievable. 
If this is the case, high natural abundant CEACAM might attract more DAF 
protein and change the immune responses and also lead to a much more com-
plicated signalling pathway (Tieng et al., 2002). 
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Figure 7.1: Possible trimer model of CEA-AfaE-DAF. AfaE/DAF model has been 
coloured in orange and AfaE/CEA model has been coloured in green. The AfaE sub-
units in these two binding models have been aligned together. 
7.2.4 AafA Functional Studies 
A recent work has shown that the AafA binds to Extracellular Matrix (ECM) 
proteins including type IV collage, larninin and fibronectin (Farfan et al., 2008). 
Previous studies also demonstrated that Dr adhesin subunit (DraE) binds to 
type IV collagen and that the binding could be inhibited by incubating with 
chloramphenicol (Selvarangan et al., 2004). However, AafA binding to type 
IV collagen is not affected by chloramphenicol, implying that the binding to 
this ECM protein may be different from that induced by DraE. The further 
mapping of the binding interface on AafA could facilitate the identification 
of the binding mechanism between these ECM proteins and AafA. Together 
with the mechanism of existing Afa/Dr family adhesins, the development of 
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inhibitors of adherence for broad-spectrum E. coli strains to host cells might 
be made possible. 
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Appendix 
Al. Primers used for cloning and mutagenesis 
Cloning 
Primers 	Sequences 
DAFl_Nde_f 
DAF2_Nde_f 
DAF3_Nde_f 
DAF4_Nde_f 
DAFl_Xho_r 
DAF2_Xho_r 
DAF3_Xho_r 
DAF4_Xho_r  
GTACGTCATATGGACTGTGGCCTTCC 
CGTAGCCATATGCGTAGCTGCGAGGTGC 
CGTAGCCATATGTCATGCCCTAATCCGGGAG 
CGTAGCCATATGTATTGTCCAGCACCAC 
CGCATGCTCGAGGCTACGATTGCAGAACTC 
CGCATGCTCGAGTGATTTCTTTTTAC 
CGCATGCTCGAGAATTTCTCTGCACTCTG 
GCTACGACTCGAGTCCTCTGCATTCAGGTG 
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Mutagenesis 
Primers 	Sequences 
AfaE_N52D_f 
AfaE_N52D_r 
AfaE_I85M_f 
AfaEJ85M.r 
AfaE_T111Ii 
AfaE_T111Iff 
CEA_1820_f 
CEA_1820_r 
CEA_V39A1 
CEA_V39A_r 
CEA_L20C_f 
CEA_L20C_r 
CEA_V39C_f 
CEA_V39C_r 
CEA_R43C_f 
CEA_R43C_r 
CEA_Q54C_f 
CEA_Q54C_r 
CEA_L95C_f 
CEA_L95C_r  
GTGCAAGCGCTGGGATGCGACGCCCG 
CGGGCGTCGCATCCCAGCGCTTGCAC 
TATGTCAATATGCGGC 
GCCGCATATTGACATA 
TGTCGGGAGCTGGGGTGGAATCATC 
GATGATTCCACCCCAGCTCCCGACA 
GAGGGGAAGGAGGTAAGCTTAACCGTCCACAATCT 
GCCCCAGCATC 
GATGCTGGGGCAGATTGTGGACGGTTAAGCTTACC 
TCCTTCCCCTC 
CTACAGTTGGTACAAAGGTGAAAGAGCGGATGGCA 
ACCGTC 
GACGGTTGCCATCCGCTCTTTCACCTTTGTACCAA 
CTGTAG 
GAGGGGAAGGAGGTAAGCTTATGCGTCCACAATCT 
GCCCCAGCATC 
GATGCTGGGGCAGATTGTGGACGCATAAGCTTACC 
TCCTTCCCCTC 
CTACAGTTGGTACAAAGGTGAAAGATGCGATGGCA 
ACCGTC 
GACGGTTGCCATCGCATCTTTCACCTTTGTACCAA 
CTGTAG 
GAGTGGATGGCAACTGTCAAATTATAGGATATG 
CATATCCTATAATTTGACAGTTGCCATCCACTC 
GTAATAGGAACTCAATGCGCTACCCCAGGGC 
GCCCTGGGGTAGCGCATTGAGTTCCTATTAC 
CACGTCATAAAGTCAGATTGTGTGAATGAAGAAGC 
GCTTCTTCATTCACACAATCTGACTTTATGACGTG 
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A2. Buffer Recipes 
Luria-Bertani (LB) media 
• 10 g tryptone, 5 g yeast extract and 5 g NaC1 per litre. 
Minimal (M9) media 
• 6 g Na2HPO4, 3 g KH2PO4 and 0.5 g NaCl. Then autoclave. 
• Filter-sterilise (with filter membrane pore size of 0.2 ILM) and add the follow-
ing: 2 ml MgSO4 (1 M), 10 ILL CaCl2. 
• 1 ml FeSO4 (0.01 M), vitamin and micronutrient mixture. 
• 0.7 g 15NH4C1 
• 2 g 13C6H1206 or 12C6111206 
Protein purification buffers 
• To 20 mM Tris-HC1 (pH 8), 0.5 mM NaC1, add 3 mM for binding buffer, 20 
mM for washing buffer and 250 mM for elution buffer. 
SDS-PAGE gel 
• Gel buffer: dissolve 72.66 g Tris and 0.6 g SDS in 200 ml H2O. Adjust pH to 
8.45 with HC1. 
• Separating gel (12%): 7.2 ml acrylamide solution, 10 ml gel buffer, 6.7 ml 
glycerol (50% w/v), 4.1 ml H2O, 100 pL APS and 25 pL TEMED. 
• Stacking gel (4%): 1 ml acrylamide solution, 4 ml gel buffer, 6.95 ml H2O, 40 
pL APS and 10 pL TEMED. 
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A3. Resonance Assignments for AafA 
Rest N C C, Other 
Ni 120.741 174.663 53.031 (4.729) 39.003 (2.736, *) 
F2 120.323 175.678 58.179 (4.519) 39.213 (3.065, 4.) C,5 1 , 131.900 (7.150); C62, 131.900 (7.150); 
Co, 131.197 (7.319); C e2, • (7.325); 
C3 121.434 171.47 56.314 (4.575) 44.599 (2.768, *) 
D4 120.954 174.529 52.396 (4.792) 44.077 (2.580, *) 
15 113.025 175.275 58.487 (5.132) 41.825 (1.517) C11, 27.035 (1.419, •); C12, 19.414(*); C61, 
15.031(e); 
T6 116.491 174.126 61.137 (4.577) 71.237 (3.898) Cy2, 21.498(*); 
17 126.731 175.335 60.119 (4.874) 40.644 (1.703) C11, 27.217 (1.450, *); C12, 18.535(*); C61, 
14.485(*); 
T8 126.547 173.037 59.138 (4.840) 69.745 (4.050) 
P9 64.800 (4.024) 32.100 (1.817, *) Cy, 27.850 (1.906, *); C5, 51.100 (3.650, *); 
A10 114.407 178.125 52.162 (4.116) 19.41 
T11 118.78 173.858 63.280 (3.925) 69.447 (4.000) C12, 22.010(*); 
N12 125.639 175.469 54.001 (4.762) 38.107 (2.794, *) 
R13 116.575 173.678 54.708 (4.809) 33.182 (1.802, *) C y , 25.039 (1.395, *); C6, 42.369 (3.006, *); 
D14 120.89 176.379 52.622 (5.455) 40.917 (2.458, *) 
V15 119.776 173.276 65.868 (3.367) 32.298 (1.957) Cy1, 22.540(*); C12, 20.957(*); 
N16 119.527 52.531 (5.767) 40.827 (2.538, *) 
V17 118.383 173.276 59.448 (4.450) 35.599 (1.944) C10, 21.750(*); C12, 21.800(*); 
D18 120.027 174.275 53.384 (4.804) 40.495 (2.533, *) 
R19 122.114 175.419 55.190 (4.600) 32.421 (1.826, *) Cy, 24.958 (1.441, •); C6, 42.097 (3.016, *); 
S20 113.02 173.126 57.806 (4.580) 64.596 (3.782, *) 
A21 123.281 176.782 50.643 (4.661) 22.563 
N22 120.485 175.051 53.255 (4.715) 38.779 (2.706, *) 
123 120.581 174.499 59.299 (4.272) 39.823 (1.752) Co., 26.854 (1.340, *); C12, 17.304(*); C61, 
13.154(*); 
D24 128.913 174.753 54.150 (4.991) 41.838 (2.218, *) 
L25 123.662 174.544 53.852 (4.589) 43.554 (1.131, *) Cy, 	26.763 (1.560); 	C41, 	24.132(e); 	C62, 
24.132(*); 
S26 116.813 172.873 57.060 (5.170) 64.580 (3.581, *) 
F27 124.134 175.932 56.130 (4.886) 43.480 (2.512, *) C51, 132.291 (7.050); C62, 132.291 (7.050); 
Co, 130.700 (7.040); Cr2,  130.700 (7.105); 
T28 115.776 172.709 61.836 (5.193) 71.014 (3.819) C12, 22.155(e); 
129 127.93 173.887 61.313 (4.907) 41.258 (1.815) C11, 29.394 (1.428, *); C12,21.138(*); C61 ,  
16.874(e); 
R30 125.168 174.544 54.618 (5.650) 35.496 (1.880, *) Cy, 28.036 (1.664, *); C5, 43.496 (3.293, *); 
Q31 120.385 172.768 52.600 (5.530) 30.800 (1.620, *) Cy, 51.080 (3.690, *); 
P32 178.931 62.806 (4.492) 32.959 (1.667, *) C y , 28.759 (2.112, *); C5, 51.136 (3.442, *); 
Q33 128.711 177.797 60.567 (3.487) 27.362 (1.350, *) C y , 33.477 (1.958, *); 
R34 115.034 178.617 58.552 (4.213) 29.079 (1.766, *) C y , 27.035 (1.599, *); C5, 43.004 (3.163, *); 
C35 119.324 176.096 56.762 (4.403) 39.749 (3.507, *) 
A36 126.333 54.822 (4.573) 18.184 
D37 121.245 176.663 57.209 (4.466) 40.047 (2.689, *) 
A38 120.459 177.364 52.550 (4.463) 18.707 
G39 105.526 174.335 45.444 (3.809, *) 
M40 117.8 176.722 55.888 (4.740) 30.937 (1.756, *) Cy, 33.750 (2.516, *); 
R41 123.495 174.29 53.926 (5.128) 34.720 (1.314, *) Cy, 26.037 (1.358, *); C5, 44.637 (3.029, *); 
142 120.089 173.529 61.650 (4.321) 39.476 (1.947) C11,28.243 (1.657, *); C12, 18.688(*); C51, 
13.970(e); 
K43 129.721 175.23 53.941 (5.827) 36.744 (1.944, *) Cy , 25.650 (1.299, *); C6, 29.660 (1.213, *); 
A44 127.457 176.29 51.464 (5.680) 24.303 
W45 118.013 174.335 58.502 (5.090) 32.735 (3.500, *) Co 1 , 128.460 (7.320); Ce3, 121.900 (7.100); 
Ch2, 124.100 (6.996); Cz2, 114.800 (7.320); 
Cz3, 121.400 (6.600); Nel, 130.229 (10.182); 
G46 110.377 174.231 43.041 (3.459, *) 
E47 113.893 176.394 57.433 (4.410) 32.287 (2.267, *) C y , 38.377 (2.422, *); 
A48 120.527 177.707 51.016 (4.476) 21.468 
N49 118.314 176.976 55.195 (4.427) 37.883 (2.500, *) 
0450 116.081 174.126 55.642 (4.556) 27.512 (3.450, *) C52, 120.260 (7.150); 
G51 105.597 175.26 46.464 (3.898, *) 
Q52 55.940 (4.300) 29.377 (1.941, AO C y , 35.020 (2.526, *); 
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L53 117.719 176.096 55.940 (4.302) 43.600 (1.067, *) Cy, 	26.770 (0.800); 	Cal, 	22.400(e); 	C62, 
25.400(*); 
1.54 125.17 174.738 53.662 (4.952) 48.190 (1.511, *) Cy, 	27.943 	(1.371); 	Cal, 	25.856(*); 	C62, 
25.856(*); 
155 125.725 172.977 58.313 (5.402) 41.723 (1.470) Cy1, 30.660 (1.047, *); Cy2, 16.470(e); C61, 
14.780(*); 
K56 126.51 171.739 52.882 (5.287) 34.899 (1.500, e) Cy, 23.030 (1.307, *); C6, 29.590 (1.244, e); 
Ce, 42.670 (2.756, *); 
P57 176.558 63.179 (3.866) 31.765 (1.641, *) Cy , 28.200 (1.994, e); CA, 50.898 (3.752, *); 
Q58 124.461 177.23 57.881 (3.841) 29.452 (1.392, *) Cy, 33.960 (2.033, *); 
G59 116.702 174.648 45.494 (3.759, e) 
G60 107.864 172.724 44.300 (3.373, *) 
N61 117.884 176.618 52.732 (4.798) 40.197 (2.781, *) 
K62 122.688 178.364 59.522 (3.773) 31.989 (1.751, *) Cy, 24.307 (1.443, *); Ca, 29.582 (1.441, e); 
Ce, 41.950 (3.029, *); 
S63 115.905 174.514 59.941 (4.172) 62.344 (3.907, *) 
A64 124.019 176.275 51.538 (4.481) 19.527 
G65 103.994 172.306 44.077 (3.575, *) 
F66 115.504 175.275 56.389 (4.975) 42.360 (2.556, *) C61, 132.290 (7.157); C62, 132.290 (7.157); 
C11, 131.200 (7.325); CE2, 131.200 (7.325); 
T67 122.773 64.064 (4.291) 68.924 (4.122) C12, 23.325(e); 
L68 124.325 176.812 55.717 (4.229) 40.047 (1.526, *) Cy, 	26.763 (1.414); 	C61, 	26.673(*); 	C62, 
23.341(*); 
A69 123.758 177.051 51.016 (4.503) 22.139 
S70 110.876 57.359 (4.053) 62.507 (3.700, e) 
P71 177.916 62.731 (4.788) 31.839 (1.817, *) Cy, 27.718 (2.074, *); CA, 50.605 (3.688, *); 
R72 122.213 174.275 54.747 (4.594) 34.376 (1.480, e) Cy , 27.079 (1.557, *); C6, 43.492 (3.110, *); 
F73 122.075 174.827 55.979 (5.444) 43.041 (2.846, *) C61, 134.080 (7.157); C62,  134.080 (7.157); 
C15, 131.740 (7.340); C'2, 131.740 (7.340); 
S74 116.939 172.186 56.341 (4.585) 65.764 (3.662, *) 
Y75 119.992 52.900 (4.730) 38.950 (2.730, *) C61, 131.190 (7.150); C62, 131.190 (7.150); 
C11, 118.075 (6.805); CE2, 118.075 (6.805); 
176 120.776 59.336 (4.269) 39.635 (1.743) C11, 26.802 (1.348, *); C-(2, 17.324(e); C61, 
13.126(*); 
P77 175.976 63.403 (4.697) 34.451 (1.835, *) C7, 26.582 (1.890, *); C6 , 51.261 (3.878, *); 
N78 115.705 174.066 53.029 (4.724) 36.764 (2.781, e) 
N79 124.666 171.992 49.748 (4.996) 38.779 (2.625, *) 
P80 62.953 (2.945) 32.864 (1.812, e) Cy , 26.906 (1.947, *); C6, 50.549 (3.498, *); 
A81 120.746 176.528 51.091 (4.282) 21.169 
N82 118.669 174.633 52.900 (4.734) 39.600 (2.745, *) 
183 123 175.484 61.467 (4.166) 37.923 (1.867) C11, 27.761 (1.118, *); 012, 18.100(e); C61 , 
12.660(*); 
M84 125.485 175.2 55.120 (4.617) 29.032 (1.660, *) Cy, 32.207 (2.409, *); 
N85 118.776 174.499 53.404 (4.566) 38.182 (2.399, e) 
G86 107.269 172.41 45.420 (3.398, e) 
F87 112.216 173.097 55.792 (5.082) 39.600 (3.055, .0 C61, 132.840 (6.750); C62,  132.840 (6.750); 
Co., 131.200 (7.120); CE2, 131.200 (7.120); 
Cz, 130.650 (7.195); 
V88 119.845 173.708 61.646 (4.321) 33.979 (2.139) Cy1, 21.500(*); C72, 21.500(.0; 
L89 128.983 177.707 53.180 (5.785) 45.993 (1.416, *) Cy, 	27.580 (1.629); 	C61, 	26.200(e); 	C62, 
24.586(*); 
T90 118.656 174.529 62.499 (4.205) 69.708 (4.566) C12, 25.130(e); 
N91 119.899 173.649 51.464 (4.907) 37.510 (2.358, *) 
P92 176.931 64.373 (4.386) 31.242 (2.355, *) Cy, 28.200 (1.879, e); C6, 51.080 (3.701, *); 
G93 113.776 173.962 45.047 (3.456, *) 
V94 119.766 176.454 63.850 (4.472) 32.436 (2.325) Cy1, 22.136(*); C12, 22.136(*); 
Y95 123.904 172.888 55.642 (5.087) 39.077 (2.422, C61, 133.930 (7.230); C62, 133.930 (7.230); 
C.1,118.075 (6.800); C12, 118.075 (6.800); 
Q96 122.226 172.022 55.734 (5.363) 32.212 (1.613, *) Cy , 34.929 (2.048, *); 
L97 127.917 173.858 52.658 (5.215) 47.061 (1.279, *) Cy, 	27.661 	(1.360); 	C61, 	25.765(*); 	C62, 
24.586(*); 
G98 115.868 172.813 44.026 (3.456, e) 
M99 121.968 173.455 55.344 (4.808) 37.560 (1.533, *) Cy, 31.871 (2.207, *); 
Q100 122.931 175.529 53.180 (5.837) 33.929 (1.796, *) Cy, 34.022 (2.236, *); 
G101 109.542 171.888 45.047 (3.535, e) 
S102 115.328 174.037 58.545 (5.691) 65.135 (3.250, e) 
1103 123.776 177.215 61.239 (4.089) 39.152 (1.891) C11,27.761 (0.707, *); C12, 17.962(.0; C61, 
14.605(e); 
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T104 121.847 175.827 59.896 (5.149) 67.880 (4.607) C7 2, 22.227(*); 
A106 
1107 59.426 (3.819) 26.854 (1.194) C.1, 37.500 (1.505, *); C72, 16.692(*); C61, 
13.063(*); 
P108 57.123 34.94 
L109 54.708 (4.101) 42.097 (1.007, *) Cy , 	26.337 (1.174); 	C61, 	24.949(*); 	C62, 
21.900(*); 
P111 64.300 (4.180) 31.700 (1.860, 4.) C7 , 28.500 (1.789, *); C6, 50.150 (3.559, *); 
G112 112.8 171 44.400 (3.874, *) 
L113 119.36 177.036 54.979 (5.181) 44.177 (1.276, *) C7 , 	28.224 	(1.693); 	C61, 	25.312(.0; 	C62, 
25.312(*); 
Y114 123.146 174.288 56.790 (5.095) 42.266 (2.845, *) Co1 , 132.837 (6.840); C62 , 132.837 (6.840); 
Co., 118.622 (7.130); CE2, 118.622 (7.130); 
E115 117.746 175.141 54.127 (5.700) 34.591 (1.899, *) Cy , 36.018 (2.000, *); 
V116 120.341 174.489 61.686 (4.777) 35.012 (2.095) C71, 20.773(*); C72, 22.317(*); 
V117 127.394 174.231 61.686 (4.684) 34.376 (1.751) C71, 21.319(*); C72, 21.319(*); 
L118 127.35 173.246 53.255 (4.338) 45.817 (1.220, *) C7 , 	26.763 	(0.535); 	C61, 	23.769(*); 	C,52, 
24.369(*); 
N119 123.09 173.186 51.258 (4.984) 41.316 (0.485, *) 
A120 119.101 174.708 51.538 (5.362) 23.93 
E121 117.053 173.693 54.282 (4.992) 34.838 (2.126, *) C7 , 35.501 (2.269, *); 
L122 121.551 176.648 53.552 (5.203) 44.204 (1.425, *) Cy , 	27.217 (1.420); 	C61, 	25.493(*); 	C62, 
23.860(.0; 
V123 120.484 175.723 59.821 (4.828) 34.824 (2.056) Cy1, 21.955(e); C72, 20.321(*); 
T124 114.114 174.66 60.493 (4.694) 70.566 (4.436) C72, 21.682(*); 
N125 118.879 174.977 54.075 (4.700) 38.928 (2.869, *) 
D126 118.526 175.812 53.702 (4.625) 41.241 (2.693, *) 
N127 119.516 53.892 (4.514) 38.256 (2.732, *) 
K128 119.363 177.053 56.790 (4.260) 32.586 (1.813, *) C,, 25.221 (1.409, *); C6, 28.941 (1.683, *); 
Ce, 41.915 (2.996, *); 
Q129 
N130 118.998 175.275 53.553 (4.708) 38.779 (2.729, *) 
A131 123.813 177.916 53.105 (4.407) 19.677 
T132 111.066 174.126 61.761 (4.323) 69.670 (4.355) C72, 22.045(*); 
A133 126.808 176.931 52.732 (4.475) 20.124 
V134 119.263 174.783 61.241 (4.303) 33.854 (2.139) C71, 21.319(*); C72, 21.319(*); 
A135 128.584 177.23 52.658 (4.799) 20.199 
K136 121.352 174.812 55.169 (4.730) 37.269 (1.562, *) C7 , 25.947 (1.518, *); C6, 29.467 (1.654, *); 
Ce, 42.580 (3.222, *); 
T137 114.248 173.514 60.493 (5.142) 72.058 (3.770) C72, 21.864(*); 
A138 127.21 174.947 51.165 (4.840) 23.631 
T139 115.3 174.201 61.537 (5.374) 71.834 (3.911) C72, 22.327(*); 
S140 122.989 173.514 58.502 (4.894) 64.944 (3.596, *) 
T141 121.609 173.843 62.209 (5.114) 69.969 (3.892) C7 2, 21.501(*); 
1142 130.255 174.633 57.806 (4.940) 39.823 (1.811) C71, 27.852 (1.209, *); C7 2, 18.707(*); C31 ,  
12.330(c); 
T143 126.29 172.917 62.731 (4.780) 69.223 (4.359) C72, 20.775(*); 
V144 129.503 175.752 60.716 (4.969) 31.258 (2.448) C71, 23.043(*); C72, 21.750(*); 
V145 130.701 179.453 62.669 (4.210) 34.031 (2.088) C71, 21.800(*); C72, 19.705(*); 
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